
<html lang="en"     class="pb-page"  data-request-id="a25098f8-af76-41ae-a85e-17442a99e65e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2015.58.issue-9;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b00197;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94" /></meta><meta name="dc.Creator" content="Hardik J.  Patel" /></meta><meta name="dc.Creator" content="Pallav D.  Patel" /></meta><meta name="dc.Creator" content="Stefan O.  Ochiana" /></meta><meta name="dc.Creator" content="Pengrong  Yan" /></meta><meta name="dc.Creator" content="Weilin  Sun" /></meta><meta name="dc.Creator" content="Maulik R.  Patel" /></meta><meta name="dc.Creator" content="Smit K.  Shah" /></meta><meta name="dc.Creator" content="Elisa  Tramentozzi" /></meta><meta name="dc.Creator" content="James  Brooks" /></meta><meta name="dc.Creator" content="Alexander  Bolaender" /></meta><meta name="dc.Creator" content="Liza  Shrestha" /></meta><meta name="dc.Creator" content="Ralph  Stephani" /></meta><meta name="dc.Creator" content="Paola  Finotti" /></meta><meta name="dc.Creator" content="Cynthia  Leifer" /></meta><meta name="dc.Creator" content="Zihai  Li" /></meta><meta name="dc.Creator" content="Daniel T.  Gewirth" /></meta><meta name="dc.Creator" content="Tony  Taldone" /></meta><meta name="dc.Creator" content="Gabriela  Chiosis" /></meta><meta name="dc.Description" content="Grp94 is involved in the regulation of a restricted number of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflamma..." /></meta><meta name="Description" content="Grp94 is involved in the regulation of a restricted number of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflamma..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 22, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00197" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00197" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00197" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00197" /></link>
        
    
    

<title>Structure–Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00197" /></meta><meta property="og:title" content="Structure–Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0014.jpeg" /></meta><meta property="og:description" content="Grp94 is involved in the regulation of a restricted number of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflammatory conditions, diabetes, coronary thrombosis, and stroke. We have recently identified a novel allosteric pocket located in the Grp94 N-terminal binding site that can be used to design ligands with a 2-log selectivity over the other Hsp90 paralogs. Here we perform extensive SAR investigations in this ligand series and rationalize the affinity and paralog selectivity of choice derivatives by molecular modeling. We then use this to design 18c, a derivative with good potency for Grp94 (IC50 = 0.22 μM) and selectivity over other paralogs (&gt;100- and 33-fold for Hsp90α/β and Trap-1, respectively). The paralog selectivity and target-mediated activity of 18c was confirmed in cells through several functional readouts. Compound 18c was also inert when tested against a large panel of kinases. We show that 18c has biological activity in several cellular models of inflammation and cancer and also present here for the first time the in vivo profile of a Grp94 inhibitor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00197"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00197">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00197&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00197&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00197&amp;href=/doi/10.1021/acs.jmedchem.5b00197" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3922-3943</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00188" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00208" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hardik+J.++Patel">Hardik J. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pallav+D.++Patel">Pallav D. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan+O.++Ochiana">Stefan O. Ochiana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pengrong++Yan">Pengrong Yan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weilin++Sun">Weilin Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maulik+R.++Patel">Maulik R. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Smit+K.++Shah">Smit K. Shah</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisa++Tramentozzi">Elisa Tramentozzi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Brooks">James Brooks</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Bolaender">Alexander Bolaender</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liza++Shrestha">Liza Shrestha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralph++Stephani">Ralph Stephani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Finotti">Paola Finotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cynthia++Leifer">Cynthia Leifer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zihai++Li">Zihai Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+T.++Gewirth">Daniel T. Gewirth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tony++Taldone">Tony Taldone</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriela++Chiosis">Gabriela Chiosis</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, New York, New York 10021, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John’s University, Jamaica, New York 11439, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology and Anesthesiology, University of Padua, Largo E. Meneghetti 2, 35131, Padua, Italy</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Microbiology and Immunology, Cornell University, Ithaca, New York 14850, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Hauptman-Woodward Medical Research Institute, Buffalo, New York 14203, United States</span></div><div class="corresp-info"><strong>*</strong>T.T.: phone, 646-888-3180. e-mail, <a href="/cdn-cgi/l/email-protection#d8acb9b4bcb7b6bdac98b5abb3bbbbf6b7aabf"><span class="__cf_email__" data-cfemail="ea9e8b868e85848f9eaa8799818989c485988d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>G.C.: phone: 646-888-2235. e-mail: <a href="/cdn-cgi/l/email-protection#bad9d2d3d5c9d3c9ddfad7c9d1d9d994d5c8dd"><span class="__cf_email__" data-cfemail="f5969d9c9a869c8692b598869e9696db9a8792">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00197&amp;href=/doi/10.1021%2Facs.jmedchem.5b00197" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3922–3943</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 22, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 February 2015</li><li><span class="item_label"><b>Published</b> online</span>22 April 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 May 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00197" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00197</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3922%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHardik%2BJ.%2BPatel%252C%2BPallav%2BD.%2BPatel%252C%2BStefan%2BO.%2BOchiana%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D9%26contentID%3Dacs.jmedchem.5b00197%26title%3DStructure%25E2%2580%2593Activity%2BRelationship%2Bin%2Ba%2BPurine-Scaffold%2BCompound%2BSeries%2Bwith%2BSelectivity%2Bfor%2Bthe%2BEndoplasmic%2BReticulum%2BHsp90%2BParalog%2BGrp94%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3943%26publicationDate%3DMay%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00197"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2206</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00197" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hardik&quot;,&quot;last_name&quot;:&quot;J. Patel&quot;},{&quot;first_name&quot;:&quot;Pallav&quot;,&quot;last_name&quot;:&quot;D. Patel&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;O. Ochiana&quot;},{&quot;first_name&quot;:&quot;Pengrong&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Weilin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Maulik&quot;,&quot;last_name&quot;:&quot;R. Patel&quot;},{&quot;first_name&quot;:&quot;Smit&quot;,&quot;last_name&quot;:&quot;K. Shah&quot;},{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;Tramentozzi&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Brooks&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Bolaender&quot;},{&quot;first_name&quot;:&quot;Liza&quot;,&quot;last_name&quot;:&quot;Shrestha&quot;},{&quot;first_name&quot;:&quot;Ralph&quot;,&quot;last_name&quot;:&quot;Stephani&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Finotti&quot;},{&quot;first_name&quot;:&quot;Cynthia&quot;,&quot;last_name&quot;:&quot;Leifer&quot;},{&quot;first_name&quot;:&quot;Zihai&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;T. Gewirth&quot;},{&quot;first_name&quot;:&quot;Tony&quot;,&quot;last_name&quot;:&quot;Taldone&quot;},{&quot;first_name&quot;:&quot;Gabriela&quot;,&quot;last_name&quot;:&quot;Chiosis&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;3922-3943&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00197&quot;},&quot;abstract&quot;:&quot;Grp94 is involved in the regulation of a restricted number of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflammatory conditions, diabetes, coronary thrombosis, and stroke. We have recently identified a novel allosteric pocket located in the Grp94 N-terminal binding site that can be used to design ligands with a 2-log selectivity over the other Hsp90 paralogs. Here we perform extensive SAR investigations in this ligand series and rationalize the affinity and paralog selectivity of choice derivatives by molecular modeling. We then use this to design 18c, a derivative with good potency for Grp94 (IC50 = 0.22 μM) and selectivity over other paralogs (&gt;100- and 33-fold for Hsp90α/β and Trap-1, respectively). The paralog selectivity and target-mediated activity of 18c was confirmed in cells through several functional readouts. Compound 18c was also inert when tested against a large panel of kinases. We show that 18c has biological a&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00197&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00197" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00197&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00197" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00197&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00197" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00197&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00197&amp;href=/doi/10.1021/acs.jmedchem.5b00197" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00197" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00197" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00197%26sid%3Dliteratum%253Aachs%26pmid%3D25901531%26genre%3Darticle%26aulast%3DPatel%26date%3D2015%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2Bin%2Ba%2BPurine-Scaffold%2BCompound%2BSeries%2Bwith%2BSelectivity%2Bfor%2Bthe%2BEndoplasmic%2BReticulum%2BHsp90%2BParalog%2BGrp94%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D9%26spage%3D3922%26epage%3D3943%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/jmcmar.2015.58.issue-9/20150514/jmcmar.2015.58.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Grp94 is involved in the regulation of a restricted number of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflammatory conditions, diabetes, coronary thrombosis, and stroke. We have recently identified a novel allosteric pocket located in the Grp94 N-terminal binding site that can be used to design ligands with a 2-log selectivity over the other Hsp90 paralogs. Here we perform extensive SAR investigations in this ligand series and rationalize the affinity and paralog selectivity of choice derivatives by molecular modeling. We then use this to design <b>18c</b>, a derivative with good potency for Grp94 (IC<sub>50</sub> = 0.22 μM) and selectivity over other paralogs (>100- and 33-fold for Hsp90α/β and Trap-1, respectively). The paralog selectivity and target-mediated activity of <b>18c</b> was confirmed in cells through several functional readouts. Compound <b>18c</b> was also inert when tested against a large panel of kinases. We show that <b>18c</b> has biological activity in several cellular models of inflammation and cancer and also present here for the first time the in vivo profile of a Grp94 inhibitor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glucose-regulated protein 94 (Grp94),<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> also known as gp96, ERp99, and endoplasmin, is the endoplasmic reticulum (ER) paralog of the Hsp90 family of molecular chaperones. In addition to Grp94, the members of this family include the cytosolic Hsp90α, Hsp90β, and the mitochondrial tumor necrosis factor receptor-associated protein-1 (Trap-1). While highly homologous, with over 50% sequence identity in their N-terminal regulatory domains and analogous ligand binding cavities, it is now recognized that each paralog has a unique biochemical role and is responsible for chaperoning a distinct set of client proteins.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a></div><div class="NLM_p">Sustained medical interest in cytoplasmic Hsp90 has come from the discovery that these chaperones play important roles in maintaining the functional conformation of a large number of malignancy- and neurodegeneration-driving proteins, such as kinases, transcription factors, and antiapoptotic proteins.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In addition, Trap-1 along with Hsp90 maintains mitochondrial integrity by protecting against oxidative stress and apoptosis.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Grp94 has recently also emerged as an attractive target in cancer. Clinically, Grp94 expression correlates with advanced stage and poor survival in a variety of cancers and is closely linked to cancer growth and metastasis in melanoma, breast cancer, ovarian cancer, multiple myeloma, lung cancer, and inflammation-associated colon cancer.<a onclick="showRef(event, 'ref2 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref7 ref8">(2, 7, 8)</a> It also is linked to tumor resistance, where Grp94 expression in tumors decreases sensitivity to X-rays and its suppression sensitizes cells to chemotherapy.<a onclick="showRef(event, 'ref2 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref7">(2, 7)</a> While the exact role for Grp94 in cancer remains elusive, its function as an essential chaperone for TLRs, integrins, GARP, and Wnt coreceptor LRP5/6 is suggestive of a potential link between Grp94 and aberrant signaling via these receptors. Evidence also points to Grp94’s involvement at the ER level in regulating a number of tyrosine kinases, such as EGFR and HER2, and in regulating the secretion of IGF-I and IGF-II.<a onclick="showRef(event, 'ref2 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref7 ref8">(2, 7, 8)</a> Finally, the recent discovery that tumor-specific translocation of Grp94 to the plasma membrane regulates the altered expression and function of membrane-associated cancer proteins, such as HER2, and its role in sustaining the transforming ability of these proteins point to a third avenue for Grp94’s involvement in cancer.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a></div><div class="NLM_p">Because Grp94 is involved in the regulation of a restricted number of proteins involved in channeling immune and inflammatory signals, it has been proposed that, in addition to cancer, numerous other diseases, including septic shock, autoimmune diseases, chronic inflammatory conditions, diabetes, coronary thrombosis, and stroke, would benefit from targeting Grp94 with small-molecule inhibitors.<a onclick="showRef(event, 'ref2 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref7 ref8">(2, 7, 8)</a> Most important from a therapeutic perspective, the chaperoning activity of Grp94 is ATPase-dependent and uncoupled from its ability to bind peptides, a role of Grp94 linked to the immunogenic activity of Grp94/peptide complexes. Together, these findings highlight a potential therapeutic role for small molecules that bind selectively to Grp94 and inhibit its chaperoning function.</div><div class="NLM_p">The rational development of selective Grp94 inhibitors has been challenging due to a high degree of sequence conservation in the ATP binding pockets of the four Hsp90 paralogs (Figure S1, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). Nevertheless, screening identified 5′-<i>N</i>-ethylcarboxamidoadenosine (NECA, <b>1</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a) as a high-affinity ligand with selectivity for Grp94.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> NECA has sub-micromolar (<i>K</i><sub>d</sub> = 200 nM) binding affinity for Grp94, while having no affinity for cytoplasmic Hsp90s.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> This serendipitous discovery was initially puzzling given the fact that the amino acids surrounding the adenine binding cavity in Grp94 and Hsp90 are almost entirely conserved. However, further examination revealed that Grp94 adopts a distinct conformation due to a 5-amino acid (QEDGQ) insertion in its helix 1,4,5-subdomain. This conformation exposes a cavity adjacent to the adenine binding pocket that accommodates the 5′-<i>N</i>-ethylcarboxamido moiety of NECA (depicted as site 3 in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a). In yeast Hsp90, the analogous cavity is blocked by the backbone carbonyl oxygen of Gly121, which suggests that this is the origin of NECA binding selectivity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> This cavity is not utilized by bound nucleotides, as modeling shows that both α- and β-phosphates of ADP experience severe steric clashes with the carbonyl oxygen of Gly196 in Grp94. Instead, binding of nucleotides induces large conformational changes in helices 1,4,5 in Grp94 that enlarge the ATP binding cavity and allow for nucleotide binding.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Unfortunately, attempts to develop more potent analogs of NECA have been unsuccessful.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> While NECA has served an important role in substantiating the feasibility of developing Grp94-selective inhibitors, its use as a probe to investigate Grp94 function suffers from its potent agonist activity against several cellular adenosine receptors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. A schematic depiction of (a) <b>1</b>, (b) <b>2</b> and <b>3</b>, and the amino acids present in site 3 of Grp94 (adapted from refs <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>, <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>, and<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>); (c) <b>4</b> and the amino acids present in the allosteric site 2 of Grp94 (adapted from ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a>); and (d) <b>5</b> (pan-Hsp90 inhibitor) and the amino acids found in site 1 of Grp94. The conserved adenine binding pocket is shown in orange. The adenine moiety is shown in blue, the quinone in green, and the resorcinol core in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Radamide (RDA, <b>2</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b) is a chimeric molecule composed of elements from both geldanamycin and radicicol and is the second ligand reported to bind into the small binding pocket unique to Grp94 (site 3, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b).<a onclick="showRef(event, 'ref14 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref16">(14, 16)</a> X-ray crystal structures of RDA bound to the N-terminal domain of either canine Grp94 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD">2GFD</a>) or yeast Hsp90 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS">2FXS</a>) reveal that it adopts distinct poses when bound to either of the two paralogs. While the resorcinol moiety binds similarly into the adenine binding cavity of each paralog, the quinone ring is oriented differently. In Grp94, the quinone ring is capable of binding in two distinct poses, one of which orients the quinone ring into the same binding pocket that accommodates the 5′-<i>N</i>-ethylcarboxamido moiety of NECA that is unique to Grp94 (site 3, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a,b) and another that orients it toward the solvent. In Hsp90, the quinone ring is blocked from binding into the analogous site 3 pocket by Lys98 and instead adopts the solvent-oriented pose. Though RDA interacts with the two paralogs in a very distinct manner and is capable of binding into the unique pocket of Grp94, it is not very selective for Grp94 (<i>K</i><sub>d</sub> = 0.52 μM) over Hsp90 (<i>K</i><sub>d</sub> = 0.87 μM).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Since the quinone moiety of RDA is joined to the resorcinol via an amide linkage, upon binding to Grp94 it can adopt either the <i>cis</i>-amide conformation to bind into the hydrophobic pocket unique to Grp94 or the <i>trans</i>-amide conformation to orient toward the outside of the pocket, similar to that adopted when bound to Hsp90. Realizing that this conformational flexibility was the likely cause for the lack of selectivity of RDA, Duerfeldt  et al.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> rationalized that compounds of greater selectivity for Grp94 might be obtained by restricting the orientation of RDA to the cis-conformation. Furthermore, observing that the pocket was lined by Phe199, Tyr200, and Trp223 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b) made them seek to enhance its hydrophobicity and potential for π–π interactions. Utilizing imidazole as a cis-bioisostere to direct a more hydrophobic benzyl moiety into the pocket provided among others compound BnIm (<b>3</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b). While BnIm was shown to have an IC<sub>50</sub> = 1.15 μM for Grp94 in a fluorescent polarization (FP) competitive binding assay using FITC-GM as a probe,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> similar competition experiments for each of the other isoforms were not performed.</div><div class="NLM_p last">Recently, we have reported the discovery of a novel, therapeutically viable allosteric pocket in Grp94 (i.e., site 2, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>c) whose occupancy led to the inhibition of Grp94’s chaperoning activity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The newly discovered site 2, which is composed of an almost completely hydrophobic cleft lined by Leu104, Leu163, Phe199, Ala202, Phe203, Val211, Ile247, and Leu249, is distinct from the pocket previously reported for <b>1</b> (i.e., site 3, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and the resorcinolic <i>N</i>-benzylimidazole <b>3</b> (i.e., site 3, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition to its distinct spatial orientation, site 2 is significantly more hydrophobic compared to site 1. Small-molecule purine-based ligands that utilize this novel pocket exhibited greater than 100-fold preference for Grp94 over Hsp90α/β and a 10–100-fold preference over Trap-1.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The crystal structure of Grp94 in complex with the selective ligand <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>c) showed that while the purine moiety of <b>4</b> occupied the site filled by the adenine ring of ATP and of the pan-Hsp90 inhibitor <b>5</b> (PU-H71; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>d), the 8-aryl group of Grp94-selective compounds inserted into site 2 when bound to Grp94 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>c).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Selectivity for Grp94 over Hsp90 is achieved because the analogous site 2 is blocked in Hsp90. Not all ligands of this purine-scaffold class can access the site 2 pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a–c). Those ligands that can access site 2 must be capable of adopting a “backward bent” conformation, whereas other ligands such as <b>5</b> adopt a “forward bent” conformation and bind to site 1 with no particular selectivity for the paralogs.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Ligand Design, Computational Analyses of Grp94–Ligand Interaction, and Biochemical Testing</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While our earlier work provided the rationale for the observed paralog selectivity, the detailed SAR of these purine-based inhibitors has not been described. Here, we discuss the design and synthesis of purine-based ligands that preferentially bind to site 2, which is unique to Grp94. Specifically, we report a tractable SAR of purine-based ligands that bind selectively and with varied degrees of affinity to the novel allosteric site 2 found only in Grp94. We focused our synthetic efforts on the exploration of various substituents on the C8-aryl ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d, substituents 2′–5′), the linker between the purine and the aryl moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d, L), as well as at the <i>N</i>9/<i>N</i>3 position of the adenine core. We also explore the possibility of exchanging the <i>N</i>3 with a carbon atom, a modification claimed to improve affinity for Hsp90 in the pan-Hsp90 inhibitor series.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> The design of these ligands is based on the resolved crystal structure of PU-H54 (<b>4</b>) with Grp94 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b) and on the determined volume available for ligand binding inside site 2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). The affinities of the synthesized compounds were determined using competitive binding assays to recombinant Grp94 protein.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> To determine the selectivity profile of our compounds, we also tested them for binding against purified Hsp90α/β and Trap-1, using a published assay protocol.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Further, to rationalize the affinity trends noted for these molecules and understand how the nature and size of substituents affect Grp94 binding, we used the reported X-ray crystal structures of PU-H54 (<b>4</b>) bound to the N-domain of Grp94 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> to dock compounds into the allosteric binding site (site 2).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Schematic depiction of the pose adapted by ligands when accessing the two binding sites, site 2 being specific to Grp94 and site 1 being common to Grp94 and Hsp90. (b) Pose adapted by <b>4</b> when bound to Grp94 showing the hydrophobic stabilization of the 8-aryl group with the hydrophobic residues of site 2 and the pose adapted by <b>5</b> when bound to Hsp90. (c) Surface area of the Grp94-selective ligands reported in ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> (left) and of the pan-Hsp90 ligand <b>5</b> (right) (surface area was generated with Macromodel/Molecular Surface). (d) Proposed modification sites on the purine scaffold performed to understand the structure–activity relationship in this series (as shown in blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">8-Arylsulfanyl derivatives containing the <i>N</i>9-pent-4-yne chain were synthesized by utilizing a copper-catalyzed cross-coupling method previously described by us to generate key intermediates <b>8a</b>–<b>r,t</b>–<b>w</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Briefly, 8-mercaptoadenine (<b>6</b>) was reacted with various aryl iodides (<b>7</b>) using CuI/neocuproine as catalyst and NaO<i>t</i>-Bu (or Na<sub>3</sub>PO<sub>4</sub> or K<sub>2</sub>CO<sub>3</sub>) as base in anhydrous DMF at 110 °C to generate 8-arylsulfanyl adenine intermediates (<b>8a</b>–<b>r,t</b>–<b>w</b>). Alkylation of <b>8a</b>–<b>r,t</b>–<b>w</b> with pent-4-yn-1-yl 4-methylbenzenesulfonate in the presence of Cs<sub>2</sub>CO<sub>3</sub> yielded a mixture of <i>N</i>9-isomers (<b>9a</b>–<b>r,t</b>–<b>w</b>) and <i>N</i>3-isomers (<b>1</b> and <b>9a′</b>–<b>d′,g′,j′</b>–<b>n′,q′,v′</b>–<b>w′</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> in roughly 2:1 ratio, which were separated by preparative TLC. The synthesis of <b>9s</b> was carried out through a route that was previously described<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> from the reaction of 8-bromo-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> with 5-mercaptoisophthalonitrile<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> in the presence of <i>t</i>-BuOK in DMF at 130 °C.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0015.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) neocuproine, CuI, NaO<i>t</i>-Bu or Na<sub>3</sub>PO<sub>4</sub> or K<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (b) pent-4-yn-1-yl 4-methylbenzenesulfonate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (c) Cl(CH<sub>2</sub>)<sub><i>n</i></sub>CCH or Cl(CH<sub>2</sub>)<sub><i>n</i></sub>CN or Br(CH<sub>2</sub>)<sub><i>n</i></sub>CF<sub>3</sub> or Br(CH<sub>2</sub>)<sub><i>n</i></sub>C<sub>6</sub>H<sub>5</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt or 80 °C; (d) pent-4-yn-2-yl 4-methylbenzenesulfonate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (e) ROH, PPh<sub>3</sub>, DBAD, CH<sub>2</sub>Cl<sub>2</sub>, toluene, rt.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>13a</b>–<b>s</b> was carried out by alkylation of intermediate <b>8g</b> or <b>8n</b> with the appropriate alkyl alcohols under Mitsunobu conditions or alkyl halides or tosylates in the presence of Cs<sub>2</sub>CO<sub>3</sub> to yield the desired <i>N</i>9-isomers after chromatographic separation (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><div class="NLM_p">The synthesis of analogs of <b>9g</b> with varying linker groups is shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Treatment of <b>9g</b> with 2 equiv of <i>m</i>-CPBA at rt yielded a mixture of sulfoxide <b>14a</b> and sulfone <b>14b</b>, in which each were readily isolated in 23% and 34% yield, respectively. The O-linked derivative <b>14c</b> was obtained from reaction of 8-bromo-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> with 2,4-dichlorophenol and KO<i>t</i>-Bu in 51% yield. Microwave-assisted cyclocondensation of 4,5,6-triaminopyrimidine (<b>15</b>) with 2,4-dichlorophenylacetic acid (<b>16</b>) yielded 8-benzyladenine <b>17</b> in 79% yield.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Heating a mixture of <b>17</b> with 1-chloropent-4-yne and 1.2 equiv of Cs<sub>2</sub>CO<sub>3</sub> at 80 °C yielded <b>14d</b>, which could be converted to carbonyl derivative <b>14e</b> in 50% yield by heating at 80 °C with additional Cs<sub>2</sub>CO<sub>3</sub>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0016.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>m</i>-CPBA, 30 min, rt; (b) P(OPh)<sub>3</sub>, pyridine, microwave 220 °C, 30 min; (c) 5-chloropent-1-yne, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (d) 2 equiv of Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C.</p></p></figure><div class="NLM_p">Compounds having an ionizable 3-isopropylamino-propyl chain were synthesized by alkylation of 8-arylsulfanyl adenine intermediates <b>8g,i,n</b> with 3-(<i>tert</i>-butoxycarbonyl-isopropyl-amino)propyl tosylate in the presence of Cs<sub>2</sub>CO<sub>3</sub>, resulting in Boc-protected <i>N</i>9- and <i>N</i>3-regioisomers after separation.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Boc-deprotection of the <i>N</i>9- and <i>N</i>3<i>-</i>regioisomers in the presence of TFA yielded desired derivatives <b>18a,c</b> and <b>18b′,c′</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), respectively. Related imidazopyridines <b>18d</b>–<b>f</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) were prepared using modifications to a synthetic route described earlier.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> PMB-protected intermediates <b>20d</b>–<b>f</b> were obtained from CuI/neocuproine-catalyzed coupling of <b>19</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> with various aryl iodides (<b>7</b>), which were then deprotected with TFA to yield <b>21d</b>–<b>f</b>. Alkylation of <b>21d</b>–<b>f</b> with 1,3-dibromopropane in the presence of Cs<sub>2</sub>CO<sub>3</sub> followed by reaction with isopropylamine yielded imidazopyridines <b>18d</b>–<b>f</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0017.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-(<i>tert</i>-butoxycarbonyl-isopropyl-amino)propyl tosylate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (b) TFA, 0 °C; (c) ArI (<b>7</b>), neocuproine, CuI, NaO<i>t</i>-Bu or Na<sub>3</sub>PO<sub>4</sub> or K<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (d) TFA, 80 °C, 3 h; (e) 1,3-dibromopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 1.5–3h; (f) isopropylamine, DMF, rt.</p></p></figure></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Structure–Activity Relationship in the Grp94 Inhibitor Series</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Modifications on the 8-Aryl Ring</h3><div class="NLM_p">We began our SAR exploration by focusing first on substitutions on the 8-aryl ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d, substituents 2′–5′) given that this region of the molecule can potentially occupy the hydrophobic site 2. Thus, with an interest in better understanding the polarity and volume of this pocket, a varied set of compounds was synthesized having substitutions on the 8-aryl ring focused primarily on the 2′-, 4′-, 2′,4′-, 2′,5′-, and 3′,5′-positions, though other substitutions were also explored (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). A deleterious effect on activity was observed for more polar functionalities, as evidenced by compounds <b>9c</b> and <b>9r</b>, which further confirmed the hydrophobic profile of the pocket. Interestingly, our SAR shows that the chlorine functionality is generally the preferred substituent in any combination as compared to other substituents explored, such as −OCH<sub>3</sub>, −OCF<sub>3</sub>, −CF<sub>3</sub>, −CN, or −CH<sub>3</sub> (e.g., see <b>9a</b> vs <b>9b</b> and <b>9d</b>, or <b>9g</b> vs <b>9i</b>, or <b>9n</b> vs <b>9q</b> and <b>9s</b>), the only exception being bromine, which we find to be tolerable (see <b>9g</b> vs <b>9h</b>, or <b>9n</b> vs <b>9o</b> or <b>9p</b>). Although subtle electronic effects could play a role, we surmise that the size and lipophilicity of the chlorine atom are ideal to satisfy binding into the hydrophobic pocket site 2. In order to obtain a better understanding of this preference, as well as to provide further insight toward the design of more potent ligands, we next pursued docking studies.</div><div class="NLM_table-wrap" id="tbl1">Table 1<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">Hsp90α</th><th class="colsep0 rowsep0" align="center">Hsp90β</th><th class="colsep0 rowsep0" align="center">Grp94</th><th class="colsep0 rowsep0" align="center">Trap-1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">2′-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.35 ± 0.05</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">2′-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">6.2 ± 2.5</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">2′-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">29.4 ± 9.1</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">2′-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">4′-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">1.13 ± 0.2</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">4′-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">2′,4′-di-Cl</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">0.12 ± 0.04</td><td class="colsep0 rowsep0" align="left">145.4 ± 13.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">2′-Cl,4′-Br</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9i</b></td><td class="colsep0 rowsep0" align="left">2′,4′-di-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">1.63 ± 0.47</td><td class="colsep0 rowsep0" align="left">13.8 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9j</b></td><td class="colsep0 rowsep0" align="left">2′,4′-di-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">34.5 ± 3.5</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9k</b></td><td class="colsep0 rowsep0" align="left">2′,5′-di-Cl</td><td class="colsep0 rowsep0" align="left">60.4 ± 1.6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.53 ± 0.10</td><td class="colsep0 rowsep0" align="left">5.1 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9l</b></td><td class="colsep0 rowsep0" align="left">2′,5′-di-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">1.14 ± 0.14</td><td class="colsep0 rowsep0" align="left">203.7 ± 11.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9m</b></td><td class="colsep0 rowsep0" align="left">2′-Cl,5′-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9n</b></td><td class="colsep0 rowsep0" align="left">3′,5′-di-Cl</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">0.26 ± 0.01</td><td class="colsep0 rowsep0" align="left">83.6 ± 11.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9o</b></td><td class="colsep0 rowsep0" align="left">3′-Cl,5′-Br</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9p</b></td><td class="colsep0 rowsep0" align="left">3′,5′-di-Br</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9q</b></td><td class="colsep0 rowsep0" align="left">3′,5′-di-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">11.45 ± 0.92</td><td class="colsep0 rowsep0" align="left">157.9 ± 9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9r</b></td><td class="colsep0 rowsep0" align="left">2′,6′-di-Cl-pyridine</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9s</b></td><td class="colsep0 rowsep0" align="left">3′,5′-di-CN</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">7.73</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9t</b></td><td class="colsep0 rowsep0" align="left">3′,4′-di-Cl</td><td class="colsep0 rowsep0" align="left">1.96</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.695</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9u</b></td><td class="colsep0 rowsep0" align="left">2′,3′,4′-tri-Cl</td><td class="colsep0 rowsep0" align="left">15.97</td><td class="colsep0 rowsep0" align="left">39.47</td><td class="colsep0 rowsep0" align="left">0.430</td><td class="colsep0 rowsep0" align="left">3.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9v</b></td><td class="colsep0 rowsep0" align="left">2′,4′,5′-tri-Cl</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">0.17 ± 0.11</td><td class="colsep0 rowsep0" align="left">78.4 ± 8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9w</b></td><td class="colsep0 rowsep0" align="left">2′,4′,6′-tri-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.56</td><td class="colsep0 rowsep0" align="left">65.5 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.043 ± 0.006</td><td class="colsep0 rowsep0" align="left">0.042 ± 0.003</td><td class="colsep0 rowsep0" align="left">0.026 ± 0.004</td><td class="colsep0 rowsep0" align="left">0.205 ± 0.006</td></tr></tbody></table></div></div><div class="NLM_p">Indeed, in our docking analysis, chlorine at 2′-position is oriented nicely to form hydrophobic interactions with Leu163, Ile247, and Val211 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a,b), which explains the higher binding affinity of <b>9a</b> for Grp94 over other substituents (i.e., <b>9b</b>–<b>d</b>). More polar substituents, as in <b>9b</b> (OCH<sub>3</sub>), <b>9c</b> (CH<sub>2</sub>OH), and <b>9d</b> (OCF<sub>3</sub>), are less favorably oriented toward these hydrophobic residues and may account for the decrease in binding affinity. At the para-position, binding affinity appears to be less affected by substituent changes, as both −OCH<sub>3</sub> (<b>9e</b>) and −Cl (<b>9f</b>) at this position result in compounds with similar affinity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Our findings suggest that while select purine analogs are indeed able to adopt the “backward bent” conformation and bind into site 2, the space available in the pocket is somewhat restricted at 2′-position, where smaller substituents are preferred, as evidenced by the drastic reduction in affinity observed for larger substituents. Our analysis of the effects of di- and trisubstitution on Grp94 affinity and selectivity further validated chlorine as the best substituent choice for the 8-aryl moiety. Briefly, dichloro substitutions at 2′,4′-, 2′,5′-, and 3′,5′-positions on the 8-phenyl ring retained high affinity and selectivity but also indicated that 2′,4′-substitution (i.e., <b>9g</b>) is preferred for higher affinity, followed by 3′,5′ (<b>9n</b>) and 2′,5′ (<b>9k</b>), as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Concurrently, the same positions on the aryl ring substituted with methyl (<b>9i</b>, <b>9q</b>, and <b>9l</b>) reveal a significant loss of activity in the low micromolar range compared to the nanomolar affinity observed for the chlorine isomers. Additionally, the SAR also shows that 3′,4′-disubstitution with chlorine (<b>9t</b>) is not as well-tolerated as 2′,4′ (<b>9g</b>), 3′,5′ (<b>9n</b>), and 2′,5′ (<b>9k</b>) given the observed loss in affinity and selectivity. Substitution of one of the chlorines with a bromine as in 2′-Cl,4′-Br (<b>9h</b>) and 3′-Cl,5′-Br (<b>9o</b>) as well as the dibrominated analog 3′,5′-di-Br (<b>9p</b>) shows that bromine is well-tolerated at these positions. Combined, the available data proposed 3′,5′ and 2′,4′ as the optimal sites for substitution on the 8-aryl ring, yielding compounds with excellent selectivity and potency for Grp94.</div><div class="NLM_p">In accordance with our previous findings, these compounds were each selective for Grp94. As mentioned above, the substitution pattern in these compounds was biased toward those that were known to favorably position the compound to attain a backward bent conformation. This should not be taken to mean that these compounds cannot attain the forward bent conformation and potentially bind into site 1 present in Hsp90 (or Grp94 for that matter). These compounds are capable of attaining a forward bent conformation; however, the substituents chosen are known to not be ideal for binding into site 1 through previous SAR studies with Hsp90.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> It can be envisioned that for any ligand there potentially exists an equilibrium whereby the 8-aryl group can adopt either a backward or forward bent conformation and thus occupy either site 2 or site 1, respectively. Energy minimization calculations show that certain ligands prefer a backward bent conformation and are thus favored entropically, but the difference in energy between these conformations is not enough to explain the observed selectivity. There is also an enthalpic component whereby stabilizing binding interactions that favor binding into one pocket over another are also necessary. The enhanced potency of ligands bearing more hydrophobic substituents is a direct consequence of the greater hydrophobic character of site 2 in Grp94. Combined, these two factors explain the high affinity and selectivity these ligands display for Grp94.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Predicted binding poses for <b>9g</b>, <b>9g′</b>, and <b>9i</b> when bound to the N-terminal domain of Grp94 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Modifications of the Linker between the Purine Core and the 8-Aryl Moiety</h3><div class="NLM_p">We next focused our efforts on examining the effect on potency and selectivity of the linker joining the purine core to the 8-aryl ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d). The adenine core binds in an essentially identical manner to each isoform, whereby a key interaction is formed between the exocyclic −NH<sub>2</sub> and N1 of the adenine with a conserved Asp149 of Grp94 (Asp93 of Hsp90α/β, Asp158 of Trap1) and a network of water molecules at the bottom of the ATP-binding pocket.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Since the adenine core is essentially static in binding to each of the isoforms, it is the linker atom that is a critical element to the ligand attaining the conformation necessary for selective Grp94 inhibition through binding into site 2. Naturally then, the linker group can be expected to have a significant impact on Grp94 binding/selectivity by impacting the dihedral angle, which is indeed the case (Figure S2, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). Substitution of the S in 2′,4′-di-Cl analog <b>9g</b> with O (<b>14c</b>), CH<sub>2</sub> (<b>14d</b>), C═O (<b>14e</b>), S═O (<b>14a</b>), and O═S═O (<b>14b</b>) was investigated by the synthesis of the corresponding analogs (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Substitution with O or CH<sub>2</sub> was tolerated, giving only a 4–6-fold decrease in activity; however, this was not the case for the sulfoxide and sulfone derivatives, which showed a significant loss of activity (∼40-fold, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Overall, the sulfur linker was found to be the best choice, as it provided the most potent analog.</div><div class="NLM_table-wrap" id="tbl2">Table 2<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0010.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">Hsp90α</th><th class="colsep0 rowsep0" align="center">Hsp90β</th><th class="colsep0 rowsep0" align="center">Grp94</th><th class="colsep0 rowsep0" align="center">Trap-1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9n</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>3</sub>CCH</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">0.26 ± 0.01</td><td class="colsep0 rowsep0" align="left">83.6 ± 11.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>2</sub>CCH</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.287</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>4</sub>CCH</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.665</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>CCCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13d</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13e</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>3</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.502</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13f</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>4</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">2.74</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13g</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>5</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">1.648</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13h</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>3</sub>CN</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.429</td><td class="colsep0 rowsep0" align="left">4.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13i</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13j</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>2</sub>C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>2.5</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13l</b></td><td class="colsep0 rowsep0" align="left">–CH(CH<sub>3</sub>)(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">14.3</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13m</b></td><td class="colsep0 rowsep0" align="left">–CH(CH<sub>3</sub>)CH<sub>2</sub>CCH</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13n</b></td><td class="colsep0 rowsep0" align="left">–CH(C<sub>2</sub>H<sub>5</sub>)CH<sub>2</sub>CCH</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13o</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13p</b></td><td class="colsep0 rowsep0" align="left">–CH(CH<sub>3</sub>)(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">2.48</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13q</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>2</sub>CCH</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="left">7.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13r</b></td><td class="colsep0 rowsep0" align="left">–CH(CH<sub>3</sub>)CH<sub>2</sub>CCH</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13s</b></td><td class="colsep0 rowsep0" align="left">–CH(C<sub>2</sub>H<sub>5</sub>)CH<sub>2</sub>CCH</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.92</td><td class="colsep0 rowsep0" align="left">>50</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl3">Table 3<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0011.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Hsp90α</th><th class="colsep0 rowsep0" align="center">Hsp90β</th><th class="colsep0 rowsep0" align="center">Grp94</th><th class="colsep0 rowsep0" align="center">Trap-1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">0.12 ± 0.04</td><td class="colsep0 rowsep0" align="left">145.4 ± 13.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">24.9</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">O═S═O</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14c</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14d</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14e</b></td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">4.98</td></tr></tbody></table></div></div></div><div id="sec1_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Modifications of the <i>N</i>3/<i>N</i>9-Substituents</h3><div class="NLM_p">We next examined the effect of different <i>N</i>9-substituents on Grp94 binding affinity and selectivity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The appendage at the <i>N</i>9-position accommodated various chain lengths up to five carbons with a further increase resulting in a decrease in potency. Increasing the chain length from five to six carbons (<b>9n</b> vs <b>13b</b>) at the <i>N</i>9-position resulted in approximately 3-fold decrease in potency for Grp94; however, a decrease in chain length to four carbons did not affect binding affinity (<b>9n</b> vs <b>13a</b>). As seen in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a, the alkyne moiety of pent-4-ynyl (<b>9n</b>) and but-3-ynyl (<b>13a</b>) orients closer to Phe195 and makes critical π–π interactions, whereas hex-5-ynyl (<b>13b</b>) is unable to form such interactions because of its orientation away from this amino acid. As predicted by docking studies, moving the alkyne internally led to a decrease in Grp94 binding affinity (<b>13a</b> vs <b>13c</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) which can be attributed to the inability of this compound to form π–π interactions with Phe195. Replacement of the alkyne with a trifluoromethyl group was also extensively investigated; however, this did not offer any improvement (see <b>13d</b>–<b>g</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Similarly, isosteric replacement of the alkyne with the more polar cyano group (<b>13h</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), while tolerated, does not offer any improvement over alkyne <b>9n</b>. Introduction of bulkier substituents, such as benzyl (<b>13i</b>) and phenethyl (<b>13j</b>), result in a drastic decrease in affinity, caused most likely by steric clash with Phe195.</div><div class="NLM_p">We had previously shown that C1′-substitution on the <i>N</i>9-substituent with a methyl group was a positive factor toward enhancing the selectivity of compounds for Grp94.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In fact, this was one subtype of compound that was identified as Grp94-selective with greater than 10-fold selectivity over Hsp90α, Hsp90β and Trap1. Modeling indicated that the presence of a methyl group at this position favorably disposed the 8-aryl ring into the backward bent conformation. Because the substituents used to decorate the 8-aryl moiety were not particularly favorable for binding, these ligands were not potent for Grp94. In contrast to Grp94 in this region, Hsp90 is characterized by a more limited volume, and indeed, previously reported SAR showed that C1′-substitution completely ablated Hsp90 binding.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Using this information, we had hoped to further enhance the selectivity for Grp94 through substitution at the C1′-position while at the same time incorporating the favorable substituents that we show above to enhance potency (i.e., 2′,4′-di-Cl and 3′,5′-di-Cl). Unfortunately, it was not possible to ascertain the effects of such modification on selectivity, since at the highest concentration tested (maximal solubility) for these analogs (<b>13l</b>–<b>n,p,r,s</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) there was essentially no inhibition of Hsp90α. However, the results do clearly show for both the butyl and butyne series that substitution with methyl (i.e., <b>13l,m,p,r</b>) or ethyl (i.e., <b>13n,s</b>) results in a decrease in potency for Grp94 relative to the unsubstituted analogs <b>13a,o,q</b>.</div><div class="NLM_p">In addition to the <i>N</i>9-substituted compounds described above, we also examined the potency and selectivity of their <i>N</i>3-substituted analogs (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), which were conveniently isolated as minor components in the syntheses of <i>N</i>9-compounds. We find that compared to the <i>N</i>9-series, <i>N</i>3-substituted compounds were considerably less potent (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> vs Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In fact, because of solubility limitations an accurate IC<sub>50</sub> could not be determined for a number of the compounds. The compounds that we were able to evaluate, such as <b>9a′</b>, <b>9g′</b>, <b>4</b>, <b>9k′</b>, <b>9n′</b>, <b>9v′</b>, <b>9w′</b>, and <b>18c′</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), displayed a 10–400-fold decrease in affinity for Grp94. Importantly, the SAR of the <i>N</i>3-isomers correlated to that of the <i>N</i>9-alkylated series, since the 2′,4′- and 2′,5′-dichloro analogs were more potent than their dimethyl analogs (<b>9g′</b> vs <b>4</b> and <b>9k′</b> vs <b>9l′</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Molecular docking studies suggested a distinct orientation and interaction of the <i>N</i>3- and <i>N</i>9-alkyl chain with Grp94. While the pent-4-ynyl moiety in the <i>N</i>9-position results in a bend that orients the chain closer to the surface of the protein to form hydrophobic interactions with Phe195 and Leu163 and π–π stacking with Phe195 (2.2 Å) of Grp94 (e.g., <b>9g</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a), this is not the case for the <i>N</i>3-analogs, where the pent-4-ynyl moiety is positioned further away and orients instead to polar residues such as Lys114, Gln194, and Asp110, accounting for the decrease in binding affinity (<b>9g</b> vs <b>9g′</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a,b).</div><div class="NLM_table-wrap" id="tbl4">Table 4<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0012.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">Hsp90α</th><th class="colsep0 rowsep0" align="center">Hsp90β</th><th class="colsep0 rowsep0" align="center">Grp94</th><th class="colsep0 rowsep0" align="center">Trap-1</th><th class="colsep0 rowsep0" align="center">Hsp90α/ Grp94</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a′</b></td><td class="colsep0 rowsep0" align="left">2′-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">100 ± 10</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b′</b></td><td class="colsep0 rowsep0" align="left">2′-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c′</b></td><td class="colsep0 rowsep0" align="left">2′-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d′</b></td><td class="colsep0 rowsep0" align="left">2′-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g′</b></td><td class="colsep0 rowsep0" align="left">2′,4′-di-Cl</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">2.37 ± 0.79</td><td class="colsep0 rowsep0" align="left">9.6 ± 0.8</td><td class="colsep0 rowsep0" align="left">>210</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">2′,4′-di-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="left">11.77 ± 3.24</td><td class="colsep0 rowsep0" align="left">54.1 ± 4.6</td><td class="colsep0 rowsep0" align="left">>21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9j′</b></td><td class="colsep0 rowsep0" align="left">2′,4′-di-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9k′</b></td><td class="colsep0 rowsep0" align="left">2′,5′-di-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">35.3 ± 5</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9l′</b></td><td class="colsep0 rowsep0" align="left">2′,5′-di-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9m′</b></td><td class="colsep0 rowsep0" align="left">2′-Cl,5′-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9n′</b></td><td class="colsep0 rowsep0" align="left">3′,5′-di-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">100 ± 8</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9q′</b></td><td class="colsep0 rowsep0" align="left">3′,5′-di-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9v′</b></td><td class="colsep0 rowsep0" align="left">2′,4′,5′-tri-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">2.08</td><td class="colsep0 rowsep0" align="left">19.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">>48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9w′</b></td><td class="colsep0 rowsep0" align="left">2′,4′,6′-tri-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">20 ± 5</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18b′</b></td><td class="colsep0 rowsep0" align="left">2′,4′-di-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18c′</b></td><td class="colsep0 rowsep0" align="left">3′,5′-di-Cl</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">2.43</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.043 ± 0.006</td><td class="colsep0 rowsep0" align="left">0.042 ± 0.003</td><td class="colsep0 rowsep0" align="left">0.026 ± 0.004</td><td class="colsep0 rowsep0" align="left">0.205 ± 0.006</td><td class="colsep0 rowsep0" align="left">1</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl5">Table 5<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0013.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">Hsp90α</th><th class="colsep0 rowsep0" align="center">Hsp90β</th><th class="colsep0 rowsep0" align="center">Grp94</th><th class="colsep0 rowsep0" align="center">Trap-1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2′,4′-di-Cl</td><td class="colsep0 rowsep0" align="left">20.3 ± 1.2</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.41 ± 0.1</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18c</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">3′,5′-di-Cl</td><td class="colsep0 rowsep0" align="left">27.3 ± 3.5</td><td class="colsep0 rowsep0" align="left">41.8 ± 1.3</td><td class="colsep0 rowsep0" align="left">0.22 ± 0.08</td><td class="colsep0 rowsep0" align="left">7.3 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18d</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2′,4′-di-Cl</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">3.44</td><td class="colsep0 rowsep0" align="left">14.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18e</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3′,5′-di-Cl</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">1.08</td><td class="colsep0 rowsep0" align="left">7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18f</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">0.028</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.101</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18g</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.265</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">0.043 ± 0.006</td><td class="colsep0 rowsep0" align="left">0.042 ± 0.003</td><td class="colsep0 rowsep0" align="left">0.026 ± 0.004</td><td class="colsep0 rowsep0" align="left">0.205 ± 0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">–</td><td class="colsep0 rowsep0" align="left">33<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">38<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">190<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1586<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values were obtained from ref <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a>.</p></div></div></div><div class="NLM_p">As described above, our initial SAR focused on modification of the 8-phenyl ring and resulted in the identification of 2′,4′- and 3′,5′-dichloro-substituted analogs <b>9g</b> and <b>9n</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), respectively, as potent and selective Grp94 inhibitors. However, we found that these compounds had limited aqueous solubility and were less than optimal for use in cell-based studies and, moreover, difficult to formulate for in vivo studies. Therefore, in an attempt to improve aqueous solubility, we aimed to modify the <i>N</i>9-position based on our prior knowledge of the purine scaffold.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Additionally, the X-ray crystal structure of PU-H54 (<b>4</b>) with Grp94 reveals the presence of polar amino acids near the exit of the pocket that could potentially form H-bonds with a hydrophilic <i>N</i>9-substituent. On the basis of our earlier experience in the development of the pan-Hsp90 inhibitor PU-H71 (<b>5</b>), where the polar <i>N</i>9-amine projects out into the solvent, we decided to introduce the ionizable 3-isopropylamino-propyl group.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Gratifyingly for us, replacement of the pent-4-ynyl chain of <b>9g</b> and <b>9n</b> with the ionizable 3-isopropylamino-propyl chain provided derivatives <b>18a</b> and <b>18c</b>, which maintained the previously observed binding affinity for Grp94, though the 3,5-dichloro analog <b>18c</b> was slightly better than the 2,4- compound <b>18a</b>. As such, <b>18c</b> shows good potency for Grp94 (IC<sub>50</sub> = 0.22 μM) and selectivity over other paralogs (>100- and 33-fold for Hsp90α/β and Trap-1, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Additionally, <b>18c</b> can be formulated as either a mesylate or hydrochloride salt, which increases its water solubility (i.e., >10 mg/mL).</div><div class="NLM_p">To rationalize the binding affinity, we docked compound <b>18c</b> into the binding site of Grp94 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). Unlike the hydrophobic chain of <b>9n</b>, the polar chain at <i>N</i>9 orients away from Phe195 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a,b) and is predicted to form hydrogen bonds with surface amino acids such as Glu158 in Grp94, which seems to compensate for the loss of hydrophobic and π–π interactions with Phe195, resulting in a similar inhibition profile (<b>18c</b> vs <b>9n</b>, Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). To determine the reason for ligand selectivity, sites were generated by SiteMap using a previously described procedure<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> on each protein, and the sites were overlaid onto the structure of <b>18c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c). In Grp94, there are two sites available for the right side phenyl ring to orient into (sites 1 and 2). The phenyl ring of <b>18c</b> orients into energetically favorable site 2 (backward bent) and is stabilized by hydrophobic interactions with Leu104, Leu163, Phe199, Ala202, Phe203, Val211, Ile247, and Leu249. Orientation of <b>18c</b> into site 1 of Grp94 was less preferred due to energy constrains and unfavorable interactions with Trp223 (NH). The ability of compound <b>18c</b> to access site 2 and favorably bind in this pocket results in the observed high affinity of this ligand for Grp94. Only site 1 is available for the phenyl ring to orient into in Hsp90α, Hsp90β, and Trap-1 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c) since a steric clash of the phenyl ring with Phe138 (Hsp90α/β) or Phe205 (Trap-1) would preclude binding into site 2. This restriction as well as unfavorable interactions of the hydrophobic substituents of <b>18c</b> (3,5-di-Cl) with polar amino acids of site 1 [i.e., Trp162 (NH) and Tyr139 (OH) in Hsp90α/β and Tyr206 (OH) in Trap-1] results in low-affinity binding to Hsp90α/β and Trap-1 and the resulting selectivity for Grp94.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design of <b>18c</b> and its proposed interaction with the Hsp90 paralogs. (a) Interactions of <b>9n</b> and <b>18c</b> with the amino acids lining the Grp94 allosteric site 2. (b) Docking of compound <b>18c</b> in the allosteric site 2 of Grp94. (c) Overlay of <b>18c</b> on to sites 1 and 2 of the four Hsp90 paralogs. Residues that constrain either the availability of the site 2 pocket or the interaction of <b>18c</b> with the protein are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Modification of the Purine Core—Substitution of N3 with C</h3><div class="NLM_p">In an attempt to explore further structural modifications that might improve pharmacological properties, we sought to modify the 3-position nitrogen of the purine to a carbon, as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Previously, such a modification was utilized by researchers at Curis in the development of Hsp90 inhibitors, since they had rationalized that the N3 nitrogen lacks direct contact with Hsp90, although it does make water-mediated hydrogen bonds with Gly97 and Asp102.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The resulting imidazopyridines are reported to bind to Hsp90 with high affinity,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> and one of these analogs, CUDC-305 (<b>22</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), is in clinical trials for cancer. Since such a change would be expected to alter the physiochemical properties, we sought to make a similar modification to <b>18a</b> and <b>18c</b>. Somewhat surprisingly, we found that such a change substantially diminished potency (5–8-fold for <b>18d</b> and <b>18e</b>) for Grp94, indicating that the N3 is significant for binding of <b>18a</b> and <b>18c</b> to Grp94. Examination of the crystal structure for PU-H54 (<b>4</b>) bound to Grp94 was not much help for us in understanding the role of N3, since this analog is <i>N</i>3-substituted and would alter the H-bond capabilities of the nitrogen by diminishing electron density as well as sterically affecting it. Therefore, we relied upon the crystal structure of NECA (<b>1</b>) bound to Grp94, which shows that N3 forms water-mediated H-bonds with Asn162 and Lys114 (Figure S3, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) in a manner highly similar to that observed for PU-H71 (<b>5</b>) bound to Hsp90.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Therefore, on the basis of this as well as our binding results between the two series (i.e., <b>18a</b> vs <b>18d</b>, and <b>18c</b> vs <b>18e</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), water-mediated hydrogen bonds made with the ligand through N3 are significant for affinity (Figure S3, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p last">Previously, when we had compared the binding mode of some pan-inhibitors to the various isoforms of Hsp90, we found that the affinity of CUDC-305 (<b>22</b>) for Grp94 (IC<sub>50</sub> = 190 nM) was ∼6-fold lower than for Hsp90α (IC<sub>50</sub> = 33 nM) or Hsp90β (IC<sub>50</sub> = 38 nM).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This was attributed by modeling to be due to steric clashes that occur between the dimethylamine group with Phe195 and Leu163 in the Grp94 binding pocket.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The significance of a nitrogen or carbon at the 3-position of the adenine ring was not considered at the time. In order to further elucidate the effects of such substitution we prepared both the dimethylamine analog (<b>18g</b>) and the C3 analog (<b>18f</b>) of the pan-inhibitor PU-H71 (<b>5</b>). We chose to make analogs of PU-H71 (<b>5</b>) because of the similar affinity this compound displays for Grp94 and Hsp90α/β, which would allow us to more carefully gauge such effects. Substitution of the iodine with dimethylamine (<b>18g</b>) resulted in a similar decrease (∼3-fold) in relative affinity for Grp94 that is observed with CUDC-305 (<b>22</b>), and when compared to PU-H71 (<b>5</b>), substitution results in a 10-fold loss of affinity for Grp94, supporting the notion of a steric clash that was earlier suggested by modeling. Similarly, the C3 analog of <b>5</b>, <b>18f</b>, displayed ∼4-fold lower affinity for Grp94 compared to Hsp90α and when compared to PU-H71 (<b>5</b>), further supporting the importance of N3 for binding to Grp94.</div></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Biochemical and Biological Evaluation of the Grp94 Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Off-Target Selectivity Testing</h3><div class="NLM_p last">Because these ligands are based on a purine scaffold, there is the misconception that they tend to nonspecifically interact with ATP-binding pockets, such as those of kinases. Both derivative <b>18c</b> and <b>9g</b> were tested at 10 μM against the scanEDGE 97 kinase panel (Figure S4, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). This panel contains a set of kinases covering AGC, CAMK, CMGC, CK1, STE, TK, TKL, lipid, and atypical kinase families, plus important mutant forms. Developed by Ambit Biosciences, it employs proprietary active-site-dependent competition binding assays to determine how compounds bind to kinases.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> It is based on a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site-directed ligand and can be used in detection of multiple inhibitor types (e.g., type I, type II, and non-ATP competitive). Compound <b>18c</b> was inert against the kinase panel, while only two minor interactions were identified for compound <b>9g</b> (MKNK2 and ROCK2, 34% and 32% inhibition, respectively) (Figure S4, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biological Evaluation of Grp94 Selectivity in Cells</h3><div class="NLM_p">We next addressed the paralog specificity of these compounds in a cellular system because the biochemical affinity and selectivity of these compounds measured in vitro with recombinant protein may differ from their effects on Hsp90 paralogs within cells. There are multiple factors that could contribute to such a profile, including differences in the cellular abundance and distribution of the Hsp90 paralogs. Additionally, post-translational modifications (PTMs) and complex formation of intracellular Grp94 could potentially render a distinct inhibition profile to that observed compared to recombinant protein.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Thus, to confirm that these compounds act in cells through paralog-specific inhibition, we tested the selective target modulation of compound <b>18c</b> by several functional readouts.</div><div class="NLM_p">TLRs are a family of pattern recognition receptors for pathogens that have critical roles in innate immunity against infection.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Thirteen TLRs exist in mammals and they localize either on the cell surface or in the endolysosome compartment. Grp94 is one of several accessory proteins that regulate intracellular trafficking of TLR9. In the absence of Grp94 or when Grp94 chaperoning function is inhibited pharmacologically, TLR9 fails to exit the endoplasmic reticulum, and therefore, Grp94-deficient macrophages fail to recognize unmethylated CpG DNA and induce TNF-α production.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Impairment of Grp94 function increases the proteolytic sensitivity of TLR9, possibly because, in the absence of Grp94, TLR9 is not folded properly and is turned over in the ER or secretory pathways. Indeed, <b>18c</b> dose-dependently inhibited the expression of TLR9 in the post-ER compartment (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a) and the CpG induced TNF-α production (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b). <b>18c</b> also dose-dependently inhibited IGF-II secretion by differentiated myoblasts (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>c) and reduced the steady-state levels of HER2 kinase in HER2 overexpressing breast cancer cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>d), both Grp94-mediated cellular processes.<a onclick="showRef(event, 'ref10 ref35'); return false;" href="javascript:void(0);" class="ref ref10 ref35">(10, 35)</a></div><div class="NLM_p">While these functional readouts confirm Grp94 inhibition in cells by <b>18c</b>, they do not exclude potential interference with Hsp90, the cytosolic paralog. Therefore, we also investigated the ability of <b>18c</b> to modulate Hsp90-specific functions (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>e). One such function is related to Hsp90’s ability to maintain the transcription factor HSF-1 sequestered to the cytosol, where it directly binds to it and prevents its activation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> When Hsp90 is inhibited, HSF-1 is released from Hsp90, trimerizes to an active transcription factor, and translocates to the nucleus to bind to several promoters of heat-shock proteins, resulting in increased transcription and synthesis of these proteins, such as Hsp70. Indeed, inhibition of Hsp90, by either the Hsp90-selective inhibitor PU29F<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> or by the pan-Hsp90 inhibitors GM<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> or PU-H71,<a onclick="showRef(event, 'ref28 ref39'); return false;" href="javascript:void(0);" class="ref ref28 ref39">(28, 39)</a> led to upregulated levels of Hsp70. As a confirmation of its retained paralog specificity in cells, <b>18c</b> did not modulate this Hsp90-related event at concentrations that resulted in Grp94 inhibition in cells.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Grp94-specific inhibitor <b>18c</b> dose-dependently inhibits several Grp94-mediated cellular effects, such as (a) TLR9 expression, (b) TNFα production in cells stimulated with CpG, (c) IGF-II production by differentiated myoblasts, and (d) HER2 degradation in HER2-overexpressing breast cancer cells. Selectivity of <b>18c</b> for Grp94 over the cytosolic Hsp90 is demonstrated by the lack of activity in cells stimulated by LPS (b) and no Hsp70 induction in SKBr3 cells (e), both effects mediated by Hsp90. PU-H71 (<b>5</b>) and GM are pan-Hsp90 inhibitors (i.e., bind equally well to both Grp94 and the cytosolic Hsp90s). Data points are mean ± error, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Distinct Grp94 Inhibitors May Result in Nonoverlapping Phenotypes</h3><div class="NLM_p">Molecular chaperones are atypical drug targets because they can exist as fluid complexes. They can exist in cells as components of complexes bound to nucleotide, cochaperone, or client proteins and are subject to PTMs.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Combined these two factors help to regulate chaperone function and enable the cell to mount a stress response as is needed under diverse cellular conditions. These can also serve to explain the differences observed with different inhibitors. For instance, there is a significant difference observed both at the biochemical and at the cellular level for Hsp90 inhibitors that target the N-terminal domain from those that target the C-terminus of Hsp90.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> There is even considerable difference observed in vitro and in vivo between those inhibitors that target the N-terminal nucleotide binding pocket.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a> Despite sharing a similar binding site, these inhibitors can display significantly different properties, and it seems that no two inhibitors are the same as a result of their ability to sample different conformations and chaperone complexes.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">In this context, we were intrigued by the previous observation that BnIm (<b>3</b>) lacked antiproliferative effects against HER2-overexpressing SKBr3 cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This contrasted with our findings that inhibition of Grp94 by <b>18c</b> or knock-down of Grp94 by siRNA led to growth impairment in these cells.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In order to directly compare the effects of these two classes of compounds, we synthesized <b>3</b> according to published procedures.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> As noted above, <b>3</b> binds into site 3 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b), in contrast to <b>18c</b>, which binds into site 2. While the IC<sub>50</sub> of <b>3</b> for Grp94 is reported,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> its specificity for the other Hsp90s was not specified, so the potency and selectivity against recombinant protein could not be clearly assessed. Although in silico docking predicted for <b>3</b> a binding mode that oriented the benzyl ring into the pocket of Grp94, no crystal structure was provided to confirm this hypothesis. The selectivity of <b>3</b> for Grp94 was hypothesized on the basis of cell-based functional assays that were interpreted to be readouts of specific Grp94 or Hsp90α/β function, and the precise paralog selectivity/potency profile of <b>3</b> remains unclear.</div><div class="NLM_p">Thus, we first chose to determine both the potency and selectivity of <b>3</b> against Grp94 and Hsp90α. We obtained an IC<sub>50</sub> of 1.2 and 14 μM for Grp94 and Hsp90α, respectively (∼12-fold selective) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a). The binding affinity of <b>3</b> for Grp94 is similar to that recorded for this compound (IC<sub>50</sub> = 1.5 μM).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Next, we tested the effect of BnIm on HER2, a protein that we have recently shown to be dependent on Grp94 in SKBr3 cells.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Specifically, we demonstrated that the stability and function of HER2 at the plasma membrane of tumor cells characterized by high HER2 expression are critically regulated by Grp94.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Consistent with previous results,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> we observed no effect of <b>3</b> in SKBr3 cells up to 10 μM, a concentration previously reported to inhibit both TLR9 trafficking and IGF-II secretion.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> We increased the concentration of BnIm to 100 μM, a concentration recently shown to inhibit the chaperoning of myocilin by Grp94.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> At 100 μM, a slight effect could be seen for <b>3</b> on SKBr3 cells, as noted by minor PARP cleavage and possibly a slight reduction in HER2 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b) and by cellular toxicity (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>c); this, however, we could not specifically attribute to Grp94 inhibition, because at this concentration Hsp70 induction (indicating cytosolic Hsp90 inhibition) was also noted (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b).</div><div class="NLM_p">Through these data we cannot conclusively attribute the lack of effect for <b>3</b> in SKBr3 cancer cells on its distinct binding interaction with Grp94; while we favor an explanation that diverse binding modes may enable each compound to sample a diverse range of conformations, resulting in different phenotypes, other mechanisms such as an inability of <b>3</b> to access Grp94 at the plasma membrane (such as Grp94 being translocated in SKBr3 to chaperone HER2<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a>) might also account for the phenotypic differences. Nonetheless, these results demonstrate that the effect of small-molecule inhibition of Grp94 is context-dependent and suggests that future efforts in the development of Grp94 inhibitors should implement, in addition to biochemical tests, relevant phenotypic and cell-specific target modulation assays.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Relative binding affinity of Grp94 inhibitors for Hsp90α and Grp94 was measured using a fluorescence polarization assay as previously reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (b) The HER2-overexpressing breast cancer cells SKBr3 were treated for 24 h with the indicated concentrations of Grp94 inhibitors, and proteins were analyzed by Western blot. Representative blots of triplicate experiments are shown. (c) Viability of cancer cells treated for 72 h with the indicated Grp94 inhibitor concentrations was measured using the CellTiter-Glo cell viability assay. Data points are mean ± error, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Pharmacokinetics</h3><div class="NLM_p">So far there is no report on the in vivo profile of a Grp94 inhibitor. Studies conducted with pan-Hsp90 inhibitors indicate a tumor-targeting and retention profile for such compounds.<a onclick="showRef(event, 'ref32 ref39'); return false;" href="javascript:void(0);" class="ref ref32 ref39">(32, 39)</a> This was rationalized by the existence of Hsp90 species in tumors distinct from those expressed in normal cells.<a onclick="showRef(event, 'ref32 ref42 ref45'); return false;" href="javascript:void(0);" class="ref ref32 ref42 ref45">(32, 42, 45)</a> Specifically, the presence of aberrant proteins, such as those present in cancer cells, may shunt Hsp90 to a highly cochaperone bound and dependent complex that exhibits high affinity not only for its endogenous ligand, ATP, but also for ligands that occupy the ATP pocket. This stress-specific Hsp90 complex we termed the oncogenic Hsp90 species.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In contrast, in normal cells, Hsp90 exists in complexes of dynamic nature that regulate normal cell physiology, also termed housekeeping Hsp90 species.</div><div class="NLM_p">To address the question whether a tumor-specific retention profile may also extend to the allosteric Grp94 inhibitors described here, we performed a pilot PK study for <b>18c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). No acute toxicity was observed upon intraperitoneal administration of the agent to mice at doses as high as 150 mg/kg (higher was not tested due to solubility limitations). In this PK study we incorporated two time points, a 2 and 24 h time of sacrifice postadministration (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a). The early time point is incorporated to test the biodistribution of the agent to the site of its action, the tumor; <b>18c</b> was readily distributed to tumor mass with ∼850 μM noted in tumor at 2 h vs 100 μM in the plasma. At 24 h, the ratio of agent in tumor vs plasma increased to 200:1 and the tumor vs heart to 100:1, indicating specific retention of <b>18c</b> in the tumor mass (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b). We further validated our findings in B6D2F1 mice, in which we conducted a “classical” pilot PK study (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>c). The fraction of agent that reached systemic circulation (<i>F</i>) after oral administration was 80%, which is suggestive of good absorption and limited first-pass metabolism (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>c). This study re-enforces our findings in the tumor-bearing mice; specifically, we see a high <i>C</i><sub>max</sub>, AUC, and %<i>F</i> (po) in the plasma in the time interval of 0–4 h, which is in accord with the rapid and good biodistribution we determined above (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a). These studies are encouraging, as they indicate that we have a very good pharmacophore and lead compound in <b>18c</b>. They also suggest that specific tumor targeting with rapid clearance from normal tissue is also possible in the Grp94 purine-scaffold series, similarly to that observed for the purine-scaffold pan-Hsp90 inhibitors.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49">(46-49)</a></div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo profile of <b>18c</b>. (a) <b>18c</b> (75 mg/kg, ip) was administered to mice (<i>n</i> = 4 per experimental point) bearing breast tumors, and mice were sacrificed at 2 and 24 h postadministration. Inhibitor levels in the indicated tissues and plasma were determined by LC–MS/MS following administration of <b>18c</b>. Each data point represents the mean ± error. (b) The concentrations of <b>18c</b> in tumor to brain, heart, and plasma of mice as in panel a were determined by LC–MS/MS and the ratios plotted. (c) <b>18c</b> was injected as a single dose iv or oral at 10 mg/kg to B6D2F1 mice (<i>n</i> = 2 male mice per experimental point, 20 mice total). The agent was formulated in 30% captisol, 5 mM citrate buffer at pH 4.2. Agent levels (μg/g or μg/mL) were determined by LC–MS/MS and converted to molar concentrations with the approximation that 1g = 1 mL. Concentrations were graphed against the time of sacrifice, which represents the time after agent administration. Each point represents mean ± error.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This report is the first to describe a comprehensive SAR of Grp94 inhibitors that interact with the allosteric site 2 and to offer valuable insight into ways to overcome the high structural similarity among Hsp90s in the ligand-binding pocket. Whereas previous efforts in the field provided useful information on the feasibility of achieving selectivity for this Hsp90 isoform, the current work provides detailed knowledge on the ligand characteristics required for selective Grp94 inhibition both in vitro and in cells. It also presents several context-dependent biological assays that probe binding to Grp94 in cellular models of disease and thus provides a blueprint for future medicinal chemistry efforts. Not last, it provides preliminary in vivo testing of a Grp94 inhibitor to suggest specific and effective targeting of tumors by a Grp94 ligand.</div><div class="NLM_p">In this paper we describe the design and synthesis of purine-based ligands that preferentially bind to site 2, which is unique to Grp94, and confers selectivity over other paralogs. Specifically, this work resulted in compounds such as <b>18c</b>, which shows good binding affinity for Grp94 and selectivity over the other Hsp90 paralogs. To come to this conclusion, we synthesized, characterized, and tested approximately 70 ligands that together encompass nine points of variation on the pharmacophore. As such, we extensively probed substitutions on the 8-aryl, the nature of the linker between the purine ring and the 8-aryl, and the nature and length of linkers attached at either N3 or N9 of the purine, and last, we modified the purine core itself by replacing N3 with a carbon.</div><div class="NLM_p">We also provide here a rationale for the preferred chemical spaces that elicit a “backward bent” that is directed toward the unique binding site of Grp94 and optimally complements volume and polarity characteristics of the site 2 binding pocket to result in high affinity binding. The conformation observed for the binding of these ligands to Grp94 is distinct from all previous structures (apo and ligand bound) reported for Grp94 and it is important to note that this novel pocket (site 2) becomes exposed and subsequently available for binding only after ligand-induced conformational changes to Grp94. Upon interaction, compounds such as those described here are capable of inducing a conformational change in Grp94 that results in the exposure of a unique binding pocket that can then be filled by the ligand.</div><div class="NLM_p">We further validated that <b>18c</b> acts in cells through Grp94-specific inhibition using a number of functional readouts. Specifically, we show that <b>18c</b> inhibits both the post-ER expression of TLR9 as well as CpG-induced/TLR9-mediated TNF-α production. <b>18c</b> also inhibits IGF-II secretion by differentiated myoblasts and reduces the steady-state levels of HER2 kinase in HER2-overexpressing breast cancer cells. At these Grp94-modulatory concentrations, we show that <b>18c</b> has no effects on Hsp90-mediated functions in cells, providing proof for its in cell selectivity.</div><div class="NLM_p">We also present data comparing the activity of two Grp94 classes and show that the phenotypes of the two compounds do not necessarily overlap. As the field is coming to appreciate, chaperones regulate proteins by co-opting activating cochaperones and adapter proteins. In disease, these complexes are context-dependent, in that they form to buffer the specific alterations in the proteome. The efficacy of an agent targeting a chaperone in these cells is therefore determined by its ability to sample and engage such complexes, stressing the need to test chaperone inhibitors in the disease context they are therapeutically developed for.</div><div class="NLM_p">We also provide for the first time information regarding the in vivo profile of a selective Grp94 inhibitor. When administered to tumor-bearing mice, <b>18c</b> was cleared relatively rapidly from normal tissue while being selectively retained in tumor; this is remarkable considering that Grp94 is similarly expressed in most tissues and organs. Such phenomenon was previously observed with pan-Hsp90 inhibitors.<a onclick="showRef(event, 'ref32 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref32 ref39 ref40">(32, 39, 40)</a> It is believed that the tumor-specific effects of HSP inhibitors are due to an activation of the chaperones in tumors by factors such as proteotoxic stress. Because of these features, and like the Hsp90 inhibitors, it is not envisioned that Grp94 inhibitors will be targeted systemically but, rather, will show preferential localization in tumors. We have confirmed these concepts with our pharmacokinetic data.</div><div class="NLM_p">It is yet unclear whether such a tumor-retention feature extends to all Grp94 pharmacophores. For Hsp90 inhibitors it was determined that not all inhibitors exhibit such preference for tumor species, possibly because not all inhibitors interact with the protein in an identical fashion.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Each inhibitor may preferentially sample specific conformations and complexes of the HSP, and it is expected that those that sample preferentially the tumor, active complexes would be those with higher therapeutic index.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> This remains to be seen as more Grp94 inhibitor classes move to in vivo studies.</div><div class="NLM_p last">In summary, our findings suggest Grp94 as a valid target for therapeutic intervention and position the Grp94 inhibitors such as <b>18c</b> as therapeutic leads in the development of drugs for the treatment of immune-related disorders and certain cancers.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker AV-III 400, 500, or 600 MHz NMR spectrometer. Chemical shifts are reported in δ values in ppm downfield from TMS as the internal standard. <sup>1</sup>H data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constant (Hz), integration. <sup>13</sup>C chemical shifts are reported in δ values in ppm downfield from TMS as the internal standard. High-resolution mass spectra were recorded on a Waters LCT Premier system. Low-resolution mass spectra were obtained on Waters Acquity Ultra Performance LC with electrospray ionization and SQ detector. The purities of title compounds were determined by analytical HPLC, performed on a Waters Autopurification system with PDA, MicroMass ZQ and ELSD detector, and a reverse-phase column (Waters X-Bridge C18, 4.6 × 150 mm, 5 μM) using method A [(a) H<sub>2</sub>O + 0.1% TFA and (b) CH<sub>3</sub>CN + 0.1% TFA, 5 to 95% b over 10 min at 1.2 mL/min] or method B [(a) H<sub>2</sub>O + 0.1% TFA and (b) CH<sub>3</sub>CN + 0.1% TFA, 20 to 90% b over 16 min at 1.0 mL/min]. Title compounds used were >95% pure. Analytical thin-layer chromatography was performed on 250 μM silica gel F<sub>254</sub> plates. Preparative thin layer chromatography was performed on 1000 μM silica gel F<sub>254</sub> plates. Flash column chromatography was performed by employing 230–400 mesh silica gel. Solvents were HPLC grade. PU-H71 (<b>5</b>) was synthesized as previously reported.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The synthesis of <b>18g</b> is described in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>. CUDC-305 (<b>22</b>) was purchased from ChemieTek.</div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure for Synthesis of 8-Arylsulfanylpurines (<b>8</b>)</h4><div class="NLM_p">8-Mercaptoadenine (<b>6</b>); corresponding aryl iodide <b>7</b> (300 mol %); neocuproine hydrate (10 mol %); CuI (10 mol %); NaO<i>t</i>-Bu, K<sub>2</sub>CO<sub>3</sub>, or Na<sub>3</sub>PO<sub>4</sub> (200 mol %); and DMF (2 mL) were charged in a dry vessel under nitrogen atmosphere. The reaction vessel was sealed and placed in an oil bath (110 °C) and stirred for 24 h. The reaction mixture was then cooled to room temperature and DMF was removed in vacuo. The crude material was purified by silica gel flash chromatography eluting with a gradient of CH<sub>2</sub>Cl<sub>2</sub>:CH<sub>3</sub>OH:CH<sub>3</sub>COOH at 60:1:0.5 to 20:1:0.5 to afford the desired products.</div><div id="sec3_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> 8-((3-Bromo-5-chlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>8o</b>)</h5><div class="NLM_p last">Yield: 42%. MS (ESI): <i>m</i>/<i>z</i> 356.1/358.1 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> 8-((3,5-Dibromophenyl)thio)-9<i>H</i>-purin-6-amine (<b>8p</b>)</h5><div class="NLM_p last">Yield: 40%. MS (ESI): <i>m</i>/<i>z</i> 401.9 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> 8-((2,6-Dichloropyridin-4-yl)thio)-9<i>H</i>-purin-6-amine (<b>8r</b>)</h5><div class="NLM_p last">Yield: 50%. MS (ESI): <i>m</i>/<i>z</i> 312.8 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 8-((3,4-Dichlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>8t</b>)</h5><div class="NLM_p last">Yield: 69%. MS (ESI): <i>m</i>/<i>z</i> 312.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 8-((2,3,4-Trichlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>8u</b>)</h5><div class="NLM_p last">Yield: 43%. MS (ESI): <i>m</i>/<i>z</i> 347.7 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 8-(Mesitylthio)-9<i>H</i>-purin-6-amine (<b>8w</b>)</h5><div class="NLM_p">Yield: 53%. <sup>1</sup>H NMR (400 MHz, DMSO): δ 13.1 (br s, 1H), 8.02 (s, 1H), 6.93–7.04 (m, 5H), 2.33 (s, 6H), 2.25 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 286.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Synthesis of <b>8a</b>–<b>n</b>, <b>8q</b>, and <b>8v</b> followed a similar protocol. The synthesis and characterization of these coupling products have been described elsewhere.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure for the Synthesis of <b>9</b> and <b>9′</b></h4><div class="NLM_p">A mixture of 8-arylsulfanyladenine <b>8</b> (100 mmol), Cs<sub>2</sub>CO<sub>3</sub> (100 mmol), and pent-4-ynyl 4-methylbenzenesulfonate (120 mmol) in DMF (1.3 mL) under nitrogen atmosphere was heated at 80 °C for 30 min. Following solvent removal, the crude material was purified by preparatory TLC with CHCl<sub>3</sub>:MeOH:NH<sub>4</sub>OH at 10:1:0.5 or CHCl<sub>3</sub>:MeOH:AcOH at 10:1:0.5 to provide the corresponding 9-alkyl-8-arylsulfanyladenine derivatives <b>9</b> and 3-alkyl-8-arylsulfanyladenine derivatives <b>9′</b>.</div><div id="sec3_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 8-(2-Chlorophenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9a′</b>)</h5><div class="NLM_p last">Yield: 10%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.02 (s, 1H), 7.48–7.51 (m, 1H), 7.40–7.42 (m, 1H), 7.14–7.17 (m, 2H), 4.49–4.51 (m, 2H), 2.17–2.22 (m, 4H), 2.05–2.06 (m, 1H). MS (ESI): <i>m</i>/<i>z</i> 344.0 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>15</sub>N<sub>5</sub>ClS 344.0737, found 344.0720. HPLC: (b) <i>t</i><sub>R</sub> = 7.84 min, 99.6%.</div></div><div id="sec3_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 8-(2-Methoxyphenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9b′</b>)</h5><div class="NLM_p last">Yield: 25%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.97 (s, 1H), 7.45 (d, <i>J</i> = 7.7 Hz, 1H), 7.22 (d, <i>J</i> = 7.8 Hz, 1H), 6.86–6.90 (m, 2H), 4.47 (t, <i>J</i> = 6.6 Hz, 2H), 3.87 (s, 3H), 2.21–2.26 (m, 4H), 2.05–2.07 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>) δ 157.7, 152.6, 141.8, 132.5, 128.3, 121.1, 111.1, 81.6, 70.5, 55.9, 49.0, 27.0, 15.3. MS (ESI): <i>m</i>/<i>z</i> 340.0 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>5</sub>OS 340.1232, found 340.1218. HPLC: (a) <i>t</i><sub>R</sub> = 7.70 min, 98.8%; (b) <i>t</i><sub>R</sub> = 6.44 min, 99.1%.</div></div><div id="sec3_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (2-(6-Amino-3-(pent-4-ynyl)-3<i>H</i>-purin-8-ylthio)phenyl)methanol (<b>9c′</b>)</h5><div class="NLM_p last">Yield: 21%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.96 (s, 1H), 7.74 (d, <i>J</i> = 7.6 Hz, 1H), 7.60 (d, <i>J</i> = 7.5 Hz, 1H), 7.44 (t, <i>J</i> = 7.4 Hz, 1H), 7.29 (t, <i>J</i> = 7.5 Hz, 1H), 4.92 (s, 2H), 4.40 (t, <i>J</i> = 6.4 Hz, 2H), 3.47 (br s, 1H), 2.11–2.20 (m, 4H), 2.03–2.06 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 146.2, 142.6, 137.3, 131.5, 130.9, 129.1, 82.1, 71.2, 64.9, 49.6, 27.1, 15.6. MS (ESI): <i>m</i>/<i>z</i> 340.1 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>5</sub>OS 340.1232, found 340.1242. HPLC: (a) <i>t</i><sub>R</sub> = 7.07 min, 98.9%; (b) <i>t</i><sub>R</sub> = 5.40 min, 99.0%.</div></div><div id="sec3_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 3-(Pent-4-ynyl)-8-(2-(trifluoromethoxy)phenylthio)-3<i>H</i>-purin-6-amine (<b>9d′</b>)</h5><div class="NLM_p last">Yield: 19%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.01 (s, 1H), 7.50 (d, <i>J</i> = 7.9 Hz, 1H), 7.21–7.27 (m, 2H), 7.13 (t, <i>J</i> = 7.1 Hz, 1H), 4.48 (t, <i>J</i> = 6.1 Hz, 2H), 2.17–2.20 (m, 4H), 2.04–2.05 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 158.3, 153.1, 142.2, 132.1, 128.1, 127.9, 126.9, 122.5, 120.7, 81.8, 70.5, 49.0, 26.9, 15.2. MS (ESI): <i>m</i>/<i>z</i> 393.7 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub>F<sub>3</sub>OS 394.0949, found 394.0946. HPLC: (a) <i>t</i><sub>R</sub> = 8.82 min, 99.7%; (b) <i>t</i><sub>R</sub> = 7.19 min, 99.4%.</div></div><div id="sec3_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 8-(2,4-Dichlorophenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9g′</b>)</h5><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.10 (s, 1H), 7.50 (s, 1H), 7.42 (d, <i>J</i> = 8.4 Hz, 1H), 7.23–7.25 (m, 1H), 4.46 (t, <i>J</i> = 6.5 Hz, 2H), 2.24–2.27 (m, 2H), 2.14–2.19 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 154.8, 152.9, 150.0, 142.8, 133.9, 132.3, 130.6, 129.3, 128.8, 127.2, 120.4, 81.3, 70.0, 49.8, 26.7, 14.7. MS (ESI): <i>m</i>/<i>z</i> 377.7 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>Cl<sub>2</sub>S 378.0347, found 378.0335. HPLC: (a) <i>t</i><sub>R</sub> = 9.18 min, 98.4%; (b) <i>t</i><sub>R</sub> = 7.35 min, 99.0%.</div></div><div id="sec3_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 8-(2,4-Dimethylphenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>1</b>)</h5><div class="NLM_p last">Yield: 27%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.94 (s, 1H), 7.48 (d, <i>J</i> = 7.7 Hz, 1H), 7.08 (s, 1H), 6.97 (d, <i>J</i> = 7.7 Hz, 1H), 4.36 (t, <i>J</i> = 6.1 Hz, 2H), 2.51 (s, 3H), 2.39 (s, 3H), 2.15–2.19 (m, 4H), 2.03–2.05 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 162.6, 151.9, 151.1, 141.5, 141.1, 138.6, 134.5, 131.3, 127.3, 127.2, 121.7, 81.8, 70.5, 48.8, 26.9, 21.1, 20.8, 15.2. MS (ESI): <i>m</i>/<i>z</i> 338.1 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>N<sub>5</sub>S 338.1439, found 338.1427. HPLC: (a) <i>t</i><sub>R</sub> = 8.24 min, 99.4%; (b) <i>t</i><sub>R</sub> = 7.19 min, 99.6%.</div></div><div id="sec3_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 8-(2,4-Dimethoxyphenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9j′</b>)</h5><div class="NLM_p last">Yield: 7%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.99 (s, 1H), 7.53 (d, <i>J</i> = 8.1 Hz, 1H), 6.56–6.59 (m, 2H), 4.43 (t, <i>J</i> = 6.8 Hz, 2H), 3.86 (s, 3H), 3.82 (s, 3H), 2.12–2.26 (m, 5H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 162.2, 160.6, 151.8, 141.6, 137.3, 135.2, 108.8, 105.3, 99.1, 81.5, 70.1, 55.6, 55.1, 26.7, 14.8. MS (ESI): <i>m</i>/<i>z</i> 370.0 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>N<sub>5</sub>O<sub>2</sub>S 370.1338, found 370.1350. HPLC: (a) <i>t</i><sub>R</sub> = 7.79 min, 97.9%; (b) <i>t</i><sub>R</sub> = 6.73 min, 98.7%.</div></div><div id="sec3_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 8-(2,5-Dichlorophenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9k′</b>)</h5><div class="NLM_p last">Yield: 21%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.06 (s, 1H), 7.43 (s, 1H), 7.26–7.28 (m, 1H), 7.06–7.08 (m, 1H), 4.50–4.52 (m, 2H), 2.21–2.24 (m, 4H), 2.05–2.06 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 153.6, 142.6, 132.7, 130.3, 129.7, 127.3, 81.7, 70.6, 49.2, 26.9, 15.2. MS (ESI): <i>m</i>/<i>z</i> 377.8 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>Cl<sub>2</sub>S 378.0347, found 378.0362. HPLC: (a) <i>t</i><sub>R</sub> = 9.07 min, 95.6%; (b) <i>t</i><sub>R</sub> = 7.30 min, 97.8%.</div></div><div id="sec3_1_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 8-(2,5-Dimethylphenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9l′</b>)</h5><div class="NLM_p last">Yield: 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.96 (s, 1H), 7.41 (s, 1H), 7.13 (d, <i>J</i> = 7.7 Hz, 1H), 7.04 (d, <i>J</i> = 7.7 Hz, 1H), 4.45 (t, <i>J</i> = 6.3 Hz, 2H), 2.43 (s, 3H), 2.37 (s, 3H), 2.17–2.27 (m, 3H), 2.04 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 152.0, 151.2, 141.7, 137.7, 135.9, 134.5, 130.9, 130.2, 129.2, 81.8, 70.5, 48.9, 27.0, 20.8, 20.4, 15.3. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>N<sub>5</sub>S 338.1439, found 338.1435. HPLC: (a) <i>t</i><sub>R</sub> = 8.67 min, 95.7%.</div></div><div id="sec3_1_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 8-(2-Chloro-5-(trifluoromethyl)phenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9m′</b>)</h5><div class="NLM_p last">Yield: 18%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.08 (s, 1H), 7.84 (s, 1H), 7.57 (d, <i>J</i> = 8.3 Hz, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 4.48 (t, <i>J</i> = 6.5 Hz, 2H), 2.16–2.26 (m, 4H), 2.09–2.10 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 157.4, 153.2, 150.4, 142.8, 138.2, 134.5, 130.1, 129.4, 128.9, 124.8, 121.9, 81.5, 70.4, 28.3, 26.7, 15.0. MS (ESI): <i>m</i>/<i>z</i> 411.8 [M + H]<sup>+</sup>. HPLC: (a) <i>t</i><sub>R</sub> = 9.38 min, 95.0%; (b) <i>t</i><sub>R</sub> = 7.66 min, 97.5%.</div></div><div id="sec3_1_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 8-(3,5-Dichlorophenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9n′</b>)</h5><div class="NLM_p last">Yield: 14%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.03 (s, 1H), 7.46 (s, 2H), 7.30 (s, 1H), 4.50–4.52 (m, 2H), 2.20–2.24 (m, 3H), 2.04–2.07 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 157.6, 152.6, 150.8, 142.9, 136.3, 134.8, 128.7, 127.1, 120.4, 81.3, 70.1, 43.8, 26.7, 14.7. MS (ESI): <i>m</i>/<i>z</i> 377.8 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>15</sub>N<sub>5</sub>Cl<sub>2</sub>S 378.0347, found 378.0340. HPLC: (a) <i>t</i><sub>R</sub> = 9.50 min, 99.3%; (b) <i>t</i><sub>R</sub> = 7.57 min, 99.5%.</div></div><div id="sec3_1_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 8-((3-Bromo-5-chlorophenyl)thio)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>9o</b>)</h5><div class="NLM_p last">Yield: 37%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.36 (1H, s), 7.42–7.44 (2H, m), 7.33 (1H, s), 6.19 (2H, br s), 4.33 (2H, t, <i>J</i> = 7.3 Hz), 2.27 (2H, td, <i>J</i> = 6.6, 2.4 Hz), 1.99–2.03 (3H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.9, 153.5, 151.5, 143.5, 135.9, 134.7, 131.2, 131.0, 128.7, 123.4, 120.3, 82.3, 69.7, 43.0, 28.3, 16.0. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>SClBr 423.9821, found 423.9822.</div></div><div id="sec3_1_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 8-((3,5-Dibromophenyl)thio)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>9p</b>)</h5><div class="NLM_p last">Yield: 37%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.31 (1H, s), 7.62 (1H, t, <i>J</i> = 1.6 Hz), 7.50 (2H, d, <i>J</i> = 1.7 Hz), 6.22 (2H, br s), 4.33 (2H, t, <i>J</i> = 7.5 Hz), 2.27 (2H, td, <i>J</i> = 6.8, 2.6 Hz), 1.99–2.05 (3H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.2, 152.9, 151.6, 145.8, 134.1, 131.8, 128.2, 123.6, 114.5, 82.4, 69.7, 43.0, 28.2, 16.0. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>SBr<sub>2</sub> 465.9337, found 465.9329.</div></div><div id="sec3_1_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 8-(3,5-Dimethylphenylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9q′</b>)</h5><div class="NLM_p last">Yield: 16%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.01 (s, 1H), 7.23 (s, 2H), 7.00 (s, 1H), 4.45 (t, <i>J</i> = 7.5 Hz, 2H), 2.26 (s, 6H), 2.21–2.25 (m, 4H), 1.94–1.99 (m, 1H). MS (ESI): <i>m</i>/<i>z</i> 338.1 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>N<sub>5</sub>S 338.1439, found 338.1426. HPLC: (a) <i>t</i><sub>R</sub> = 8.80 min, 98.9%; (b) <i>t</i><sub>R</sub> = 7.36 min, 99.2%.</div></div><div id="sec3_1_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 8-((2,6-Dichloropyridin-4-yl)thio)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>9r</b>)</h5><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.32 (s, 1H), 7.47 (s, 1H), 7.18 (s, 1H), 4.38 (t, <i>J</i> = 7.2 Hz, 2H), 2.26–2.29 (m, 2H), 2.03–2.05 (m, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 159.3, 157.6, 155.0, 154.9, 153.9, 124.4, 124.3, 85.8, 73.6, 47.3, 41.7, 32.3, 19.7. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>6</sub>SCl<sub>2</sub> 379.0299, found 379.0312.</div></div><div id="sec3_1_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 8-((3,4-Dichlorophenyl)thio)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>9t</b>)</h5><div class="NLM_p last">Yield: 54%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.25 (1H, s), 7.58 (1H, d, <i>J</i> = 2.2 Hz), 7.40 (1H, d, <i>J</i> = 8.4 Hz), 7.25 (1H, dd, <i>J</i> = 8.3, 2.1 Hz), 6.97 (2H, br s), 4.32 (2H, t, <i>J</i> = 7.4 Hz), 2.28 (2H, td, <i>J</i> = 6.8, 2.6 Hz), 1.97–2.02 (3H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.8, 153.3, 151.5, 144.6, 133.6, 133.0, 132.5, 131.3, 130.6, 130.2, 120.1, 82.3, 69.6, 42.9, 28.2, 16.0. MS (ESI): <i>m</i>/<i>z</i> 378.9 [M + H]<sup>+</sup>. HPLC: <i>t</i><sub>R</sub> = 8.50 min. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>SCl<sub>2</sub> 378.0347, found 378.0353.</div></div><div id="sec3_1_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 9-(Pent-4-yn-1-yl)-8-((2,3,4-trichlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>9u</b>)</h5><div class="NLM_p last">Yield: 39%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.35 (1H, s), 7.29 (1H, d, <i>J</i> = 8.6 Hz), 6.97 (1H, d, <i>J</i> = 8.6 Hz), 6.18 (2H, br s), 4.34 (2H, t, <i>J</i> = 7.3 Hz), 2.26 (2H, td, <i>J</i> = 6.8, 2.4 Hz), 2.03 (2H, p, <i>J</i> = 6.9 Hz), 1.98 (1H, t, <i>J</i> = 2.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.8, 153.6, 151.5, 143.2, 133.5, 133.4, 133.0, 132.4, 128.8, 128.4, 120.5, 82.1, 69.7, 43.1, 28.4, 16.0. MS (ESI): <i>m</i>/<i>z</i> 412.0 [M + H]<sup>+</sup>. HPLC: <i>t</i><sub>R</sub> = 8.78 min. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>13</sub>N<sub>5</sub>SCl<sub>3</sub> 411.9957, found 411.9967.</div></div><div id="sec3_1_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 3-(Pent-4-ynyl)-8-(2,4,5-trichlorophenylthio)-3<i>H</i>-purin-6-amine (<b>9v′</b>)</h5><div class="NLM_p last">Yield: 23%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.04 (s, 1H), 7.73 (s, 1H), 7.55 (s, 1H), 4.50 (t, <i>J</i> = 6.4 Hz, 2H), 2.08–2.29 (m, 4H), 2.06–2.07 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 159.6, 154.7, 152.4, 144.3, 135.3, 134.9, 134.7, 133.5, 132.9, 132.4, 128.8, 83.4, 72.2, 48.6, 28.6, 16.8. MS (ESI): <i>m</i>/<i>z</i> 411.9 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>13</sub>N<sub>5</sub>Cl<sub>3</sub>S 411.9957, found 411.9947. HPLC: (a) <i>t</i><sub>R</sub> = 9.84 min, 99.5%; (b) <i>t</i><sub>R</sub> = 7.96 min, 99.4%.</div></div><div id="sec3_1_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 8-(Mesitylthio)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>9w</b>)</h5><div class="NLM_p last">Yield: 32%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.21 (s, 1H), 6.98 (s, 2H), 5.87 (br s, 2H), 4.31 (t, 2H), 2.40 (s, 6H), 2.29–2.34 (m, 2H), 2.23 (s, 3H), 2.12 (m, 2H), 2.01 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 153.7, 151.8, 151.7, 143.3, 140.2, 129.5, 123.1, 119.7, 82.5, 69.4, 49.9, 42.4, 28.2, 21.8, 21.0, 16.1. MS (ESI): <i>m</i>/<i>z</i> 352.1 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>N<sub>5</sub>S 352.1596, found 352.1598. HPLC: (a) <i>t</i><sub>R</sub> = 6.58 min, 99.6%.</div></div><div id="sec3_1_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 8-(Mesitylthio)-3-(pent-4-ynyl)-3<i>H</i>-purin-6-amine (<b>9w′</b>)</h5><div class="NLM_p">Yield: 15%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.93 (s, 1H), 6.97 (s, 2H), 4.38 (t, <i>J</i> = 6.5 Hz, 2H), 2.41 (s, 6H), 2.30 (s, 3H), 2.04–2.16 (m, 5H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 157.4, 150.4, 143.0, 142.2, 139.2, 128.9, 124.8, 81.5, 70.1, 26.7, 21.6, 21.3, 20.5, 14.8. MS (ESI): <i>m</i>/<i>z</i> 351.8 [M + H]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>N<sub>5</sub>S 352.1596, found 352.1594. HPLC: (a) <i>t</i><sub>R</sub> = 9.05 min, 99.6%; (b) <i>t</i><sub>R</sub> = 7.49 min, 99.7%.</div><div class="NLM_p last">Formation of <b>9a</b>–<b>n</b>, <b>9q</b>, and <b>9v</b> followed a similar protocol. Synthesis and characterization of these coupling products have been described elsewhere.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec3_1_2_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 8-Bromo-9<i>H</i>-purin-6-amine (<b>11</b>)</h5><div class="NLM_p last">Adenine (2.2 g, 16.3 mmol) was added to a solution of bromine (6.0 mL, 117.7 mmol) in water (200 mL), and the resulting mixture was stirred overnight at room temperature. The solvent was evaporated to dryness to yield <b>11</b>, which was used further without additional purification. MS (ESI): <i>m</i>/<i>z</i> 213.5/215.6 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_2_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 8-Bromo-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>12</b>)</h5><div class="NLM_p last">A mixture of 8-bromoadenine (<b>11</b>; 0.1 g, 0.47 mmol), Cs<sub>2</sub>CO<sub>3</sub> (0.3 g, 0.94 mmol), and 5-chloropent-1-yne (0.13g, 0.65 mmol) in DMF (1.5 mL) under nitrogen protection was heated at 80 °C for 2 h. Following solvent removal, the crude material was purified by preparatory TLC with CH<sub>2</sub>Cl<sub>2</sub>:MeOH:AcOH at 20:1:0.1 to provide 36 mg (30%) of <b>12</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.29 (s, 1H), 4.33 (t, <i>J</i> = 7.2 Hz, 2H), 2.28–2.33 (m, 2H), 2.09 (q, <i>J</i> = 7.0 Hz, 2H), 2.01–2.03 (t, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 154.4, 153.1, 151.3, 127.4, 119.9, 82.4, 69.7, 43.8, 28.2, 16.1. MS (ESI): <i>m</i>/<i>z</i> 280.1/282.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_2_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 5-((6-Amino-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-8-yl)thio)isophthalonitrile (<b>9s</b>)</h5><div class="NLM_p last">A mixture of 5-mercaptoisophthalonitrile<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (11 mg, 0.069 mmol) and <i>t</i>-BuOK (7 mg, 0.069 mmol) in 1.5 mL of DMF was stirred for 15 min at room temperature. Compound <b>12</b> (16 mg, 0.057 mmol) was then added and the reaction mixture was allowed to stir at 80 °C for 2 h. Following solvent removal, the crude material was purified by preparatory TLC with CH<sub>2</sub>Cl<sub>2</sub>:MeOH at 20:1 to provide 10.2 mg (51%) of the title compound. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.38 (s, 1H), 7.98 (s, 2H), 7.85 (s, 1H), 4.37 (t, <i>J</i> = 7.3 Hz, 2H), 2.27–2.30 (m, 2H), 2.05 (q, <i>J</i> = 6.9 Hz, 2H), 2.01–2.03 (t, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 154.7, 153.8, 151.7, 142.2, 136.9, 136.1, 134.3, 120.5, 115.8, 115.2, 82.2, 69.8, 43.1, 28.3, 15.9. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>14</sub>N<sub>7</sub>S 360.1031, found 360.1028.</div></div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> General Procedure for the Synthesis of <b>13a</b>–<b>k,m,o,q,r</b></h4><div class="NLM_p">A mixture of 8-((3,5-dichlorophenyl)thio)-9<i>H</i>-purin-6-amine (1.0 mmol), Cs<sub>2</sub>CO<sub>3</sub> (1.2 mmol), and the respective alkyl bromides or alkyl benzenesulfonate (2.0 mmol) in DMF (1.5 mL) under nitrogen atmosphere was heated at 80 °C for 30 min. Following solvent removal, the crude material was purified by preparatory TLC with CHCl<sub>3</sub>:MeOH:NH<sub>4</sub>OH at 10:1:0.5 or CHCl<sub>3</sub>:MeOH:AcOH at 10:1:0.5 to provide the corresponding 9-alkyl-8-arylsulfanyladenine derivatives.</div><div id="sec3_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 9-(But-3-yn-1-yl)-8-((3,5-dichlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>13a</b>)</h5><div class="NLM_p last">Yield: 47%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.37 (1H, s), 7.28 (3H, s), 6.04 (2H, br s), 4.45 (2H, t, <i>J</i> = 7.0 Hz), 2.76 (2H, td, <i>J</i> = 6.8, 2.3 Hz), 1.95 (1H, t, <i>J</i> = 2.4 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.9, 153.6, 151.3, 143.7, 135.8, 134.9, 128.3, 127.9, 120.4, 79.4, 71.5, 42.3, 19.5. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>12</sub>N<sub>5</sub>SCl<sub>2</sub> 364.0190, found 364.0194.</div></div><div id="sec3_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 8-((3,5-Dichlorophenyl)thio)-9-(hex-5-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>13b</b>)</h5><div class="NLM_p last">Yield: 41%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.29 (1H, s), 7.28 (3H, s), 6.71 (2H, br s), 4.26 (2H, t, <i>J</i> = 7.2 Hz), 2.22 (2H, td, <i>J</i> = 6.8, 2.7 Hz), 1.95 (1H, t, <i>J</i> = 2.6 Hz), 1.87–1.93 (2H, m), 1.53 (2H, pentet, <i>J</i> = 6.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 155.0, 151.2, 143.6, 135.9, 134.4, 129.0, 128.5, 128.2, 120.0, 83.3, 69.1, 43.5, 28.8, 25.3, 17.9. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub>SCl<sub>2</sub> 392.0503, found 392.0493.</div></div><div id="sec3_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 9-(But-2-yn-1-yl)-8-((3,5-dichlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>13c</b>)</h5><div class="NLM_p last">Yield: 40%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.33 (1H, s), 7.32 (2H, s), 7.28 (1H, s), 6.63 (2H, br s), 4.98–4.99 (2H, m), 1.70 (3H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 155.1, 153.2, 150.8, 143.3, 135.7, 134.5, 128.5, 128.3, 120.0, 82.1, 71.7, 33.4, 3.5. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>12</sub>N<sub>5</sub>SCl<sub>2</sub> 364.0190, found 364.0197.</div></div><div id="sec3_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 8-((3,5-Dichlorophenyl)thio)-9-(3,3,3-trifluoropropyl)-9<i>H</i>-purin-6-amine (<b>13d</b>)</h5><div class="NLM_p last">Yield: 43%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.33 (1H, s), 7.29 (3H, s), 6.44 (2H, br s), 4.49 (2H, t, <i>J</i> = 6.8 Hz), 2.64–2.68 (2H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 155.0, 153.4, 151.2, 143.5, 136.0, 133.8, 128.8, 128.4, 126.6, 120.2, 37.3, 33.3. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>11</sub>N<sub>5</sub>SCl<sub>2</sub>F<sub>3</sub> 408.0064, found 408.0074.</div></div><div id="sec3_1_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 8-((3,5-Dichlorophenyl)thio)-9-(4,4,4-trifluorobutyl)-9<i>H</i>-purin-6-amine (<b>13e</b>)</h5><div class="NLM_p last">Yield: 44%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.36 (1H, s), 7.28 (3H, s), 6.16 (2H, br s), 4.30 (2H, t, <i>J</i> = 6.6 Hz), 2.10–2.14 (2H, m), 2.03–2.05 (2H, m). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.9, 153.7, 151.5, 143.2, 135.9, 134.2, 128.6, 128.1, 125.1, 120.3, 42.5, 31.3, 22.5. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>5</sub>SCl<sub>2</sub>F<sub>3</sub> 422.0221, found 422.0222.</div></div><div id="sec3_1_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 8-((3,5-Dichlorophenyl)thio)-9-(5,5,5-trifluoropentyl)-9<i>H</i>-purin-6-amine (<b>13f</b>)</h5><div class="NLM_p last">Yield: 45%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.28 (1H, s), 7.28 (3H, s), 6.82 (2H, br s), 4.25 (2H, t, <i>J</i> = 7.2 Hz), 2.07–2.14 (2H, m), 1.85 (2H, pentet, <i>J</i> = 7.4 Hz), 1.57 (2H, pentet, <i>J</i> = 7.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 155.1, 152.7, 151.2, 143.5, 135.9, 134.1, 128.6, 128.2, 125.4, 120.1, 43.3, 33.1, 28.8, 19.2. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>15</sub>N<sub>5</sub>SF<sub>3</sub>Cl<sub>2</sub> 436.0377, found 436.0363.</div></div><div id="sec3_1_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 8-((3,5-Dichlorophenyl)thio)-9-(6,6,6-trifluorohexyl)-9<i>H</i>-purin-6-amine (<b>13g</b>)</h5><div class="NLM_p last">Yield: 47%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.35 (1H, s), 7.29 (3H, s), 6.33 (2H, br s), 4.24 (2H, t, <i>J</i> = 7.2 Hz), 2.00–2.07 (2H, m), 1.79 (2H, pentet, <i>J</i> = 7.4 Hz), 1.57 (2H, pentet, <i>J</i> = 7.6 Hz), 1.37 (2H, pentet, <i>J</i> = 7.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 155.1, 152.8, 151.3, 143.4, 135.9, 134.4, 128.5, 128.1, 125.8, 120.0, 43.6, 33.9, 29.4, 25.7, 21.4. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>SCl<sub>2</sub>F<sub>3</sub> 450.0534, found 450.0549.</div></div><div id="sec3_1_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 4-(6-Amino-8-((3,5-dichlorophenyl)thio)-9<i>H</i>-purin-9-yl)butanenitrile (<b>13h</b>)</h5><div class="NLM_p last">Yield: 41%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.34 (1H, s), 7.31 (3H, s), 6.04 (2H, br s), 4.36 (2H, t, <i>J</i> = 7.0 Hz), 2.42 (2H, t, <i>J</i> = 7.1 Hz), 2.18 (2H, pentet, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.8, 152.7, 151.5, 143.4, 136.0, 133.9, 129.2, 127.5, 120.2, 118.3, 42.4, 25.6, 14.9. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>6</sub>SCl<sub>2</sub> 379.0299, found 379.0303.</div></div><div id="sec3_1_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 9-Benzyl-8-((3,5-dichlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>13i</b>)</h5><div class="NLM_p last">Yield: 48%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.43 (1H, s), 7.23 (3H, s), 7.15–7.19 (3H, m), 7.04–7.05 (2H, m), 5.97 (2H, br s), 5.45 (2H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 154.9, 153.9, 151.7, 143.6, 135.6, 135.3, 134.5, 128.7, 128.2, 128.1, 127.9, 127.5, 120.8, 47.0. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>14</sub>N<sub>5</sub>SCl<sub>2</sub> 402.0347, found 402.0335.</div></div><div id="sec3_1_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 8-((3,5-Dichlorophenyl)thio)-9-phenethyl-9<i>H</i>-purin-6-amine (<b>13j</b>)</h5><div class="NLM_p last">Yield: 45%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.35 (1H, s), 7.22–7.26 (4H, m), 7.19–7.20 (2H, m), 7.04–7.06 (2H, m), 6.45 (2H, br s), 4.47 (2H, t, <i>J</i> = 7.2 Hz), 3.09 (2H, t, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 153.8, 151.5, 151.2, 145.1, 136.8, 135.8, 134.0, 128.9, 128.8, 128.6, 128.5, 127.2, 120.1, 45.5, 35.7. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>16</sub>N<sub>5</sub>SCl<sub>2</sub> 416.0503, found 416.0508.</div></div><div id="sec3_1_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 8-((3,5-Dichlorophenyl)thio)-9-(pent-4-yn-2-yl)-9<i>H</i>-purin-6-amine (<b>13m</b>)</h5><div class="NLM_p last">Yield: 12%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.27 (s, 1H), 7.26–7.28 (m, 3H), 6.28 (br s, 2H), 4.96 (m, 1H), 3.31 (ddd, <i>J</i> = 2.6, 9.6, 16.9 Hz, 1H), 2.82 (ddd, <i>J</i> = 2.6, 5.9, 16.9 Hz, 1H), 1.83 (t, <i>J</i> = 2.6 Hz, 1H), 1.66 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 155.0, 152.4, 151.1, 143.6, 135.8, 135.3, 128.2, 127.9, 120.6, 80.0, 70.8, 53.4, 24.9, 19.3. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>SCl<sub>2</sub> 378.0347, found 378.0336.</div></div><div id="sec3_1_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 9-Butyl-8-((2,4-dichlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>13o</b>)</h5><div class="NLM_p last">Yield: 23%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.36 (s, 1H), 7.47 (d, <i>J</i> = 2.1 Hz, 1H), 7.17–7.19 (m, 1H), 7.13–7.15 (m, 1H), 5.71 (br s, 2H), 4.22 (t, <i>J</i> = 7.5 Hz, 2H), 1.72–1.77 (m, 2H), 1.32–1.36 (m, 2H), 0.92 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 154.6, 153.4, 151.6, 143.8, 134.9, 134.6, 132.3, 130.1, 129.9, 128.1, 120.4, 43.8, 31.4, 19.9, 13.5. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>16</sub>N<sub>5</sub>SCl<sub>2</sub> 368.0503, found 368.0493.</div></div><div id="sec3_1_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 9-(But-3-yn-1-yl)-8-((2,4-dichlorophenyl)thio)-9<i>H</i>-purin-6-amine (<b>13q</b>)</h5><div class="NLM_p last">Yield: 20%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.33 (s, 1H), 7.47 (s, 1H), 7.21 (m, 2H), 5.96 (br s, 2H), 4.45 (t, <i>J</i> = 7.0 Hz, 2H), 2.75–2.78 (m, 2H), 1.95 (t, <i>J</i> = 2.5 Hz, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 154.6, 153.1, 151.3, 144.4, 135.2, 134.8, 132.6, 130.2, 129.8, 128.1, 120.3, 79.3, 71.5, 42.3, 19.6. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>12</sub>N<sub>5</sub>SCl<sub>2</sub> 364.0190, found 364.0177.</div></div><div id="sec3_1_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 8-((2,4-Dichlorophenyl)thio)-9-(pent-4-yn-2-yl)-9<i>H</i>-purin-6-amine (<b>13r</b>)</h5><div class="NLM_p last">Yield: 12%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.27 (s, 1H), 7.47 (d, <i>J</i> = 2.0 Hz, 1H), 7.14–7.18 (m, 2H), 6.13 (br s, 2H), 4.98 (m, 1H), 3.31 (ddd, <i>J</i> = 2.6, 9.2, 16.9 Hz, 1H), 2.82 (ddd, <i>J</i> = 2.6, 6.2, 16.9 Hz, 1H), 1.83 (t, <i>J</i> = 2.6 Hz, 1H), 1.66 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 154.8, 152.3, 151.2, 144.1, 134.8, 134.5, 132.3, 130.2, 130.0, 127.9, 120.7, 80.0, 70.8, 53.4, 24.5, 19.1. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>SCl<sub>2</sub> 378.0347, found 378.0354.</div></div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> General Procedure for the Synthesis of <b>13l,n,p,s</b></h4><div class="NLM_p">To a suspension of 8-((2,4-dichlorophenyl)thio)-9<i>H</i>-purin-6-amine (1.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub>:toluene (0.5:2.5 mL) were added PPh<sub>3</sub> (4.0 mmol) and alcohol (2.0 mmol) under nitrogen protection. After stirring for 10 min, DBAD (6 mmol) was added and the reaction mixture was stirred at rt for 2–5 h. Following solvent removal, the crude material was purified by preparative TLC [CH<sub>2</sub>Cl<sub>2</sub>:CH<sub>3</sub>OH:AcOH, 20:1:0.1 or CH<sub>2</sub>Cl<sub>2</sub>:NH<sub>3</sub>–CH<sub>3</sub>OH (7 N), 20:1] to afford the desired compounds.</div><div id="sec3_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 8-((3,5-Dichlorophenyl)thio)-9-(pentan-2-yl)-9<i>H</i>-purin-6-amine (<b>13l</b>)</h5><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>, two rotamers): δ 8.17–8.21 (m, 1H), 7.40–7.56 (m, 3H), 4.76–4.79 (m, 0.4H), 4.65–4.69 (m, 0.6H), 2.21–2.27 (m, 0.6H), 1.97–2.03 (m, 0.4H), 1.81–1.92 (m, 1H), 1.60–1.63 (m, 3H), 1.03–1.28 (m, 2H), 0.87–0.89 (m, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 153.3, 151.2, 150.0, 145.6, 135.9, 135.2, 133.5, 130.2, 129.1, 128.1, 120.4, 54.4, 36.7, 19.8, 19.7, 13.6. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>5</sub>S 382.0660, found 382.0663.</div></div><div id="sec3_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 8-((3,5-Dichlorophenyl)thio)-9-(hex-5-yn-3-yl)-9<i>H</i>-purin-6-amine (<b>13n</b>)</h5><div class="NLM_p last">Yield: 37%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.25 (s, 1H), 7.35–7.37 (m, 2H), 7.33 (t, <i>J</i> = 1.7 Hz, 1H), 4.71–4.74 (m, 1H), 3.27–3.33 (m, 1H), 2.80–2.84 (m, 1H), 2.32–2.35 (m, 1H), 2.02–2.05 (m, 1H), 1.84 (t, <i>J</i> = 2.5 Hz, 1H), 0.79 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 153.6, 150.5, 147.7, 135.8, 133.6, 132.1, 131.9, 129.3, 128.9, 128.4, 79.6, 71.1, 59.9, 26.2, 23.3, 10.9. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>5</sub>S 392.0503, found 392.0503.</div></div><div id="sec3_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 8-((2,4-Dichlorophenyl)thio)-9-(pentan-2-yl)-9<i>H</i>-purin-6-amine (<b>13p</b>)</h5><div class="NLM_p last">Yield: 15%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.22 (s, 1H), 7.43 (d, <i>J</i> = 1.8 Hz, 1H), 7.13–7.20 (m, 2H), 6.14 (br s, 2H), 4.65–4.70 (m, 1H), 2.17–2.23 (m, 1H), 1.80–1.86 (m, 1H), 1.54 (d, <i>J</i> = 6.9 Hz, 3H), 1.12–1.19 (m, 1H), 0.97–1.02 (m, 1H), 0.79 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 153.3, 151.2, 150.0, 145.6, 135.9, 135.2, 133.5, 130.2, 129.1, 128.1, 120.4, 54.4, 36.7, 19.8, 19.7, 13.6. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>5</sub>S 382.0660, found 382.0663.</div></div><div id="sec3_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 8-((2,4-Dichlorophenyl)thio)-9-(hex-5-yn-3-yl)-9<i>H</i>-purin-6-amine (<b>13s</b>)</h5><div class="NLM_p last">Yield: 24%. <sup>1</sup>H NMR (600 MHz, MeOH-<i>d</i><sub>4</sub>): δ 8.27 (s, 1H), 7.69 (d, <i>J</i> = 2.2 Hz, 1H), 7.63 (d, <i>J</i> = 8.5 Hz, 1H), 7.42 (d, <i>J</i> = 8.5 and 2.3 Hz, 1H), 4.75–4.79 (m, 1H), 3.24–3.28 (m, 1H), 2.89–2.94 (m, 1H), 2.35–2.41 (m, 1H), 2.25 (t, <i>J</i> = 2.6 Hz, 1H), 2.05–2.10 (m, 1H), 0.84 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (150 MHz, MeOH-<i>d</i><sub>4</sub>): δ 153.3, 151.2, 150.0, 145.6, 135.9, 135.2, 133.5, 130.2, 129.1, 128.1, 120.4, 54.4, 36.7, 19.8, 19.7, 13.6. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>5</sub>S 392.0660, found 392.0663.</div></div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Synthesis of <b>14a</b> and <b>14b</b></h4><div class="NLM_p">A mixture of <b>9g</b> (20 mg, 0.053 mmol) and <i>m</i>-CPBA (18.2 mg, 0.106 mmol) in THF:CH<sub>2</sub>Cl<sub>2</sub> (2 mL) under nitrogen protection was stirred at room temperature for 30 min. Following solvent removal, the crude material was purified by preparative TLC [CH<sub>2</sub>Cl<sub>2</sub>:CH<sub>3</sub>OH–NH<sub>3</sub> (7 N), 20:1] to afford <b>14a</b> and <b>14b</b>.</div><div id="sec3_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 8-((2,4-Dichlorophenyl)sulfinyl)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>14a</b>)</h5><div class="NLM_p last">Yield: 23%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.29 (s, 1H), 8.04 (d, <i>J</i> = 8.5 Hz, 1H), 7.58 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 7.41 (d, <i>J</i> = 2.0 Hz, 1H), 4.57 (t, <i>J</i> = 7.1 Hz, 2H), 2.30 (td, <i>J</i> = 7.0, 2.6 Hz, 2H), 2.06–2.20 (m, 2H), 1.98 (t, <i>J</i> = 2.6 Hz, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 155.1, 152.6, 150.6, 139.2, 136.3, 131.9, 130.1, 128.7, 128.6, 119.1, 81.9, 70.0, 43.5, 28.7, 16.0. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>5</sub>OS 394.0296, found 394.0279.</div></div><div id="sec3_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 8-((2,4-Dichlorophenyl)sulfonyl)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>14b</b>)</h5><div class="NLM_p last">Yield: 34%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.39 (s, 1H), 8.24 (d, <i>J</i> = 8.4 Hz, 1H), 7.48–7.51 (m, 2H), 6.24 (br s, 2H), 4.88 (t, <i>J</i> = 7.6 Hz, 2H), 2.29 (td, <i>J</i> = 7.0, 2.6 Hz, 2H), 2.10–2.16 (m, 2H), 1.92 (t, <i>J</i> = 2.6 Hz, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 155.4, 153.3, 150.7, 146.2, 142.2, 134.9, 134.8, 132.6, 132.0, 127.9, 119.3, 82.1, 69.6, 44.4, 28.9, 16.1. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub>S 410.0245, found 410.0228.</div></div><div id="sec3_1_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 8-(2,4-Dichlorophenoxy)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>14c</b>)</h5><div class="NLM_p last">A mixture of 2,4-dichlorophenol (0.069 mmol) and KO<i>t</i>-Bu (0.069 mmol) in DMF (1.5 mL) was stirred for 15 min at room temperature. Compound <b>12</b> (0.057 mmol) was added and the reaction mixture was allowed to stir at 80 °C for 2 h. Following solvent removal, the crude material was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 20:1) to afford <b>14c</b>. Yield: 51%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.22 (s, 1H), 7.45 (d, <i>J</i> = 2.5 Hz, 1H), 7.43 (d, <i>J</i> = 8.7 Hz, 1H), 7.27 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 5.42 (br s, 2H), 4.26 (t, <i>J</i> = 7.1 Hz, 2H), 2.27 (td, <i>J</i> = 7.0, 2.6 Hz, 2H), 2.09–2.14 (m, 2H), 1.90 (t, <i>J</i> = 2.6 Hz, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 153.2, 152.7, 151.4, 149.9, 147.4, 132.1, 130.6, 128.9, 128.3, 127.1, 123.7, 115.4, 82.5, 69.4, 41.2, 27.9, 16.1. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>5</sub>O 362.0575, found 362.0570.</div></div><div id="sec3_1_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 8-(2,4-Dichlorobenzyl)-9<i>H</i>-purin-6-amine (<b>17</b>)</h5><div class="NLM_p last">In a conical-bottomed Smith process vial, the mixture of 4,5,6-triaminopyrimidine (<b>15</b>, 0.21 g, 1.7 mmol), 2,4-dichlorophenylacetic acid (<b>16</b>; 0.25 g, 1.4 mmol), and triphenyl phosphite (0.52 g, 443 μL, 1.7 mmol) in 1.5 mL of anhydrous pyridine was charged. The sealed vial was irradiated in the microwave for 30 min at 220 °C. After cooling, the reaction mixture was concentrated under vacuum and the residue purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 10:0 to 10:1) to give the desired product 1<b>7</b>. Yield: 79%. MS (ESI): <i>m</i>/<i>z</i> 294.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 8-(2,4-Dichlorobenzyl)-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-6-amine (<b>14d</b>)</h5><div class="NLM_p last">A mixture of <b>17</b> (1.0 mmol), Cs<sub>2</sub>CO<sub>3</sub> (1.2 mmol), and 1-chloro-pent-4-yne (2.0 mmol) in DMF (1.5 mL) under nitrogen protection was heated at 80 °C for 2 h. Following solvent removal, the crude material was purified by preparatory TLC (CH<sub>2</sub>Cl<sub>2</sub>:MeOH:AcOH, 15:1:0.1) to provide <b>14d</b>. Yield: 13%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.25 (s, 1H), 7.38 (d, <i>J</i> = 2.2 Hz, 1H), 7.13 (dd, <i>J</i> = 8.3 and 2.2 Hz, 1H), 7.01 (d, <i>J</i> = 8.3 Hz, 1H), 5.86 (br s, 2H), 4.29 (s, 2H), 4.15 (t, <i>J</i> = 7.4 Hz, 2H), 2.17 (td, <i>J</i> = 6.8 and 2.6 Hz, 2H), 1.90–1.96 (m, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 154.3, 151.7, 151.4, 150.2, 134.7, 134.1, 132.4, 131.4, 129.8, 127.8, 118.9, 82.5, 70.1, 42.3, 31.3, 28.4, 15.9. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>5</sub> 360.0783, found 360.0772.</div></div><div id="sec3_1_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> (6-Amino-9-(pent-4-yn-1-yl)-9<i>H</i>-purin-8-yl)(2,4-dichlorophenyl)methanone (<b>14e</b>)</h5><div class="NLM_p last">A mixture of <b>14d</b> (1.0 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (2.0 mmol) in DMF (1.3 mL) was heated at 80 °C for 3 h. Following solvent removal, the crude material was purified by preparatory TLC [CH<sub>2</sub>Cl<sub>2</sub>:CH<sub>3</sub>OH–NH<sub>3</sub> (7 N), 20:1] to provide the corresponding aryl ketone <b>14e</b>. Yield: 50%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.25 (s, 1H), 7.49 (d, <i>J</i> = 8.2 Hz, 1H), 7.43 (d, <i>J</i> = 1.9 Hz, 1H), 7.33 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 6.26 (br s, 2H), 4.73 (t, <i>J</i> = 7.2 Hz, 2H), 2.28 (td, <i>J</i> = 7.0, 2.6 Hz, 2H), 2.07–2.13 (m, 2H), 1.88 (t, <i>J</i> = 2.6 Hz, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 185.5, 155.9, 153.5, 151.3, 144.4, 137.9, 135.5, 133.5, 131.4, 130.3, 127.1, 119.6, 82.4, 69.3, 44.1, 28.9, 16.1. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>5</sub>O 374.0575, found 374.0571.</div></div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> General Procedure for the Synthesis of <b>18a</b> and <b>18b′</b></h4><div class="NLM_p">A mixture of 8-arylsulfanyladenine (100 mmol), Cs<sub>2</sub>CO<sub>3</sub> (100 mmol), and 3-(<i>tert</i>-butoxycarbonyl-isopropyl-amino)propyl tosylate (200 mmol) in DMF (1.3 mL) under nitrogen protection was heated at 80 °C for 30 min. Following solvent removal, the crude material was purified by preparatory TLC with CH<sub>2</sub>Cl<sub>2</sub>:MeOH:AcOH at 20:1:0.1 to afford the Boc-protected <i>N</i>9- and <i>N</i>3-alkylated compounds. They were separately treated with TFA (1 mL) at 0 °C for 1.5 h to provide with corresponding 9-alkyl-8-arylsulfanyladenine and 3-alkyl-8-arylsulfanyladenine derivatives.</div><div id="sec3_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> 8-((2,4-Dichlorophenyl)thio)-9-(3-(isopropylamino)propyl)-9<i>H</i>-purin-6-amine (<b>18a</b>)</h5><div class="NLM_p last">Yield: 35%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.23 (s, 1H), 7.55 (s, 1H), 7.38 (d, <i>J</i> = 8.3 Hz, 1H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 4.34 (t, <i>J</i> = 6.7 Hz, 2H), 2.92 (septet, <i>J</i> = 5.8 Hz, 1H), 2.69 (t, <i>J</i> = 6.4 Hz, 2H), 2.13 (quintet, <i>J</i> = 6.5 Hz, 2H), 1.16 (d, <i>J</i> = 5.7 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>6</sub>S 411.0925, found 411.0907.</div></div><div id="sec3_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> 8-((2,4-Dimethylphenyl)thio)-3-(3-(isopropylamino)propyl)-3<i>H</i>-purin-6-amine (<b>18b′</b>)</h5><div class="NLM_p last">Yield: 29%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.96 (s, 1H), 7.48 (d, <i>J</i> = 7.9 Hz, 1H), 7.11 (s, 1H), 7.00 (d, <i>J</i> = 7.8 Hz, 1H), 4.48 (t, <i>J</i> = 6.3 Hz, 2H), 2.91 (septet, <i>J</i> = 6.3 Hz, 1H), 2.65 (t, <i>J</i> = 6.1 Hz, 2H), 2.25–2.29 (m, 2H), 1.18 (d, <i>J</i> = 6.3 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>27</sub>N<sub>6</sub>S 371.2018, found 371.2035.</div></div><div id="sec3_1_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> 8-((3,5-Dichlorophenyl)thio)-9-(3-(isopropylamino)propyl)-9<i>H</i>-purin-6-amine (<b>18c</b>)</h5><div class="NLM_p last">Yield: 32%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 8.21 (s, 1H), 7.26 (t, <i>J</i> = 1.7 Hz, 1H), 7.24 (d, <i>J</i> = 1.9 Hz, 2H), 4.23 (t, <i>J</i> = 6.9 Hz, 2H), 2.63 (septet, <i>J</i> = 6.2 Hz, 1H), 2.46 (t, <i>J</i> = 6.4 Hz, 2H), 1.89 (quintet, <i>J</i> = 6.9 Hz, 2H), 0.97 (d, <i>J</i> = 6.3 Hz, 6H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 154.7, 153.1, 151.3, 144.1, 135.9, 133.7, 128.8, 128.7, 119.7, 48.6, 43.4, 41.6, 29.8, 22.4. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>6</sub>S 411.0925, found 411.0917. HPLC: (a) <i>t</i><sub>R</sub> = 6.28 min, 99.5%.</div></div><div id="sec3_1_6_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> 8-((3,5-Dichlorophenyl)thio)-3-(3-(isopropylamino)propyl)-3<i>H</i>-purin-6-amine (<b>18c′</b>)</h5><div class="NLM_p last">Yield: 18%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.98 (s, 1H), 7.33 (d, <i>J</i> = 1.8 Hz, 2H), 7.06 (t, <i>J</i> = 1.8 Hz, 1H), 4.40 (t, <i>J</i> = 6.7 Hz, 2H), 2.66 (septet, <i>J</i> = 6.2 Hz, 1H), 2.51 (t, <i>J</i> = 6.4 Hz, 2H), 2.06 (quintet, <i>J</i> = 6.5 Hz, 2H), 0.96 (d, <i>J</i> = 6.2 Hz, 6H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 157.9, 153.4, 151.0, 142.8, 137.8, 134.9, 127.9, 126.8, 122.6, 48.9, 48.1, 43.0, 29.5, 22.9. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>6</sub>S 411.0925, found 411.0928. HPLC: (a) <i>t</i><sub>R</sub> = 4.95 min, 99.7%.</div></div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> General Procedure for the Synthesis of <b>20d</b>–<b>f</b></h4><div class="NLM_p">To 4-amino-1-(4-methoxybenzyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridine-2-thiol (<b>19</b>;<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> 50 mg, 0.174 mmol) were added the respective aryl iodide (0.348 mmol), neocuproine hydrate (3.6 mg, 0.0174 mmol), CuI (3.3 mg, 0.0174 mmol), sodium <i>tert</i>-butoxide (25 mg, 0.261 mmol), and DMF (5 mL), and the reaction mixture was stirred at 110 °C for 24 h. Then, the solvent was removed under reduced pressure and the crude product was purified by preparatory TLC [CH<sub>2</sub>Cl<sub>2</sub>:MeOH–NH<sub>3</sub> (7 N), 10:1] to afford desired coupling derivatives <b>20d</b>–<b>f</b>.</div><div id="sec3_1_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 2-((2,4-Dichlorophenyl)thio)-1-(4-methoxybenzyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>20d</b>)</h5><div class="NLM_p last">Yield: 40%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.78 (d, <i>J</i> = 5.9 Hz, 1H), 7.36 (d, <i>J</i> = 2.1 Hz, 1H), 7.02 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 6.98 (d, <i>J</i> = 8.6 Hz, 2H), 6.91 (d, <i>J</i> = 8.6 Hz, 1H), 6.73 (d, <i>J</i> = 8.6 Hz, 2H), 6.65 (d, <i>J</i> = 6.0 Hz, 1H), 5.30 (s, 2H), 3.75 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 430.9 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 2-((3,5-Dichlorophenyl)thio)-1-(4-methoxybenzyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>20e</b>)</h5><div class="NLM_p last">Yield: 39%. MS (ESI): <i>m</i>/<i>z</i> 431.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_7_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 2-((6-Iodobenzo[<i>d</i>][1,3]dioxol-5-yl)thio)-1-(4-methoxybenzyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>20f</b>)</h5><div class="NLM_p last">Yield: 20%. MS (ESI): <i>m</i>/<i>z</i> 533.0 [M + H]<sup>+</sup>.</div></div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> General Procedure for the Synthesis of <b>21d</b>–<b>f</b></h4><div class="NLM_p">To coupling products <b>20d</b>–<b>f</b> (0.067 mmol) was added trifluoroacetic acid (3 mL), and the reaction mixture was stirred at 80 °C for 3 h. Then, the solvent was removed under reduced pressure and the crude product was purified by preparatory TLC [CH<sub>2</sub>Cl<sub>2</sub>:MeOH–NH<sub>3</sub> (7 N), 15:1] to afford corresponding deprotected intermediates <b>21d</b>–<b>f</b>.</div><div id="sec3_1_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> 2-((2,4-Dichlorophenyl)thio)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>21d</b>)</h5><div class="NLM_p last">Yield: 92%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/MeOH-<i>d</i><sub>4</sub>): δ 7.46–7.48 (m, 2H), 7.30 (d, <i>J</i> = 8.5 Hz, 1H), 7.02 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 6.85 (d, <i>J</i> = 6.4 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 310.8 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> 2-((3,5-Dichlorophenyl)thio)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>21e</b>)</h5><div class="NLM_p last">Yield: 71%. <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>): δ 7.47 (d, <i>J</i> = 6.7 Hz, 1H), 7.41–7.43 (m, 3H), 6.96 (d, <i>J</i> = 6.7 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 310.8 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_8_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 2-((6-Iodobenzo[<i>d</i>][1,3]dioxol-5-yl)thio)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>21f</b>)</h5><div class="NLM_p last">Yield: 78%. MS (ESI): <i>m</i>/<i>z</i> 412.8 [M + H]<sup>+</sup>.</div></div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> General Procedure for the Synthesis of <b>18d</b>–<b>f</b></h4><div class="NLM_p">To the appropriate intermediate (<b>21d</b>–<b>f</b>; 0.0477 mmol) in dry DMF (1.5 mL) were added Cs<sub>2</sub>CO<sub>3</sub> (0.0572 mmol) and 1,3-dibromopropane (0.238 mmol), and the reaction mixture was stirred at rt for 2 h. The solvent was removed under reduced pressure and the crude product was purified by preparatory TLC [CH<sub>2</sub>Cl<sub>2</sub>:MeOH–NH<sub>3</sub> (7 N), 20:1] to afford corresponding alkylated derivatives (confirmed by LC–MS). To these 3-bromopropyl alkylated intermediates (0.0175 mmol) in dry DMF was added isopropylamine (0.35 mmol), and the reaction mixture was stirred at rt for 24 h. Then, the solvent was removed under reduced pressure and the crude product was purified by preparatory TLC [CH<sub>2</sub>Cl<sub>2</sub>:MeOH–NH<sub>3</sub> (7 N), 15:1] to afford the desired final products <b>18d</b>–<b>f</b>.</div><div id="sec3_1_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> 2-((2,4-Dichlorophenyl)thio)-1-(3-(isopropylamino)propyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>18d</b>)</h5><div class="NLM_p last">Yield: 35%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.86 (d, <i>J</i> = 5.9 Hz, 1H), 7.43 (d, <i>J</i> = 2.2 Hz, 1H), 7.13 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.02 (d, <i>J</i> = 8.6 Hz, 1H), 6.75 (d, <i>J</i> = 5.9 Hz, 1H), 5.29 (br s, 2H), 4.25 (t, <i>J</i> = 7.1 Hz, 2H), 2.71 (m, 1H), 2.56 (t, <i>J</i> = 6.8 Hz, 2H), 1.88 (m, 2H), 1.02 (d, <i>J</i> = 6.3 Hz, 6H).</div></div><div id="sec3_1_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> 2-((3,5-Dichlorophenyl)thio)-1-(3-(isopropylamino)propyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>18e</b>)</h5><div class="NLM_p last">Yield: 39%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.88 (d, <i>J</i> = 5.9 Hz, 1H), 7.21–7.25 (m, 3H), 6.75 (d, <i>J</i> = 5.9 Hz, 1H), 5.26 (br s, 2H), 4.26 (t, <i>J</i> = 7.1 Hz, 2H), 2.71 (m, 1H), 2.56 (t, <i>J</i> = 6.8 Hz, 2H), 1.88 (m, 2H), 1.02 (d, <i>J</i> = 6.2 Hz, 6H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 151.3, 142.7, 141.7, 140.8, 135.9, 135.7, 127.8, 127.5, 127.0, 97.6, 48.8, 44.0, 43.3, 30.5, 22.8. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>22</sub>N<sub>5</sub>SCl<sub>2</sub> 410.0973, found 410.0978.</div></div><div id="sec3_1_9_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> 2-((6-Iodobenzo[<i>d</i>][1,3]dioxol-5-yl)thio)-1-(3-(isopropylamino)propyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-amine (<b>18f</b>)</h5><div class="NLM_p last">Yield: 40%. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 5.9 Hz, 1H), 7.26 (s, 1H), 6.77 (s, 1H), 6.73 (d, <i>J</i> = 5.9 Hz, 1H), 5.97 (s, 2H), 5.31 (br s, 2H), 4.23 (t, <i>J</i> = 7.2 Hz, 2H), 2.74–2.77 (m, 1H), 2.60 (t, <i>J</i> = 6.9 Hz, 2H), 1.90–1.93 (m, 2H), 1.06 (d, <i>J</i> = 6.2 Hz, 6H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 151.2, 149.3, 148.6, 141.3, 140.9, 129.2, 127.4, 118.9, 111.2, 102.2, 97.5, 89.3, 48.9, 44.0, 43.3, 30.4, 22.8. HRMS (ESI): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>IN<sub>5</sub>O<sub>2</sub>S 512.0617, found 512.0628.</div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Reagents</h3><div class="NLM_p last">Recombinant Hsp90α (ADI-SPP-776), Hsp90β (ADI-SPP-777), and Trap-1 (ADI-SPP-848) were purchased from Enzo Life Sciences. Canine Grp94 was generated as previously reported.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> FP Measurements</h3><div class="NLM_p last">The Hsp90 FP competition assays were performed on an Analyst GT instrument (Molecular Devices, Sunnyvale, CA) and carried out in black 96-well microplates (Corning # 3650) in a total volume of 100 μL in each well. A stock of 10 μM Cy3B-GM<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and PU-FITC3<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was prepared in DMSO and diluted with Felts buffer [20 mM Hepes (K), pH 7.3, 50 mM KCl, 2 mM DTT, 5 mM MgCl<sub>2</sub>, 20 mM Na<sub>2</sub>MoO<sub>4</sub>, and 0.01% NP40 with 0.1 mg/mL BGG]. To each well was added the fluorescent dye labeled Hsp90 ligand (6 nM Cy3B-GM for Hsp90α, Hsp90β, and Grp94 and 3 nM PU-FITC3 for Trap-1), protein (10 nM Hsp90α, 10 nM Hsp90β, 10 nM Grp94, 30 nM Trap-1) and the tested inhibitor (initial stock in DMSO) in a final volume of 100 μL of Felts buffer. Compounds were added in duplicate or triplicate wells. For each assay, background wells (buffer only), tracer controls (free, fluorescent dye labeled Hsp90 ligand only), and bound controls (fluorescent dye labeled Hsp90 ligand in the presence of protein) were included on each assay plate. The assay plate was incubated on a shaker at 4 °C for 24 h and the FP values (in mP) were measured. The fraction of fluorescent dye labeled Hsp90 ligand bound to Hsp90 was correlated to the mP value and plotted against values of competitor concentrations. The inhibitor concentration at which 50% of bound fluorescent dye labeled Hsp90 ligand was displaced was obtained by fitting the data. For Cy3B-GM, an excitation filter at 530 nm and an emission filter at 580 nm were used with a dichroic mirror of 561 nm. For PU-FITC3, an excitation filter at 485 nm and an emission filter at 530 nm were used with a dichroic mirror of 505 nm. All experimental data were analyzed using SOFTmax Pro 4.3.1 and plotted using Prism 4.0 (Graphpad Software Inc., San Diego, CA).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Molecular Modeling</h3><div class="NLM_p last">All computations were carried out on a HP workstation xw8200 with the Ubuntu 8.10 operating system using Maestro v8.5. Protein sequence and crystal structures were downloaded from NCBI and RCSB databases, respectively.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Ligand Preparation</h3><div class="NLM_p last">All the compounds were constructed using the fragment dictionary of Maestro 8.5. The geometry of compounds was optimized using the Macromodel program v9.6 and the OLPS-AA force field.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Ensuing ligands were further prepared using the Ligprep (v2.2) utility provided by Schrödinger LLC.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Docking</h3><div class="NLM_p last">The X-ray crystal structure of PU-H54-bound Grp94 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>) was first aligned using a protein structure alignment tool and then optimized for subsequent grid generation and docking using the default parameters in Protein Preparation Wizard provided by Schrödinger LLC. Grids were then prepared using the Receptor Grid Generation tool in Glide 5.0.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> Next, the extraprecision (XP) Glide docking method was used to dock compounds flexibly into the ATP binding site of Grp94 according to the previously reported procedure.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Upon completion of each docking calculation, at most 100 poses per docking were run and at most 10 poses per ligand were allowed to be generated. Top-scored docking poses (orientation plus conformation) based on the Glide scoring (Gscore) function were analyzed. Docking accuracy was measured by resemblance of the lowest energy pose (binding conformation) predicted by the object scoring function Gscore with the experimental binding mode as determined by X-ray crystallography. Bound inhibitors PU-H54 (<b>4</b>) was removed from the Grp94 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>) binding site and redocked into the respective binding sites. Very good agreement was found between the localization of the inhibitor from docking and from the crystal structure with a RMSD of 0.04 Å (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>) between the predicted conformation and the observed X-ray crystallographic conformation, validating the docking strategy.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Kinase Assays</h3><div class="NLM_p last">For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an <i>Escherichia coli</i> host derived from the BL21 strain. <i>E. coli</i> cells were grown to log-phase and infected with T7 phage from a frozen stock (multiplicity of infection = 0.4) and incubated with shaking at 32 °C until lysis (90–150 min). The lysates were centrifuged (6000<i>g</i>) and filtered (0.2 μm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small molecule ligands for 30 min at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer [SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT] to remove unbound ligand and to reduce nonspecific phage binding. Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17× PBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 40× stocks in 100% DMSO and directly diluted into the assay. All reactions were performed in polypropylene 384-well plates in a final volume of 0.04 mL. The assay plates were incubated at room temperature with shaking for 1 h, and the affinity beads were washed with wash buffer (1× PBS, 0.05% Tween 20). The beads were then resuspended in elution buffer (1× PBS, 0.05% Tween 20, 0.5 μM nonbiotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by qPCR.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Cell Lines</h3><div class="NLM_p last">The HER2-overexpressing breast cancer cells SKBr3 were obtained from the American Type Culture Collection (ATCC). Cells were cultured routinely in McCoy’s 5A supplemented with 10% FBS and 1% penicillin and streptomycin (Pen/Strep). C2C12 and HEK293 cells were purchased from ATCC and cultured in DMEM in the presence of 10% FBS and 1% penicillin/streptomycin. RAW 264.7 cells was purchased from ATCC and cultured in DMEM with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 10% low endotoxin FBS, and 1% Pen/Strep. When cultured, cells were incubated in the humidified cell incubators with CO<sub>2</sub> at 37 °C.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Immunoblotting</h3><div class="NLM_p last">Cells were either treated with DMSO (vehicle) or indicated compounds for 24 h and lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% sodium deoxycholate, and 0.5% NP40) supplemented with cocktail protease inhibitors (Roche) to produce whole-cell lysates. Protein concentrations were determined using the BCA kit (Pierce) according to the manufacturer’s instructions. The protein lysates (5–50 μg) were electrophoretically resolved by SDS–PAGE, transferred onto nitrocellulose membranes, and probed with primary antibodies against HER2 (Zymed, 28004; 1:500), Hsp70 (Stressgen, SPA-810; 1:2500), cleaved PARP (Promega, G7341; 1:2500), and β-actin (Sigma, A1978; 1:3000). After washing off the excess antibodies, the membranes were incubated with the corresponding horseradish peroxidase (HRP)-conjugated secondary antibody. Blots were visualized by autoradiography using the Enhanced Chemiluminescence Detection System (GE Healthcare) according to the manufacturer’s instructions. Films were scanned in Adobe Photoshop CS5, and quantitative densitometric analysis was performed using ImageJ (US National Institutes of Health).</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Cell Viability Assessment</h3><div class="NLM_p last">Cells were treated for 72 h with vehicle or inhibitors. Cell viability was assessed using CellTiter-Glo luminescent cell viability assay (Promega). The method determines the number of viable cells in culture based on quantification of the ATP present, which signals the presence of metabolically active cells. Drugs were added to quadruplicate wells.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> C2C12 Differentiation and IGF-II Secretion Assay</h3><div class="NLM_p last">C2C12 is an immortal line of mouse skeletal myoblasts originally derived from satellite cells from the thigh muscle of a 2-month-old female mouse donor. These cells differentiate well into myocytes under appropriate culture conditions. The cells were induced to differentiate by replacing the culture medium with DMEM supplemented with 2% horse serum and 1% penicillin/streptomycin (differentiation medium) for 36–48 h. Secreted IGF-II was quantified by using an IGF-II mouse ELISA kit (Abcam, AB100696) according to the manufacturer’s instructions. Briefly, after shifting the culture medium to differentiation medium, C2C12 cells were treated for 24 h with the indicated compounds. Medium from each experimental condition was then transferred into ELISA plates coated with anti-IGF-II and incubated overnight at 4 °C. The bound IGF-II was detected with a biotinylated anti-IGF-II antibody provided in the kit. After the sequential incubation with HRP-conjugated streptavidin, TMB one-step substrate reagent, and the stop solution, the absorbance was measured at 450 nm. The secreted IGF-II was quantified against a standard curve generated with recombinant IGF-II provided by the kit.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> TLR9 Assay</h3><div class="NLM_p last">HEK 293T cells were transfected with pUNO-hTLR9-HA (Invivogen) using X-tremgene HP (Roche) according to the manufacturer’s instructions. At 24 h after transfection, cells were split onto cell culture chamber slides (Lab-Tek). Cells were then treated for 24 h with compounds at varying concentrations. After treatment, cells were fixed for 20 min in 4% paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100 in PBS for 10 min, and blocked with 3% BSA in PBS for 30 min, followed by staining for 1 h with anti-HA (Abcam, ab9110; 1:250) or a normal rabbit IgG (Abcam, ab37415; 1:250). Cells were washed with PBS, stained with an anti-rabbit-Cy3 antibody (Invitrogen, A10520; 1:400), and finally mounted in the dark at 4 °C with with one drop of Prolong Gold Antifade reagent (with DAPI, Life Technologies, P36935). Cells were visualized under a confocal microscope (Leica Upright Confocal SP5). Fluorescence intensity was quantified using MetaMorph Microscopy Automation and Image Analysis Software (Molecular Devices Inc.) and normalized to the cell number.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> TNFα ELISA</h3><div class="NLM_p last">Raw264.7 cells were stimulated with 10 ng/mL LPS or 2.5 μM ODN1585 (G*G*G* GTC AAC GTT GAG G*G*G* G*G), followed by the 18 h treatments with the indicated inhibitors. The mouse TNFα ELISA MAX Set (BioLegend) was used to quantify the TNFα according to the manufacturer’s instructions.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Animal Studies</h3><div class="NLM_p last">Four- to 6-week-old <i>nu</i>/<i>nu</i> athymic female mice were obtained from Harlan Laboratories. Experiments were carried out under an Institutional Animal Care and Use Committee approved protocol, and institutional guidelines for the proper and humane use of animals in research were followed. MDA-MB-468 cells (1 × 10<sup>7</sup>) were sc implanted in the right flank of mice using a 20-gauge needle and allowed to grow. All mice received Augmentin (amoxicillin/clavulanate potassium; SmithKline Beecham) in their drinking water while on therapy. Mice were sacrificed by CO<sub>2</sub> euthanasia.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Pharmacodynamic (PD) and Pharmacokinetic (PK) Studies</h3><div class="NLM_p last"><b>18c</b> (75 or 150 mg/kg, ip) was administered to mice (<i>n</i> = 4) bearing breast tumors, and mice were sacrificed at 2 and 24 h postadministration. Drug levels in tissues and plasma were determined by LC–MS/MS. Compound <b>18c</b> was injected as a single dose intravenously or orally at 10 mg/kg to B6D2F1 mice (<i>n</i> = 2 male mice per experimental point, 20 mice total). The agent was formulated in 30% captisol, 5 mM citrate buffer at pH 4.2. Drug levels in plasma were determined by LC–MS/MS.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00197">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details for the synthesis of <b>18g</b> and Figures S1–S4. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00197/suppl_file/jm5b00197_si_001.pdf">jm5b00197_si_001.pdf (1.04 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00197" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tony Taldone</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#deaabfb2bab1b0bbaa9eb3adb5bdbdf0b1acb9"><span class="__cf_email__" data-cfemail="c7b3a6aba3a8a9a2b387aab4aca4a4e9a8b5a0">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriela Chiosis</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a9cac1c0c6dac0dacee9c4dac2caca87c6dbce"><span class="__cf_email__" data-cfemail="0f6c6766607c667c684f627c646c6c21607d68">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hardik J. Patel</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pallav D. Patel</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy and Allied Health
Professions, St. John’s University, Jamaica, New York 11439, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan O. Ochiana</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pengrong Yan</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weilin Sun</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maulik R. Patel</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Smit K. Shah</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa Tramentozzi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Anesthesiology, University
of Padua, Largo E. Meneghetti
2, 35131, Padua, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Brooks</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Cornell
University, Ithaca, New York 14850, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Bolaender</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liza Shrestha</span> - <span class="hlFld-Affiliation affiliation">Molecular
Pharmacology and Chemistry Program, Sloan-Kettering
Institute, New York, New York 10021, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralph Stephani</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, College of Pharmacy and Allied Health
Professions, St. John’s University, Jamaica, New York 11439, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Finotti</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Anesthesiology, University
of Padua, Largo E. Meneghetti
2, 35131, Padua, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cynthia Leifer</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Cornell
University, Ithaca, New York 14850, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zihai Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Medical
University of South Carolina, Charleston, South Carolina United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel T. Gewirth</span> - <span class="hlFld-Affiliation affiliation">Hauptman-Woodward
Medical
Research Institute, Buffalo, New York 14203, United
States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>H.J.P., P.D.P., S.O.O., P.Y., W.S., and M.R.P. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2558e8738-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">H.J.P. is funded by Susan G. Komen, Award # PDF14301695, S.O.O. is supported by PF-14-154-01-CDD from the American Cancer Society, P.Y. is supported by AACI Translational Cancer Research Fellowship. G.C. is funded by the Leukemia and Lymphoma Society, Breast Cancer Research Fund, U01 AG032969-01A1, R21 AI090501, R01 CA172546, and R01 CA155226. P.D.P and R.A.S. are supported by funds and resources from St. John’s University. Z.L. is funded by R01 AI070603 and R01 AI077283, C.L. and J.B. by R03 AI097671 and R01 AI076588, and D.G. by R01 CA095130.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i109" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i109"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i110" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i110"> Abbreviations Used</h2><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">Grp94</td><td class="NLM_def"><p class="first last">glucose regulated protein 94</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">Trap-1</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor-associated protein-1</p></td></tr><tr><td class="NLM_term">Abs</td><td class="NLM_def"><p class="first last">antibodies</p></td></tr><tr><td class="NLM_term">TLRs</td><td class="NLM_def"><p class="first last">toll-like receptors</p></td></tr><tr><td class="NLM_term">IgG</td><td class="NLM_def"><p class="first last">immunoglobulin</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">HUVECs</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cells</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sorger, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelham, H. R.</span><span> </span><span class="NLM_article-title">The glucose-regulated protein Grp94 is related to heat shock protein Hsp90</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=1987&pages=341-344&author=P.+K.+Sorgerauthor=H.+R.+Pelham&title=The+glucose-regulated+protein+Grp94+is+related+to+heat+shock+protein+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DPelham%26aufirst%3DH.%2BR.%26atitle%3DThe%2520glucose-regulated%2520protein%2520Grp94%2520is%2520related%2520to%2520heat%2520shock%2520protein%2520Hsp90%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1987%26volume%3D194%26spage%3D341%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Marzec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span> </span><span class="NLM_article-title">GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=774-787&author=M.+Marzecauthor=D.+Elettoauthor=Y.+Argon&title=GRP94%3A+An+HSP90-like+protein+specialized+for+protein+folding+and+quality+control+in+the+endoplasmic+reticulum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarzec%26aufirst%3DM.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DGRP94%253A%2520An%2520HSP90-like%2520protein%2520specialized%2520for%2520protein%2520folding%2520and%2520quality%2520control%2520in%2520the%2520endoplasmic%2520reticulum%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1823%26spage%3D774%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S. L.</span><span> </span><span class="NLM_article-title">Hsp90 and the chaperoning of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=Hsp90+and+the+chaperoning+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0ljdelU1brc7uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHsp90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Altieri, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lian, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Languino, L. R.</span><span> </span><span class="NLM_article-title">TRAP-1, the mitochondrial Hsp90</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=767-773&author=D.+C.+Altieriauthor=G.+S.+Steinauthor=J.+B.+Lianauthor=L.+R.+Languino&title=TRAP-1%2C+the+mitochondrial+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26aulast%3DStein%26aufirst%3DG.%2BS.%26aulast%3DLian%26aufirst%3DJ.%2BB.%26aulast%3DLanguino%26aufirst%3DL.%2BR.%26atitle%3DTRAP-1%252C%2520the%2520mitochondrial%2520Hsp90%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1823%26spage%3D767%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doxsey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, D. C.</span><span> </span><span class="NLM_article-title">Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=257-270&author=B.+H.+Kangauthor=J.+Plesciaauthor=T.+Dohiauthor=J.+Rosaauthor=S.+J.+Doxseyauthor=D.+C.+Altieri&title=Regulation+of+tumor+cell+mitochondrial+homeostasis+by+an+organelle-specific+Hsp90+chaperone+network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DB.%2BH.%26aulast%3DPlescia%26aufirst%3DJ.%26aulast%3DDohi%26aufirst%3DT.%26aulast%3DRosa%26aufirst%3DJ.%26aulast%3DDoxsey%26aufirst%3DS.%2BJ.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26atitle%3DRegulation%2520of%2520tumor%2520cell%2520mitochondrial%2520homeostasis%2520by%2520an%2520organelle-specific%2520Hsp90%2520chaperone%2520network%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D257%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Costantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddalena, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calise, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscazzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirino, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fersini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landriscina, M.</span><span> </span><span class="NLM_article-title">TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1016%2Fj.canlet.2009.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=19217207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlejtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2009&pages=39-46&author=E.+Costantinoauthor=F.+Maddalenaauthor=S.+Caliseauthor=A.+Piscazziauthor=V.+Tirinoauthor=A.+Fersiniauthor=A.+Ambrosiauthor=V.+Neriauthor=F.+Espositoauthor=M.+Landriscina&title=TRAP1%2C+a+novel+mitochondrial+chaperone+responsible+for+multi-drug+resistance+and+protection+from+apoptotis+in+human+colorectal+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptosis in human colorectal carcinoma cells</span></div><div class="casAuthors">Costantino, Eleonora; Maddalena, Francesca; Calise, Serena; Piscazzi, Annamaria; Tirino, Virginia; Fersini, Alberto; Ambrosi, Antonio; Neri, Vincenzo; Esposito, Franca; Landriscina, Matteo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-46</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">TRAP1 is a component of a pro-survival mitochondrial pathway up-regulated in tumor cells.  The evaluation of TRAP1 expression in 26 human colorectal carcinomas showed up-regulation in 17/26 tumors.  Accordingly, TRAP1 levels were increased in HT-29 colorectal carcinoma cells resistant to 5-fluorouracil, oxaliplatin, and irinotecan.  Thus, we investigated the role of TRAP1 in multi-drug resistance in human colorectal cancer.  Interestingly, TRAP1 overexpression leads to 5-fluorouracil-, oxaliplatin- and irinotecan-resistant phenotypes in different neoplastic cells.  Conversely, the inhibition of TRAP1 activity by TRAP1 ATPase antagonist, shepherdin, increased the sensitivity to oxaliplatin and irinotecan in colorectal carcinoma cells resistant to the single agents.  These results suggest that the increased expression of TRAP1 could be part of a pro-survival pathway responsible for multi-drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl_RCfgt-FFbVg90H21EOLACvtfcHk0lg7B7GypBKBsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlejtrY%253D&md5=a5ea811014b3a3761dd45c3921437d9d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2009.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2009.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DE.%26aulast%3DMaddalena%26aufirst%3DF.%26aulast%3DCalise%26aufirst%3DS.%26aulast%3DPiscazzi%26aufirst%3DA.%26aulast%3DTirino%26aufirst%3DV.%26aulast%3DFersini%26aufirst%3DA.%26aulast%3DAmbrosi%26aufirst%3DA.%26aulast%3DNeri%26aufirst%3DV.%26aulast%3DEsposito%26aufirst%3DF.%26aulast%3DLandriscina%26aufirst%3DM.%26atitle%3DTRAP1%252C%2520a%2520novel%2520mitochondrial%2520chaperone%2520responsible%2520for%2520multi-drug%2520resistance%2520and%2520protection%2520from%2520apoptotis%2520in%2520human%2520colorectal%2520carcinoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D279%26spage%3D39%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lee, A. S.</span><span> </span><span class="NLM_article-title">Glucose-regulated proteins in cancer: Molecular mechanisms and therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnrc3701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=24658275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslCqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=263-276&author=A.+S.+Lee&title=Glucose-regulated+proteins+in+cancer%3A+Molecular+mechanisms+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential</span></div><div class="casAuthors">Lee, Amy S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">263-276</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The glucose-regulated proteins (GRPs) are stress-inducible chaperones that mostly reside in the endoplasmic reticulum or the mitochondria.  Recent advances show that the GRPs have functions that are distinct from those of the related heat shock proteins, and they can be actively translocated to other cellular locations and assume novel functions that control signalling, proliferation, invasion, apoptosis, inflammation and immunity.  Mouse models further identified their specific roles in development, tumorigenesis, metastasis and angiogenesis.  This Review describes their discovery and regulation, as well as their biol. functions in cancer.  Promising agents that use or target the GRPs are being developed, and their efficacy as anticancer therapeutics is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozBF42yfN9I7Vg90H21EOLACvtfcHk0lg7B7GypBKBsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslCqs7c%253D&md5=8a8539550b16c4ac0630114261b1302e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc3701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3701%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DGlucose-regulated%2520proteins%2520in%2520cancer%253A%2520Molecular%2520mechanisms%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D263%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zammit, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefrançois, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=215-226&author=Y.+Yangauthor=B.+Liuauthor=J.+Daiauthor=P.+K.+Srivastavaauthor=D.+J.+Zammitauthor=L.+Lefran%C3%A7oisauthor=Z.+Li&title=Heat+shock+protein+gp96+is+a+master+chaperone+for+toll-like+receptors+and+is+important+in+the+innate+function+of+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DSrivastava%26aufirst%3DP.%2BK.%26aulast%3DZammit%26aufirst%3DD.%2BJ.%26aulast%3DLefran%25C3%25A7ois%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DHeat%2520shock%2520protein%2520gp96%2520is%2520a%2520master%2520chaperone%2520for%2520toll-like%2520receptors%2520and%2520is%2520important%2520in%2520the%2520innate%2520function%2520of%2520macrophages%26jtitle%3DImmunity%26date%3D2007%26volume%3D26%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White-Gilbertson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachidi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depinho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6242</span><span class="NLM_x">–</span> <span class="NLM_lpage">6251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1158%2F1078-0432.CCR-13-2083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=24077352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6242-6251&author=Y.+Huaauthor=S.+White-Gilbertsonauthor=J.+Kellnerauthor=S.+Rachidiauthor=S.+Z.+Usmaniauthor=G.+Chiosisauthor=R.+Depinhoauthor=Z.+Liauthor=B.+Liu&title=Molecular+chaperone+gp96+is+a+novel+therapeutic+target+of+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma</span></div><div class="casAuthors">Hua, Yunpeng; White-Gilbertson, Shai; Kellner, Joshua; Rachidi, Saleh; Usmani, Saad Z.; Chiosis, Gabriela; DePinho, Ronald; Li, Zihai; Liu, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6242-6251</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: gp96 (grp94) is a key downstream chaperone in the endoplasmic reticulum (ER) to mediate unfolded protein response (UPR) and the pathogenesis of multiple myeloma is closely linked to dysregulated UPR.  In this study, we aimed to det. the roles of gp96 in the initiation and progression of multiple myeloma in vivo and in vitro.  Exptl. Design: We generated a mouse model with overexpression of XBP1s and conditional deletion of gp96 in B-cell compartment simultaneously to identify the roles of gp96 in the development of multiple myeloma in vivo.  Using a short hairpin RNA (shRNA) system, we silenced gp96 in multiple human multiple myeloma cells and examd. the effect of gp96 knockdown on multiple myeloma cells by cell proliferation, cell-cycle anal., apoptosis assay, immunohistochem., and human myeloma xenograft model.  The anticancer activity of gp96 selective inhibitor, WS13, was evaluated by apoptosis assay and MTT assay.  Results: Genetic deletion of gp96 in XBP1s-Tg mice attenuates multiple myeloma.  Silencing of gp96 causes severe compromise in human multiple myeloma cell growth through inhibiting Wnt-LRP-survivin pathway.  We also confirmed that knockdown of gp96 decreased human multiple myeloma growth in a murine xenograft model.  The targeted gp96 inhibitor induced apoptosis and blocked multiple myeloma cell growth, but did not induce apoptosis in pre-B leukemic cells.  We have demonstrated that myeloma growth is dependent on gp96 both genetically and pharmacol.  Conclusions: gp96 is essential for multiple myeloma cell proliferation and survival, suggesting that gp96 is a novel therapeutic target for multiple myeloma.  Clin Cancer Res; 19(22); 6242-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-ajwmlaUPrVg90H21EOLACvtfcHk0lgrxx8EN_1wUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP&md5=adb618074ee3e9d6ee4795b95c1d906c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2083%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DWhite-Gilbertson%26aufirst%3DS.%26aulast%3DKellner%26aufirst%3DJ.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDepinho%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520chaperone%2520gp96%2520is%2520a%2520novel%2520therapeutic%2520target%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6242%26epage%3D6251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidler, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Que, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D.+Patelauthor=P.+Yanauthor=P.+M.+Seidlerauthor=H.+J.+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S.+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A.+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+Hsp90+inhibitors+define+tumor-specific+regulation+of+HER2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0lgrxx8EN_1wUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520Hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520HER2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Soldano, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jivan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structure of the N-terminal domain of GRP94</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">48330</span><span class="NLM_x">–</span> <span class="NLM_lpage">48338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2003&pages=48330-48338&author=K.+L.+Soldanoauthor=A.+Jivanauthor=C.+V.+Nicchittaauthor=D.+T.+Gewirth&title=Structure+of+the+N-terminal+domain+of+GRP94"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DJivan%26aufirst%3DA.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520of%2520the%2520N-terminal%2520domain%2520of%2520GRP94%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D279%26spage%3D48330%26epage%3D48338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Rosser, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span> </span><span class="NLM_article-title">Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">22798</span><span class="NLM_x">–</span> <span class="NLM_lpage">22805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22798-22805&author=M.+F.+Rosserauthor=C.+V.+Nicchitta&title=Ligand+interactions+in+the+adenosine+nucleotide-binding+domain+of+the+Hsp90+chaperone%2C+GRP94.+I.+Evidence+for+allosteric+regulation+of+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosser%26aufirst%3DM.%2BF.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26atitle%3DLigand%2520interactions%2520in%2520the%2520adenosine%2520nucleotide-binding%2520domain%2520of%2520the%2520Hsp90%2520chaperone%252C%2520GRP94.%2520I.%2520Evidence%2520for%2520allosteric%2520regulation%2520of%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22798%26epage%3D22805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldano, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">46162</span><span class="NLM_x">–</span> <span class="NLM_lpage">46171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46162-46171&author=R.+M.+Immorminoauthor=D.+E.+Dollinsauthor=P.+L.+Shafferauthor=K.+L.+Soldanoauthor=M.+A.+Walkerauthor=D.+T.+Gewirth&title=Ligand-induced+conformational+shift+in+the+N-terminal+domain+of+GRP94%2C+an+Hsp90+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DP.%2BL.%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DWalker%26aufirst%3DM.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DLigand-induced%2520conformational%2520shift%2520in%2520the%2520N-terminal%2520domain%2520of%2520GRP94%252C%2520an%2520Hsp90%2520chaperone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46162%26epage%3D46171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: Implications for paralog-specific drug design</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=1033-1042&author=R.+M.+Immorminoauthor=L.+E.+Metzgerauthor=P.+N.+Reardonauthor=D.+E.+Dollinsauthor=B.+S.+Blaggauthor=D.+T.+Gewirth&title=Different+poses+for+ligand+and+chaperone+in+inhibitor-bound+Hsp90+and+GRP94%3A+Implications+for+paralog-specific+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DMetzger%26aufirst%3DL.%2BE.%26aulast%3DReardon%26aufirst%3DP.%2BN.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DDifferent%2520poses%2520for%2520ligand%2520and%2520chaperone%2520in%2520inhibitor-bound%2520Hsp90%2520and%2520GRP94%253A%2520Implications%2520for%2520paralog-specific%2520drug%2520design%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D1033%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taffi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of adenosine A2A receptor agonists</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.2174%2F1568026033392282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=12570757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=387-401&author=G.+Cristalliauthor=C.+Lambertucciauthor=S.+Taffiauthor=S.+Vittoriauthor=R.+Volpini&title=Medicinal+chemistry+of+adenosine+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine A2A receptor agonists</span></div><div class="casAuthors">Cristalli, Gloria; Lambertucci, Catia; Taffi, Sara; Vittori, Sauro; Volpini, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The search for potent and selective A2A adenosine receptor agonists has been particularly fruitful in the early nineties.  A series of 2-amino, 2-alkoxy, 2-alkythio-, 2-alkynyl-, and 2-alkenyl-derivs. of adenosine (Ado, 1) and N-ethylcarboxamidoadenosine (NECA, 30) have been synthesized and tested mainly on different model of rat A1 and A2A receptor subtypes.  From these studies some ligands, such as CGS 21680 (33), HENECA (42), and (S)-PHPNECA (46b), showed to possess high A2A affinity combined with good A2A vs A1 selectivity.  More detailed characterization of these ligands at the four cloned human adenosine receptor subtypes revealed that none of the prototypical adenosine receptor agonists exhibits at the same time high affinity and selectivity for the human A2AAR subtype.  Both NECA and CGS 21680, which are available as radioligands for this subtype, have lower affinity at human than at rat receptor.  The 2-alkynylNECA derivs. HENECA an PHPNECA showed high affinity also at human A3 receptors.  In particular, (S)-PHPNECA displayed Kis in the low nanomolar range at A1, A2A, and A3 subtypes and an EC50 of 220 nM at human A2B receptor.  It is now well known that the coronary vasodilation induced by Ado in different species is mediated by activation of A2AAR and a compd. capable of producing coronary vasodilation through activation of A2AAR, but that is devoid of A1-and A3-agonist activity would have advantage over Ado for use in myocardial perfusion imaging studies.  Other potential therapeutic applications of selective A2AAR agonists are as anti-aggregatory, anti-inflammatory, anti-psychotic, and anti-Huntington's disease agents.  This review is aimed at presenting a complete overview of the medicinal chem. development of A2A adenosine receptor agonists and at stressing the strong need for more selective ligands at A2A human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZ9WytCwyQLVg90H21EOLACvtfcHk0lhBPNme5RcsXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D&md5=4d2aef4b8cb3f1f30efe8d4f839e01d1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1568026033392282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392282%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DTaffi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26atitle%3DMedicinal%2520chemistry%2520of%2520adenosine%2520A2A%2520receptor%2520agonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Clevenger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4459</span><span class="NLM_x">–</span> <span class="NLM_lpage">4462</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol048266o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4459-4462&author=R.+C.+Clevengerauthor=B.+S.+Blagg&title=Design%2C+synthesis%2C+and+evaluation+of+a+radicicol+and+geldanamycin+chimera%2C+radamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fol048266o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol048266o%26sid%3Dliteratum%253Aachs%26aulast%3DClevenger%26aufirst%3DR.%2BC.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520radicicol%2520and%2520geldanamycin%2520chimera%252C%2520radamide%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4459%26epage%3D4462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Duerfeldt, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinogle, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9804</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lhyimFn70NjEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Stothert, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suntharalingam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span> </span><span class="NLM_article-title">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6470</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1093%2Fhmg%2Fddu367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=25027323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=6470-6480&author=A.+R.+Stothertauthor=A.+Suntharalingamauthor=D.+J.+Huardauthor=S.+N.+Fontaineauthor=V.+M.+Crowleyauthor=S.+Mishraauthor=B.+S.+Blaggauthor=R.+L.+Liebermanauthor=C.+A.+Dickey&title=Exploiting+the+interaction+between+Grp94+and+aggregated+myocilin+to+treat+glaucoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span></div><div class="casAuthors">Stothert, Andrew R.; Suntharalingam, Amirthaa; Huard, Dustin J. E.; Fontaine, Sarah N.; Crowley, Vincent M.; Mishra, Sanket; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6470-6480</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Gain-of-function mutations in the olfactomedin domain of the MYOC gene facilitate the toxic accumulation of amyloid-contg. myocilin aggregates, hastening the onset of the prevalent ocular disorder primary open-angle glaucoma.  Aggregation of wild-type myocilin has been reported in other glaucoma subtypes, suggesting broader relevance of misfolded myocilin across the disease spectrum, but the absence of myocilin does not cause disease.  Thus, strategies aimed at eliminating myocilin could be therapeutically relevant for glaucoma.  Here, a novel and selective Grp94 inhibitor reduced the levels of several mutant myocilin proteins as well as wild-type myocilin when forced to misfold in cells.  This inhibitor rescued mutant myocilin toxicity in primary human trabecular meshwork cells.  Mechanistically, in vitro kinetics studies demonstrate that Grp94 recognizes on-pathway aggregates of the myocilin olfactomedin domain (myoc-OLF), accelerates rates of aggregation and co-ppts. with myoc-OLF.  These results indicate that aberrant myocilin quaternary structure drives Grp94 recognition, rather than peptide motifs exposed by unfolded protein.  Inhibition of Grp94 ameliorates the effects of Grp94-accelerated myoc-OLF aggregation, and Grp94 remains in soln.  In cells, when wild-type myocilin is driven to misfold and aggregate, it becomes a client of Grp94 and sensitive to Grp94 inhibition.  Taken together, the interaction of Grp94 with myocilin aggregates can be manipulated by cellular environment and genetics; this process can be exploited with Grp94 inhibitors to promote the clearance of toxic forms of myocilin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQYeK777kKLVg90H21EOLACvtfcHk0lhXhp7qxVNevw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D&md5=cbabbce383403838a4cbc3ffe24bdce8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu367%26sid%3Dliteratum%253Aachs%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DSuntharalingam%26aufirst%3DA.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%26aulast%3DFontaine%26aufirst%3DS.%2BN.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DExploiting%2520the%2520interaction%2520between%2520Grp94%2520and%2520aggregated%2520myocilin%2520to%2520treat%2520glaucoma%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D6470%26epage%3D6480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zifcak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atoyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DellaRocca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span> </span><span class="NLM_article-title">CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4046</span><span class="NLM_x">–</span> <span class="NLM_lpage">4057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1158%2F1078-0432.CCR-09-0152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=19509149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlOisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=4046-4057&author=R.+Baoauthor=C.+J.+Laiauthor=H.+Quauthor=D.+Wangauthor=L.+Yinauthor=B.+Zifcakauthor=R.+Atoyanauthor=J.+Wangauthor=M.+Samsonauthor=J.+Forresterauthor=S.+DellaRoccaauthor=G.+X.+Xuauthor=X.+Taoauthor=H.+X.+Zhaiauthor=X.+Caiauthor=C.+Qian&title=CUDC-305%2C+a+novel+synthetic+HSP90+inhibitor+with+unique+pharmacologic+properties+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy</span></div><div class="casAuthors">Bao, Rudi; Lai, Cheng-Jung; Qu, Hui; Wang, Dagong; Yin, Ling; Zifcak, Brian; Atoyan, Ruzanna; Wang, Jing; Samson, Maria; Forrester, Jeffrey; Della Rocca, Steven; Xu, Guang-Xin; Tao, Xu; Zhai, Hai-Xiao; Cai, Xiong; Qian, Changgeng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4046-4057</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We designed and synthesized CUDC-305, an HSP90 inhibitor of the novel imidazopyridine class.  Here, we report its unique pharmacol. properties and antitumor activities in a variety of tumor types.  The potency of the compd. was analyzed by fluorescence polarization competition binding assay.  Its antiproliferative activities were assessed in 40 human cancer cell lines.  Its pharmacol. properties and antitumor activities were evaluated in a variety of tumor xenograft models.  CUDC-305 shows high affinity for HSP90α/β (IC50, ∼100 nmol/L) and HSP90 complex derived from cancer cells (IC50, 48.8 nmol/L).  It displays potent antiproliferative activity against a broad range of cancer cell lines (mean IC50, 220 nmol/L).  CUDC-305 exhibits high oral bioavailability (96.0%) and selective retention in tumor (half-life, 20.4 h) compared with normal tissues.  Furthermore, CUDC-305 can cross blood-brain barrier and reach therapeutic levels in brain tissue.  CUDC-305 exhibits dose-dependent antitumor activity in an s.c. xenograft model of U87MG glioblastoma and significantly prolongs animal survival in U87MG orthotopic model.  CUDC-305 also displays potent antitumor activity in animal models of erlotinib-resistant non-small cell lung cancer and induces tumor regression in animal models of MDA-MB-468 breast cancer and MV4-11 acute myelogenous leukemia.  Correlating with its efficacy in these various tumor models, CUDC-305 robustly inhibits multiple signaling pathways, including PI3K/AKT and RAF/MEK/ERK, and induces apoptosis.  In combination studies, CUDC-305 enhances the antitumor activity of std.-of-care agents in breast and colorectal tumor models.  CUDC-305 is a promising drug candidate for the treatment of a variety of cancers, including brain malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxsZpWkM4MrVg90H21EOLACvtfcHk0lhXhp7qxVNevw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlOisL4%253D&md5=b872c7658a2fc98f263f7e6a23cb58f6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-0152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-0152%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DC.%2BJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DZifcak%26aufirst%3DB.%26aulast%3DAtoyan%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSamson%26aufirst%3DM.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DDellaRocca%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DG.%2BX.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.%2BX.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DCUDC-305%252C%2520a%2520novel%2520synthetic%2520HSP90%2520inhibitor%2520with%2520unique%2520pharmacologic%2520properties%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D4046%26epage%3D4057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cai, X.; Qian, C.; Zhai, H.</span><span> </span><span class="NLM_article-title">Preparation of imidazo[4,5-c]pyridine derivatives as HSP90 inhibitors</span>. Patent WO2008115719A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=X.+Cai&author=C.+Qian&author=H.+Zhai&title=Preparation+of+imidazo%5B4%2C5-c%5Dpyridine+derivatives+as+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26atitle%3DPreparation%2520of%2520imidazo%255B4%252C5-c%255Dpyridine%2520derivatives%2520as%2520HSP90%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Synthesis of a red-shifted fluorescence polarization probe for Hsp90</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4515-4518&author=K.+Moulickauthor=C.+C.+Clementauthor=J.+Aguirreauthor=J.+Kimauthor=Y.+Kangauthor=S.+Feltsauthor=G.+Chiosis&title=Synthesis+of+a+red-shifted+fluorescence+polarization+probe+for+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520a%2520red-shifted%2520fluorescence%2520polarization%2520probe%2520for%2520Hsp90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4515%26epage%3D4518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6803</span><span class="NLM_x">–</span> <span class="NLM_lpage">6818</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400619b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6803-6818&author=T.+Taldoneauthor=P.+D.+Patelauthor=M.+Patelauthor=H.+J.+Patelauthor=C.+E.+Evansauthor=A.+Rodinaauthor=S.+Ochianaauthor=S.+K.+Shahauthor=M.+Uddinauthor=D.+Gewirthauthor=G.+Chiosis&title=Experimental+and+structural+testing+module+to+analyze+paralogue-specificity+and+affinity+in+the+Hsp90+inhibitors+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series</span></div><div class="casAuthors">Taldone, Tony; Patel, Pallav D.; Patel, Maulik; Patel, Hardik J.; Evans, Christopher E.; Rodina, Anna; Ochiana, Stefan; Shah, Smit K.; Uddin, Mohammad; Gewirth, Daniel; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6803-6818</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We here describe the first reported comprehensive anal. of Hsp90 paralogue affinity and selectivity in the clin. Hsp90 inhibitor chemotypes.  This has been possible through the development of a versatile exptl. assay based on a new FP-probe that we both describe here.  The assay can test rapidly and accurately the binding affinity of all major Hsp90 chemotypes and has a testing range that spans low nanomolar to millimolar binding affinities.  We couple this assay with a computational anal. that allows for rationalization of paralogue selectivity and defines not only the major binding modes that relay pan-paralogue binding or, conversely, paralogue selectivity, but also identifies mol. characteristics that impart such features.  The methods developed here provide a blueprint for parsing out the contribution of the four Hsp90 paralogues to the perceived biol. activity with the current Hsp90 chemotypes and set the ground for the development of paralogue selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgOst3-n58BrVg90H21EOLACvtfcHk0ljcUGJw0YwSRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWltbvM&md5=bda49f7f2f61553e344b100d5d6949dd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm400619b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400619b%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DEvans%26aufirst%3DC.%2BE.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DOchiana%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DUddin%26aufirst%3DM.%26aulast%3DGewirth%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DExperimental%2520and%2520structural%2520testing%2520module%2520to%2520analyze%2520paralogue-specificity%2520and%2520affinity%2520in%2520the%2520Hsp90%2520inhibitors%2520series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6803%26epage%3D6818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">General method for the synthesis of 8-arylsulfanyl adenine derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3230</span><span class="NLM_x">–</span> <span class="NLM_lpage">3232</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049875c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3230-3232&author=H.+Heauthor=L.+Llaugerauthor=N.+Rosenauthor=G.+Chiosis&title=General+method+for+the+synthesis+of+8-arylsulfanyl+adenine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo049875c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049875c%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DGeneral%2520method%2520for%2520the%2520synthesis%2520of%25208-arylsulfanyl%2520adenine%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D3230%26epage%3D3232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2892</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049012b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2892-2905&author=L.+Llaugerauthor=H.+Heauthor=J.+Kimauthor=J.+Aguirreauthor=N.+Rosenauthor=U.+Petersauthor=P.+Daviesauthor=G.+Chiosis&title=Evaluation+of+8-arylsulfanyl%2C+8-arylsulfoxyl%2C+and+8-arylsulfonyl+adenine+derivatives+as+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm049012b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049012b%26sid%3Dliteratum%253Aachs%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DEvaluation%2520of%25208-arylsulfanyl%252C%25208-arylsulfoxyl%252C%2520and%25208-arylsulfonyl%2520adenine%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2892%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Orally active purine-based inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=817-828&author=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Hongauthor=D.+C.+Hurstauthor=L.+Zhangauthor=J.+Fanauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=A.+A.+Maldonadoauthor=J.+L.+Sensintaffarauthor=Y.+C.+Yangauthor=A.+Kamalauthor=R.+E.+Loughauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=G.+A.+Timonyauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Orally+active+purine-based+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0503087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503087%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DHurst%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DMaldonado%26aufirst%3DA.%2BA.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DOrally%2520active%2520purine-based%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D817%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">About the reaction of aryl fluorides with sodium sulfide: Investigation into the selectivity of substitution of fluorobenzonitriles to yield mercaptobenzonitriles via SNAr displacement of fluorine</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2548</span><span class="NLM_x">–</span> <span class="NLM_lpage">2551</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=2548-2551&author=T.+Taldoneauthor=P.+D.+Patelauthor=H.+J.+Patelauthor=G.+Chiosis&title=About+the+reaction+of+aryl+fluorides+with+sodium+sulfide%3A+Investigation+into+the+selectivity+of+substitution+of+fluorobenzonitriles+to+yield+mercaptobenzonitriles+via+SNAr+displacement+of+fluorine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAbout%2520the%2520reaction%2520of%2520aryl%2520fluorides%2520with%2520sodium%2520sulfide%253A%2520Investigation%2520into%2520the%2520selectivity%2520of%2520substitution%2520of%2520fluorobenzonitriles%2520to%2520yield%2520mercaptobenzonitriles%2520via%2520SNAr%2520displacement%2520of%2520fluorine%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D2548%26epage%3D2551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Microwave-assisted one step synthesis of 8-arylmethyl-9<i>H</i>-purin-6-amines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=415-417&author=H.+Taoauthor=Y.+Kangauthor=T.+Taldoneauthor=G.+Chiosis&title=Microwave-assisted+one+step+synthesis+of+8-arylmethyl-9H-purin-6-amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DMicrowave-assisted%2520one%2520step%2520synthesis%2520of%25208-arylmethyl-9H-purin-6-amines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D415%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0ljtCSQpd9AQ1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shtil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3555</span><span class="NLM_x">–</span> <span class="NLM_lpage">3564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=3555-3564&author=G.+Chiosisauthor=B.+Lucasauthor=A.+Shtilauthor=H.+Huezoauthor=N.+Rosen&title=Development+of+a+purine-scaffold+novel+class+of+Hsp90+binders+that+inhibit+the+proliferation+of+cancer+cells+and+induce+the+degradation+of+Her2+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DShtil%26aufirst%3DA.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DDevelopment%2520of%2520a%2520purine-scaffold%2520novel%2520class%2520of%2520Hsp90%2520binders%2520that%2520inhibit%2520the%2520proliferation%2520of%2520cancer%2520cells%2520and%2520induce%2520the%2520degradation%2520of%2520Her2%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D3555%26epage%3D3564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4953</span><span class="NLM_x">–</span> <span class="NLM_lpage">4960</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060297x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4953-4960&author=R.+M.+Immorminoauthor=Y.+Kangauthor=G.+Chiosisauthor=D.+T.+Gewirth&title=Structural+and+quantum+chemical+studies+of+8-aryl-sulfanyl+adenine+class+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060297x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060297x%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructural%2520and%2520quantum%2520chemical%2520studies%2520of%25208-aryl-sulfanyl%2520adenine%2520class%2520Hsp90%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4953%26epage%3D4960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lg6WFuUPhKu0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Selective targeting of the stress chaperome as a therapeutic strategy</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">592</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=592-603&author=T.+Taldoneauthor=S.+Ochianaauthor=P.+D.+Patelauthor=G.+Chiosis&title=Selective+targeting+of+the+stress+chaperome+as+a+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DOchiana%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSelective%2520targeting%2520of%2520the%2520stress%2520chaperome%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D592%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Medzhitov, R.</span><span> </span><span class="NLM_article-title">Toll-like receptors and innate immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2F35100529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=11905821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=135-145&author=R.+Medzhitov&title=Toll-like+receptors+and+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors and innate immunity</span></div><div class="casAuthors">Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-145</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors have a crucial role in the detection of microbial infection in mammals and insects.  In mammals, these receptors have evolved to recognize conserved products unique to microbial metab.  This specificity allows the Toll proteins to detect the presence of infection and to induce activation of inflammatory and antimicrobial innate immune responses.  Recognition of microbial products by Toll-like receptors expressed on dendritic cells triggers functional maturation of dendritic cells and leads to initiation of antigen-specific adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouf0HceqTgkrVg90H21EOLACvtfcHk0lg6WFuUPhKu0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qu74%253D&md5=d88de3ef802486ba2611b056bcfd0c41</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2F35100529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35100529%26sid%3Dliteratum%253Aachs%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DToll-like%2520receptors%2520and%2520innate%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2001%26volume%3D1%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Brooks, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leifer, C. A.</span><span> </span><span class="NLM_article-title">Heat shock protein gp96 regulates toll-like receptor 9 proteolytic processing and conformational stability</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=780-784&author=J.+C.+Brooksauthor=W.+Sunauthor=G.+Chiosisauthor=C.+A.+Leifer&title=Heat+shock+protein+gp96+regulates+toll-like+receptor+9+proteolytic+processing+and+conformational+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DJ.%2BC.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLeifer%26aufirst%3DC.%2BA.%26atitle%3DHeat%2520shock%2520protein%2520gp96%2520regulates%2520toll-like%2520receptor%25209%2520proteolytic%2520processing%2520and%2520conformational%2520stability%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D421%26spage%3D780%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ostrovsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span> </span><span class="NLM_article-title">The chaperone activity of GRP94 towards of insulin-like growth factor II is necessary for the stress response to serum deprivation</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1091%2Fmbc.E08-04-0346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=19158397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1855-1864&author=O.+Ostrovskyauthor=N.+T.+Ahmedauthor=Y.+Argon&title=The+chaperone+activity+of+GRP94+towards+of+insulin-like+growth+factor+II+is+necessary+for+the+stress+response+to+serum+deprivation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The chaperone activity of GRP94 toward insulin-like growth factor II is necessary for the stress response to serum deprivation</span></div><div class="casAuthors">Ostrovsky, Olga; Ahmed, Noreen T.; Argon, Yair</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1855-1864</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Insulin-like growth factor (IGF)-II is a hormone with mitogenic activity for many cell types and tissues.  We demonstrate that its intracellular processing and secretion strictly depend on the endoplasmic reticulum chaperone glucose-regulated protein (GRP) 94.  GRP94 interacts phys. and transiently with pro-IGF-II intermediates, and its activity is essential for secretion of active IGF-II, thus establishing IGF-II as a client of GRP94.  Embryonic stem (ES) cells that lack GRP94 are hypersensitive to stress conditions such as serum deprivation and die by apoptosis because they cannot respond to the stress by producing active IGF-II.  This chaperone-client interaction may explain the previously documented antiapoptotic activity of GRP94 in a no. of stress responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknJ115ssE_rVg90H21EOLACvtfcHk0lisEL3u8pBPRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFygs74%253D&md5=a38b8f235e33dd0e6c01fe3a04d3587e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E08-04-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E08-04-0346%26sid%3Dliteratum%253Aachs%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DAhmed%26aufirst%3DN.%2BT.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DThe%2520chaperone%2520activity%2520of%2520GRP94%2520towards%2520of%2520insulin-like%2520growth%2520factor%2520II%2520is%2520necessary%2520for%2520the%2520stress%2520response%2520to%2520serum%2520deprivation%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2009%26volume%3D20%26spage%3D1855%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90: The cancer chaperone</span> <span class="citation_source-journal">J. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1007%2Fs12038-007-0051-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=17536171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFamu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=517-530&author=L.+Neckers&title=Heat+shock+protein+90%3A+The+cancer+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90: the cancer chaperone</span></div><div class="casAuthors">Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biosciences (Bangalore, India)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-530</span>CODEN:
                <span class="NLM_cas:coden">JOBSDN</span>;
        ISSN:<span class="NLM_cas:issn">0250-5991</span>.
    
            (<span class="NLM_cas:orgname">Indian Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is a mol. chaperone required for the stability and function of a no. of conditionally activated and/or expressed signaling proteins, as well as multiple mutated, chimeric, and/or overexpressed signaling proteins, that promote cancer cell growth and/or survival.  Hsp90 inhibitors are unique in that, although they are directed towards a specific mol. target, they simultaneously inhibit multiple cellular signaling pathways.  By inhibiting nodal points in multiple overlapping survival pathways utilized by cancer cells, combination of an Hsp90 inhibitor with std. chemotherapeutic agents may dramatically increase the in vivo efficacy of the std. agent.  Hsp90 inhibitors may circumvent the characteristic genetic plasticity that has allowed cancer cells to eventually evade the toxic effects of most molecularly targeted agents.  The mechanism-based use of Hsp90 inhibitors, both alone and in combination with other drugs, should be effective toward multiple forms of cancer.  Further, because Hsp90 inhibitors also induce Hsf-1-dependent expression of Hsp70, and because certain mutated Hsp90 client proteins are neurotoxic, these drugs display ameliorative properties in several neurodegenerative disease models, suggesting a novel role for Hsp90 inhibitors in treating multiple pathologies involving neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorZSMvQPzup7Vg90H21EOLACvtfcHk0lisEL3u8pBPRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFamu7k%253D&md5=ffc9fd7cba8e3b9e03b2da9c29bc275f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs12038-007-0051-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12038-007-0051-y%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520The%2520cancer%2520chaperone%26jtitle%3DJ.%2520Biosci.%26date%3D2007%26volume%3D32%26spage%3D517%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Supko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span> </span><span class="NLM_article-title">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1007%2FBF00689048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=7628050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=305-315&author=J.+G.+Supkoauthor=R.+L.+Hickmanauthor=M.+R.+Greverauthor=L.+Malspeis&title=Preclinical+pharmacologic+evaluation+of+geldanamycin+as+an+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span></div><div class="casAuthors">Supko, Jeffrey G.; Hickman, Robert L.; Grever, Michael R.; Malspeis, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-15</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The plasma pharmacokinetics of the antitumor antibiotic geldanamycin (GM; NSC 122750), a naturally occurring benzoquinoid ansamycin, were characterized in mice and a beagle dog.  Concns. of GM well above 0.1 μg/mL, which were typically effective against neoplastic cell lines responsive to the drug in vitro, were achieved in the plasma of the mice and the dog treated by i.v. injection.  However, the systemic duration of the drug was relatively short.  Plasma levels decayed to <0.1 μg/mL within 3-4 h after administration of the apparent max. tolerated doses, which were approx. 20 mg/kg for the mice and 4 mg/kg for the dog.  The drug exhibited linear pharmacokinetic behavior within the dose ranges studied.  However, there were significant interspecies differences in its disposition.  Whereas the mean biol. half-life of GM was slightly longer in the mice (77.7 min) than in the dog (57.9 min), its mean residence time in the dog (46.6 min) was >2-fold greater than that in the mice (20.7 min).  Nevertheless, the drug was cleared from plasma much faster by the dog (49.4 mL/min/kg) than by the mice (30.5 mL/min/kg).  These apparent anomalies were principally assocd. with differences in the relative significance of the terminal phase upon overall drug disposition.  The liver appeared to be the principal target organ of acute drug toxicity in the dog.  Doses of 2.0 and 4.2 mg/kg both produced elevations in serum levels of the transaminases and other indicators of liver function characteristic of acute hepatic necrosis.  Addnl. effects included symptoms of minor gastrointestinal toxicity and alterations in serum chem. parameters consistent with less severe nephrotoxicity.  The drug-related toxicity appeared to be reversible.  In consideration of the potential for acute hepatotoxic reactions to GM, as well as to the other benzoquinoid ansamycins based upon structural analogy, addnl. pharmacol. and therapeutic information is required to ascertain whether these compds. are viable candidates for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-P4wBmA1f7Vg90H21EOLACvtfcHk0lhFlaLcYqHIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D&md5=cde4aa9e616ff38b67dafed67b05d174</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2FBF00689048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00689048%26sid%3Dliteratum%253Aachs%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DHickman%26aufirst%3DR.%2BL.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26aulast%3DMalspeis%26aufirst%3DL.%26atitle%3DPreclinical%2520pharmacologic%2520evaluation%2520of%2520geldanamycin%2520as%2520an%2520antitumor%2520agent%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1995%26volume%3D36%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Chaperoning oncogenes: Hsp90 as a target of geldanamycin</span> <span class="citation_source-journal">Handb. Exp. Pharmacol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1007%2F3-540-29717-0_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=16610363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWqsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=259-277&author=L.+Neckers&title=Chaperoning+oncogenes%3A+Hsp90+as+a+target+of+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Chaperoning oncogenes: Hsp90 as a target of geldanamycin</span></div><div class="casAuthors">Neckers, L.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">Molecular Chaperones in Health and Disease</span>),
    <span class="NLM_cas:pages">259-277</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is a mol. chaperone required for the stability and function of a no. of conditionally activated and/or expressed signaling proteins, as well as multiple mutated, chimeric, and/or over-expressed signaling proteins, that promote cancer cell growth and/or survival.  Hsp90 inhibitors, by interacting specifically with a single mol. target, cause the inactivation, destabilization, and eventual degrdn. of Hsp90 client proteins, and they have shown promising anti-tumor activity in preclin. model systems.  One Hsp90 inhibitor, 17-AAG, has completed Phase I clin. trial and several Phase II trials of this agent are in progress.  Hsp90 inhibitors are unique in that, although they are directed toward a specific mol. target, they simultaneously inhibit multiple signaling pathways that frequently interact to promote cancer cell survival.  Further, by inhibiting nodal points in multiple overlapping survival pathways utilized by cancer cells, a combination of an Hsp90 inhibitor with std. chemotherapeutic agents may dramatically increase the in vivo efficacy of the std. agent.  Hsp90 inhibitors may circumvent the characteristic genetic plasticity that has allowed cancer cells to eventually evade the toxic effects of most molecularly targeted agents.  The mechanism-based use of Hsp90 inhibitors, both alone and in combination with other drugs, should be effective toward multiple forms of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9Ocei7to9NrVg90H21EOLACvtfcHk0lhFlaLcYqHIRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWqsbvO&md5=e30ac77974f27ca96cadbe45bf516f7a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2F3-540-29717-0_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F3-540-29717-0_11%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DChaperoning%2520oncogenes%253A%2520Hsp90%2520as%2520a%2520target%2520of%2520geldanamycin%26jtitle%3DHandb.%2520Exp.%2520Pharmacol%26date%3D2006%26spage%3D259%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Jhaveri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerecitano, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corben, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janjigian, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes-DaGama, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koren, J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=611-628&author=K.+Jhaveriauthor=S.+O.+Ochianaauthor=M.+P.+Dunphyauthor=J.+F.+Gerecitanoauthor=A.+D.+Corbenauthor=R.+I.+Peterauthor=Y.+Y.+Janjigianauthor=E.+M.+Gomes-DaGamaauthor=J.+Korenauthor=S.+Modiauthor=G.+Chiosis&title=Heat+shock+protein+90+inhibitors+in+the+treatment+of+cancer%3A+Current+status+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DDunphy%26aufirst%3DM.%2BP.%26aulast%3DGerecitano%26aufirst%3DJ.%2BF.%26aulast%3DCorben%26aufirst%3DA.%2BD.%26aulast%3DPeter%26aufirst%3DR.%2BI.%26aulast%3DJanjigian%26aufirst%3DY.%2BY.%26aulast%3DGomes-DaGama%26aufirst%3DE.%2BM.%26aulast%3DKoren%26aufirst%3DJ.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHeat%2520shock%2520protein%252090%2520inhibitors%2520in%2520the%2520treatment%2520of%2520cancer%253A%2520Current%2520status%2520and%2520future%2520directions%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D611%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span> </span><span class="NLM_article-title">Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=559-587&author=H.+J.+Patelauthor=S.+Modiauthor=G.+Chiosisauthor=T.+Taldone&title=Advances+in+the+discovery+and+development+of+heat-shock+protein+90+inhibitors+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DTaldone%26aufirst%3DT.%26atitle%3DAdvances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520heat-shock%2520protein%252090%2520inhibitors%2520for%2520cancer%2520treatment%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D559%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Matts, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">A systematic protocol for the characterization of Hsp90 modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1016%2Fj.bmc.2010.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=21129982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1eisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=684-692&author=R.+L.+Mattsauthor=G.+E.+Brandtauthor=Y.+Luauthor=A.+Dixitauthor=M.+Mollapourauthor=S.+Wangauthor=A.+C.+Donnellyauthor=L.+Neckersauthor=G.+Verkhivkerauthor=B.+S.+Blagg&title=A+systematic+protocol+for+the+characterization+of+Hsp90+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic protocol for the characterization of Hsp90 modulators</span></div><div class="casAuthors">Matts, Robert L.; Brandt, Gary E. L.; Lu, Yuanming; Dixit, Anshuman; Mollapour, Mehdi; Wang, Suiquan; Donnelly, Alison C.; Neckers, Leonard; Verkhivker, Gennady; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">684-692</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several Hsp90 modulators have been identified including the N-terminal ligand geldanamycin (GDA), the C-terminal ligand novobiocin (NB), and the co-chaperone disruptor celastrol.  Other Hsp90 modulators elicit a mechanism of action that remains unknown.  For example, the natural product gedunin and the synthetic anti-spermatogenic agent H2-gamendazole, recently identified Hsp90 modulators, manifest biol. activity through undefined mechanisms.  Herein, we report a series of biochem. techniques used to classify such modulators into identifiable categories.  Such studies provided evidence that gedunin and H2-gamendazole both modulate Hsp90 via a mechanism similar to celastrol, and unlike NB or GDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosBErc5glK77Vg90H21EOLACvtfcHk0lhIXurRtziE0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1eisw%253D%253D&md5=d271e44296a05bab9c70cb0d0ea48748</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DMatts%26aufirst%3DR.%2BL.%26aulast%3DBrandt%26aufirst%3DG.%2BE.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DDixit%26aufirst%3DA.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DDonnelly%26aufirst%3DA.%2BC.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DVerkhivker%26aufirst%3DG.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DA%2520systematic%2520protocol%2520for%2520the%2520characterization%2520of%2520Hsp90%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D684%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes DaGama, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas-Lopes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpaugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillarsetty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnchembio.670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=21946277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1anurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=818-826&author=K.+Moulickauthor=J.+H.+Ahnauthor=H.+Zongauthor=A.+Rodinaauthor=L.+Cerchiettiauthor=E.+M.+Gomes+DaGamaauthor=E.+Caldas-Lopesauthor=K.+Beebeauthor=F.+Pernaauthor=K.+Hatziauthor=L.+P.+Vuauthor=X.+Zhaoauthor=D.+Zatorskaauthor=T.+Taldoneauthor=P.+Smith-Jonesauthor=M.+Alpaughauthor=S.+S.+Grossauthor=N.+Pillarsettyauthor=T.+Kuauthor=J.+S.+Lewisauthor=S.+M.+Larsonauthor=R.+Levineauthor=H.+Erdjument-Bromageauthor=M.+L.+Guzmanauthor=S.+D.+Nimerauthor=A.+Melnickauthor=L.+Neckersauthor=G.+Chiosis&title=Affinity-based+proteomics+reveal+cancer-specific+networks+coordinated+by+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90</span></div><div class="casAuthors">Moulick, Kamalika; Ahn, James H.; Zong, Hongliang; Rodina, Anna; Cerchietti, Leandro; Gomes DaGama, Erica M.; Caldas-Lopes, Eloisi; Beebe, Kristin; Perna, Fabiana; Hatzi, Katerina; Vu, Ly P.; Zhao, Xinyang; Zatorska, Danuta; Taldone, Tony; Smith-Jones, Peter; Alpaugh, Mary; Gross, Steven S.; Pillarsetty, Nagavarakishore; Ku, Thomas; Lewis, Jason S.; Larson, Steven M.; Levine, Ross; Erdjument-Bromage, Hediye; Guzman, Monica L.; Nimer, Stephen D.; Melnick, Ari; Neckers, Len; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-826</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Most cancers were characterized by multiple mol. alterations, but identification of the key proteins involved in these signaling pathways is currently beyond reach.  The inhibitor PU-H71 preferentially targets tumor-enriched Hsp90 complexes and affinity captures Hsp90-dependent oncogenic client proteins.  The authors used PU-H71 affinity capture to design a proteomic approach that, when combined with bioinformatic pathway anal., identifies dysregulated signaling networks and key oncoproteins in chronic myeloid leukemia.  The identified interactome overlaps with the well-characterized altered proteome in this cancer, indicating that this method can provide global insights into the biol. of individual tumors, including primary patient specimens.  In addn., this approach can be used to identify previously uncharacterized oncoproteins and mechanisms, potentially leading to new targeted therapies.  Further the abundance of the PU-H71-enriched Hsp90 species, which is not dictated by Hsp90 expression alone, is predictive of the cell's sensitivity to Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXTlQWF_MFU7Vg90H21EOLACvtfcHk0lhIXurRtziE0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1anurbN&md5=d62e663a2e054f3715a3a6e2d5e2c10e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.670%26sid%3Dliteratum%253Aachs%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DZong%26aufirst%3DH.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DGomes%2BDaGama%26aufirst%3DE.%2BM.%26aulast%3DCaldas-Lopes%26aufirst%3DE.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DPerna%26aufirst%3DF.%26aulast%3DHatzi%26aufirst%3DK.%26aulast%3DVu%26aufirst%3DL.%2BP.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DSmith-Jones%26aufirst%3DP.%26aulast%3DAlpaugh%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DS.%2BS.%26aulast%3DPillarsetty%26aufirst%3DN.%26aulast%3DKu%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DLevine%26aufirst%3DR.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAffinity-based%2520proteomics%2520reveal%2520cancer-specific%2520networks%2520coordinated%2520by%2520Hsp90%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D818%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scroggins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zierer, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.18632%2Foncotarget.1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=23867252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1065-1074&author=K.+Beebeauthor=M.+Mollapourauthor=B.+Scrogginsauthor=C.+Prodromouauthor=W.+Xuauthor=M.+Tokitaauthor=T.+Taldoneauthor=L.+Pullenauthor=B.+K.+Ziererauthor=M.+J.+Leeauthor=J.+Trepelauthor=J.+Buchnerauthor=D.+Bolonauthor=G.+Chiosisauthor=L.+Neckers&title=Posttranslational+modification+and+conformational+state+of+heat+shock+protein+90+differentially+affect+binding+of+chemically+diverse+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span></div><div class="casAuthors">Beebe Kristin; Mollapour Mehdi; Scroggins Bradley; Prodromou Chrisostomos; Xu Wanping; Tokita Mari; Taldone Tony; Pullen Lester; Zierer Bettina K; Lee Min-Jung; Trepel Jane; Buchner Johannes; Bolon Daniel; Chiosis Gabriela; Neckers Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1065-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an essential molecular chaperone in eukaryotes that facilitates the conformational maturation and function of a diverse protein clientele, including aberrant and/or over-expressed proteins that are involved in cancer growth and survival.  A role for Hsp90 in supporting the protein homeostasis of cancer cells has buoyed interest in the utility of Hsp90 inhibitors as anti-cancer drugs.  Despite the fact that all clinically evaluated Hsp90 inhibitors target an identical nucleotide-binding pocket in the N domain of the chaperone, the precise determinants that affect drug binding in the cellular environment remain unclear, and it is possible that chemically distinct inhibitors may not share similar binding preferences.  Here we demonstrate that two chemically unrelated Hsp90 inhibitors, the benzoquinone ansamycin geldanamycin and the purine analog PU-H71, select for overlapping but not identical subpopulations of total cellular Hsp90, even though both inhibitors bind to an amino terminal nucleotide pocket and prevent N domain dimerization.  Our data also suggest that PU-H71 is able to access a broader range of N domain undimerized Hsp90 conformations than is geldanamycin and is less affected by Hsp90 phosphorylation, consistent with its broader and more potent anti-tumor activity.  A more complete understanding of the impact of the cellular milieu on small molecule inhibitor binding to Hsp90 should facilitate their more effective use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLZ-jT50Ygfa91pGlMMoT5fW6udTcc2eao953QDFy48Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D&md5=1db8c9dca9517cd39a1b911107869582</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1099%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DScroggins%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DTokita%26aufirst%3DM.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPullen%26aufirst%3DL.%26aulast%3DZierer%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DBolon%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DPosttranslational%2520modification%2520and%2520conformational%2520state%2520of%2520heat%2520shock%2520protein%252090%2520differentially%2520affect%2520binding%2520of%2520chemically%2520diverse%2520small%2520molecule%2520inhibitors%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D1065%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourboulia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodford, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chelluri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotooh-Abadi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetler-Stevenson, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bratslavsky, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1016%2Fj.molcel.2013.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=24462205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=317-329&author=M.+Mollapourauthor=D.+Bourbouliaauthor=K.+Beebeauthor=M.+R.+Woodfordauthor=S.+Polierauthor=A.+Hoangauthor=R.+Chelluriauthor=Y.+Liauthor=A.+Guoauthor=M.+J.+Leeauthor=E.+Fotooh-Abadiauthor=S.+Khanauthor=T.+Princeauthor=N.+Miyajimaauthor=S.+Yoshidaauthor=S.+Tsutsumiauthor=W.+Xuauthor=B.+Panaretouauthor=W.+G.+Stetler-Stevensonauthor=G.+Bratslavskyauthor=J.+B.+Trepelauthor=C.+Prodromouauthor=L.+Neckers&title=Asymmetric+Hsp90+N+domain+SUMOylation+recruits+Aha1+and+ATP-competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors</span></div><div class="casAuthors">Mollapour, Mehdi; Bourboulia, Dimitra; Beebe, Kristin; Woodford, Mark R.; Polier, Sigrun; Hoang, Anthony; Chelluri, Raju; Li, Yu; Guo, Ailan; Lee, Min-Jung; Fotooh-Abadi, Elham; Khan, Sahar; Prince, Thomas; Miyajima, Naoto; Yoshida, Soichiro; Tsutsumi, Shinji; Xu, Wanping; Panaretou, Barry; Stetler-Stevenson, William G.; Bratslavsky, Gennady; Trepel, Jane B.; Prodromou, Chrisostomos; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-329</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The stability and activity of numerous signaling proteins in both normal and cancer cells depends on the dimeric mol. chaperone heat shock protein 90 (Hsp90).  Hsp90's function is coupled to ATP binding and hydrolysis and requires a series of conformational changes that are regulated by cochaperones and numerous post-translational modifications (PTMs).  SUMOylation is one of the least-understood Hsp90 PTMs.  Here, we show that asym. SUMOylation of a conserved lysine residue in the N domain of both yeast (K178) and human (K191) Hsp90 facilitates both recruitment of the ATPase-activating cochaperone Aha1, and unexpectedly, the binding of Hsp90 inhibitors, suggesting that these drugs assoc. preferentially with Hsp90 proteins that are actively engaged in the chaperone cycle.  Importantly, cellular transformation is accompanied by elevated steady-state N domain SUMOylation, and increased Hsp90 SUMOylation sensitizes yeast and mammalian cells to Hsp90 inhibitors, providing a mechanism to explain the sensitivity of cancer cells to these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptnIeF9glnb7Vg90H21EOLACvtfcHk0ljR_MsYgSZKEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kjtr8%253D&md5=a55d7b394c04a4d8a9a0fe0afd67a86d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DBourboulia%26aufirst%3DD.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DWoodford%26aufirst%3DM.%2BR.%26aulast%3DPolier%26aufirst%3DS.%26aulast%3DHoang%26aufirst%3DA.%26aulast%3DChelluri%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DFotooh-Abadi%26aufirst%3DE.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DPrince%26aufirst%3DT.%26aulast%3DMiyajima%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DStetler-Stevenson%26aufirst%3DW.%2BG.%26aulast%3DBratslavsky%26aufirst%3DG.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DAsymmetric%2520Hsp90%2520N%2520domain%2520SUMOylation%2520recruits%2520Aha1%2520and%2520ATP-competitive%2520inhibitors%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D53%26spage%3D317%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0ljqLgpyIyTLwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Cerchietti, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsikitas, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varticovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaknovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span> </span><span class="NLM_article-title">A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnm.2059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=19966776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWksb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1369-1376&author=L.+C.+Cerchiettiauthor=E.+C.+Lopesauthor=S.+N.+Yangauthor=K.+Hatziauthor=K.+L.+Buntingauthor=L.+A.+Tsikitasauthor=A.+Mallikauthor=A.+I.+Roblesauthor=J.+Wallingauthor=L.+Varticovskiauthor=R.+Shaknovichauthor=K.+N.+Bhallaauthor=G.+Chiosisauthor=A.+Melnick&title=A+purine+scaffold+Hsp90+inhibitor+destabilizes+BCL-6+and+has+specific+antitumor+activity+in+BCL-6-dependent+B+cell+lymphomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas</span></div><div class="casAuthors">Cerchietti, Leandro C.; Lopes, Eloisi C.; Yang, Shao Ning; Hatzi, Katerina; Bunting, Karen L.; Tsikitas, Lucas A.; Mallik, Alka; Robles, Ana I.; Walling, Jennifer; Varticovski, Lyuba; Shaknovich, Rita; Bhalla, Kapil N.; Chiosis, Gabriela; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1369-1376</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors report that heat shock protein 90 (Hsp90) inhibitors selectively kill diffuse large B cell lymphomas (DLBCLs) that depend on the BCL-6 transcriptional repressor.  The authors found that endogenous Hsp90 interacts with BCL-6 in DLBCL cells and can stabilize BCL-6 mRNA and protein.  Hsp90 formed a complex with BCL-6 at its target promoters, and Hsp90 inhibitors derepressed BCL-6 target genes.  A stable mutant of BCL-6 rescued DLBCL cells from Hsp90 inhibitor-induced apoptosis.  BCL-6 and Hsp90 were almost invariantly coexpressed in the nuclei of primary DLBCL cells, suggesting that their interaction is relevant in this disease.  The authors examd. the pharmacokinetics, toxicity and efficacy of PU-H71, a recently developed purine-derived Hsp90 inhibitor.  PU-H71 preferentially accumulated in lymphomas compared to normal tissues and selectively suppressed BCL-6-dependent DLBCLs in vivo, inducing reactivation of key BCL-6 target genes and apoptosis.  PU-H71 also induced cell death in primary human DLBCL specimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQhx-_9IeVp7Vg90H21EOLACvtfcHk0ljqLgpyIyTLwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWksb3N&md5=5d6da58190e2418631034e71c8a5730e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnm.2059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2059%26sid%3Dliteratum%253Aachs%26aulast%3DCerchietti%26aufirst%3DL.%2BC.%26aulast%3DLopes%26aufirst%3DE.%2BC.%26aulast%3DYang%26aufirst%3DS.%2BN.%26aulast%3DHatzi%26aufirst%3DK.%26aulast%3DBunting%26aufirst%3DK.%2BL.%26aulast%3DTsikitas%26aufirst%3DL.%2BA.%26aulast%3DMallik%26aufirst%3DA.%26aulast%3DRobles%26aufirst%3DA.%2BI.%26aulast%3DWalling%26aufirst%3DJ.%26aulast%3DVarticovski%26aufirst%3DL.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DA%2520purine%2520scaffold%2520Hsp90%2520inhibitor%2520destabilizes%2520BCL-6%2520and%2520has%2520specific%2520antitumor%2520activity%2520in%2520BCL-6-dependent%2520B%2520cell%2520lymphomas%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D1369%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Breinig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas-Lopes, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goeppert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirmacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, M. A.</span><span> </span><span class="NLM_article-title">Targeting the heat shock protein Hsp90 with non-quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=102-112&author=M.+Breinigauthor=E.+M.+Caldas-Lopesauthor=B.+Goeppertauthor=M.+Malzauthor=F.+Bergmannauthor=R.+Riekerauthor=P.+Schirmacherauthor=G.+Chiosisauthor=M.+A.+Kern&title=Targeting+the+heat+shock+protein+Hsp90+with+non-quinone+inhibitors%3A+A+novel+chemotherapeutic+approach+in+human+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreinig%26aufirst%3DM.%26aulast%3DCaldas-Lopes%26aufirst%3DE.%2BM.%26aulast%3DGoeppert%26aufirst%3DB.%26aulast%3DMalz%26aufirst%3DM.%26aulast%3DBergmann%26aufirst%3DF.%26aulast%3DRieker%26aufirst%3DR.%26aulast%3DSchirmacher%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DKern%26aufirst%3DM.%2BA.%26atitle%3DTargeting%2520the%2520heat%2520shock%2520protein%2520Hsp90%2520with%2520non-quinone%2520inhibitors%253A%2520A%2520novel%2520chemotherapeutic%2520approach%2520in%2520human%2520hepatocellular%2520carcinoma%26jtitle%3DHepatology%26date%3D2009%26volume%3D50%26spage%3D102%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Caldas-Lopes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Stanchina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varticovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">8368</span><span class="NLM_x">–</span> <span class="NLM_lpage">8373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=8368-8373&author=E.+Caldas-Lopesauthor=L.+Cerchiettiauthor=J.+H.+Ahnauthor=C.+C.+Clementauthor=A.+I.+Roblesauthor=A.+Rodinaauthor=K.+Moulickauthor=T.+Taldoneauthor=A.+Gozmanauthor=Y.+Guoauthor=N.+Wuauthor=E.+de+Stanchinaauthor=J.+Whiteauthor=S.+S.+Grossauthor=Y.+Maauthor=L.+Varticovskiauthor=A.+Melnickauthor=G.+Chiosis&title=Hsp90+inhibitor+PU-H71%2C+a+multimodal+inhibitor+of+malignancy%2C+induces+complete+responses+in+triple-negative+breast+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaldas-Lopes%26aufirst%3DE.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DRobles%26aufirst%3DA.%2BI.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3Dde%2BStanchina%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DS.%2BS.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DVarticovski%26aufirst%3DL.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHsp90%2520inhibitor%2520PU-H71%252C%2520a%2520multimodal%2520inhibitor%2520of%2520malignancy%252C%2520induces%2520complete%2520responses%2520in%2520triple-negative%2520breast%2520cancer%2520models%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D8368%26epage%3D8373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodsky, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Selective compounds define Hsp90 as a major inhibitor of apoptosis in small cell lung cancer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnchembio.2007.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=17603540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFaru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=498-507&author=A.+Rodinaauthor=M.+Vilenchikauthor=K.+Moulickauthor=J.+Aguirreauthor=J.+Kimauthor=A.+Chiangauthor=J.+Litzauthor=C.+C.+Clementauthor=Y.+Kangauthor=Y.+Sheauthor=N.+Wuauthor=S.+Feltsauthor=P.+Wipfauthor=J.+Massagueauthor=X.+Jiangauthor=J.+L.+Brodskyauthor=G.+W.+Krystalauthor=G.+Chiosis&title=Selective+compounds+define+Hsp90+as+a+major+inhibitor+of+apoptosis+in+small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer</span></div><div class="casAuthors">Rodina, Anna; Vilenchik, Maria; Moulick, Kamalika; Aguirre, Julia; Kim, Joungnam; Chiang, Anne; Litz, Julie; Clement, Cristina C.; Kang, Yanlong; She, Yuhong; Wu, Nian; Felts, Sara; Wipf, Peter; Massague, Joan; Jiang, Xuejun; Brodsky, Jeffrey L.; Krystal, Geoffrey W.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">498-507</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The heat shock protein 90 (Hsp90) has a crit. role in malignant transformation.  Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood.  By using selective compds., the authors the authors have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90.  Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled.  These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZlX5SIced7Vg90H21EOLACvtfcHk0ljgxgq5MZzU4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFaru78%253D&md5=79f2a09bca626726b09895f80c40f001</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2007.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2007.10%26sid%3Dliteratum%253Aachs%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DA.%26aulast%3DLitz%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DMassague%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DBrodsky%26aufirst%3DJ.%2BL.%26aulast%3DKrystal%26aufirst%3DG.%2BW.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSelective%2520compounds%2520define%2520Hsp90%2520as%2520a%2520major%2520inhibitor%2520of%2520apoptosis%2520in%2520small%2520cell%2520lung%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D498%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structure of unliganded GRP94, the endoplasmic reticulum Hsp90. Basis for nucleotide-induced conformational change</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">30438</span><span class="NLM_x">–</span> <span class="NLM_lpage">30447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30438-30447&author=D.+E.+Dollinsauthor=R.+M.+Immorminoauthor=D.+T.+Gewirth&title=Structure+of+unliganded+GRP94%2C+the+endoplasmic+reticulum+Hsp90.+Basis+for+nucleotide-induced+conformational+change"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520of%2520unliganded%2520GRP94%252C%2520the%2520endoplasmic%2520reticulum%2520Hsp90.%2520Basis%2520for%2520nucleotide-induced%2520conformational%2520change%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30438%26epage%3D30447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span> </span><span class="NLM_article-title">Development and testing of the OPLS-All Atom force field on conformational energetics and properties of organic liquids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">11225</span><span class="NLM_x">–</span> <span class="NLM_lpage">11236</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9621760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=11225-11236&author=W.+L.+Jorgensenauthor=D.+Maxwellauthor=J.+Tirado-Rives&title=Development+and+testing+of+the+OPLS-All+Atom+force+field+on+conformational+energetics+and+properties+of+organic+liquids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fja9621760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9621760%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMaxwell%26aufirst%3DD.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520the%2520OPLS-All%2520Atom%2520force%2520field%2520on%2520conformational%2520energetics%2520and%2520properties%2520of%2520organic%2520liquids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D11225%26epage%3D11236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lhTycx1tsn8ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span> </span><span class="NLM_article-title">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1750</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+A+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lhTycx1tsn8ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520A%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaushik-Basu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talele, T. T.</span><span> </span><span class="NLM_article-title">3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700266z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWgu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=42-55&author=P.+D.+Patelauthor=M.+R.+Patelauthor=N.+Kaushik-Basuauthor=T.+T.+Talele&title=3D+QSAR+and+molecular+docking+studies+of+benzimidazole+derivatives+as+hepatitis+C+virus+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">3D QSAR and Molecular Docking Studies of Benzimidazole Derivatives as Hepatitis C Virus NS5B Polymerase Inhibitors</span></div><div class="casAuthors">Patel, Pallav D.; Patel, Maulik R.; Kaushik-Basu, Neerja; Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-55</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The urgent need for novel HCV antiviral agents has provided an impetus for understanding the structural requisites of NS5B polymerase inhibitors at the mol. level.  Toward this objective, comparative mol. field anal. (CoMFA) and comparative mol. similarity indexes anal. (CoMSIA) of 67 HCV NS5B polymerase inhibitors were performed using two methods.  First, ligand-based 3D QSAR studies were performed based on the lowest energy conformations employing the atom fit alignment method.  Second, receptor-based 3D QSAR models were derived from the predicted binding conformations obtained by docking all NS5B inhibitors at the allosteric binding site of NS5B (PDB ID: 2dxs).  Results generated from the ligand-based model were found superior (r2cv values of 0.630 for CoMFA and 0.668 for CoMSIA) to those obtained by the receptor-based model (r2cv values of 0.536 and 0.561 for CoMFA and CoMSIA, resp.).  The predictive ability of the models was validated using a structurally diversified test set of 22 compds. that had not been included in a preliminary training set of 45 compds.  The predictive r2 values for the ligand-based CoMFA and CoMSIA models were 0.734 and 0.800, resp., while the corresponding predictive r2 values for the receptor-based CoMFA and CoMSIA models were 0.538 and 0.639, resp.  The greater potency of the tryptophan derivs. over that of the tyrosine derivs. was interpreted based on CoMFA steric and electrostatic contour maps.  The CoMSIA results revealed that for a NS5B inhibitor to have appreciable inhibitory activity it requires hydrogen bond donor and acceptor groups at the 5-position of the indole ring and an R substituent at the chiral carbon, resp.  Interpretation of the CoMFA and CoMSIA contour maps in context of the topol. of the allosteric binding site of NS5B provided insight into NS5B-inhibitor interactions.  Taken together, the present 3D QSAR models were found to accurately predict the HCV NS5B polymerase inhibitory activity of structurally diverse test set compds. and to yield reliable clues for further optimization of the benzimidazole derivs. in the data set.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHU3VUoaMP-LVg90H21EOLACvtfcHk0lj7me1jJKTgfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWgu7zL&md5=3cfac0244f3b6447997dd97626fdc7c2</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fci700266z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700266z%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DKaushik-Basu%26aufirst%3DN.%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3D3D%2520QSAR%2520and%2520molecular%2520docking%2520studies%2520of%2520benzimidazole%2520derivatives%2520as%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D42%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Dany Pechalrieu, Fanny Assemat, Ludovic Halby, Marlene Marcellin, Pengrong Yan, Karima Chaoui, Sahil Sharma, Gabriela Chiosis, Odile Burlet-Schiltz, Paola B. Arimondo, <span class="NLM_string-name hlFld-ContribAuthor">Marie Lopez</span>. </span><span class="cited-content_cbyCitation_article-title">Bisubstrate-Type Chemical Probes Identify GRP94 as a Potential Target of Cytosine-Containing Adenosine Analogs. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (4)
                                     , 952-961. <a href="https://doi.org/10.1021/acschembio.9b00965" title="DOI URL">https://doi.org/10.1021/acschembio.9b00965</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00965%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DBisubstrate-Type%252BChemical%252BProbes%252BIdentify%252BGRP94%252Bas%252Ba%252BPotential%252BTarget%252Bof%252BCytosine-Containing%252BAdenosine%252BAnalogs%26aulast%3DPechalrieu%26aufirst%3DDany%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30112019%26date%3D19032020%26date%3D06042020%26date%3D19032020%26volume%3D15%26issue%3D4%26spage%3D952%26epage%3D961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mariarosaria Ferraro, Ilda D’Annessa, Elisabetta Moroni, Giulia Morra, Antonella Paladino, Silvia Rinaldi, Federica Compostella, <span class="NLM_string-name hlFld-ContribAuthor">Giorgio Colombo</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 60-87. <a href="https://doi.org/10.1021/acs.jmedchem.8b00825" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00825%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulators%252Bof%252BHSP90%252Band%252BHSP70%25253A%252BDynamics%252BMeets%252BFunction%252Bthrough%252BStructure-Based%252BDrug%252BDesign%26aulast%3DFerraro%26aufirst%3DMariarosaria%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D24052018%26date%3D09082018%26date%3D26072018%26volume%3D62%26issue%3D1%26spage%3D60%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fen Jiang, An-ping Guo, Jia-chen Xu, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Li Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9513-9533. <a href="https://doi.org/10.1021/acs.jmedchem.8b00800" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00800%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BGrp94%252BSelective%252BInhibitor%252Bwith%252BAnti-Inflammatory%252BEfficacy%252Bin%252Ba%252BMouse%252BModel%252Bof%252BUlcerative%252BColitis%26aulast%3DJiang%26aufirst%3DFen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19052018%26date%3D26102018%26date%3D15102018%26volume%3D61%26issue%3D21%26spage%3D9513%26epage%3D9533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nanette
L. S. Que, Vincent M. Crowley, Adam S. Duerfeldt, Jinbo Zhao, Caitlin N. Kent, Brian S. J. Blagg, <span class="NLM_string-name hlFld-ContribAuthor">Daniel T. Gewirth</span>. </span><span class="cited-content_cbyCitation_article-title">Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (7)
                                     , 2793-2805. <a href="https://doi.org/10.1021/acs.jmedchem.7b01608" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01608%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252BBased%252BDesign%252Bof%252Ba%252BGrp94-Selective%252BInhibitor%25253A%252BExploiting%252Ba%252BKey%252BResidue%252Bin%252BGrp94%252BTo%252BOptimize%252BParalog-Selective%252BBinding%26aulast%3DQue%26aufirst%3DNanette%2BL.%2BS.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D31102017%26date%3D20032018%26date%3D12032018%26volume%3D61%26issue%3D7%26spage%3D2793%26epage%3D2805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuj  Khandelwal</span>, <span class="hlFld-ContribAuthor ">Vincent M.  Crowley</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Resorcinol-Based Grp94-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1013-1018. <a href="https://doi.org/10.1021/acsmedchemlett.7b00193" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DResorcinol-Based%252BGrp94-Selective%252BInhibitors%26aulast%3DKhandelwal%26aufirst%3DAnuj%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08052017%26date%3D01092017%26date%3D07092017%26date%3D12102017%26date%3D01092017%26volume%3D8%26issue%3D10%26spage%3D1013%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Hui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Min  Jia</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, and <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10498-10519. <a href="https://doi.org/10.1021/acs.jmedchem.6b00912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BTetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidines%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DJiang%26aufirst%3DFen%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D22112016%26date%3D08122016%26date%3D09112016%26volume%3D59%26issue%3D23%26spage%3D10498%26epage%3D10519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent M.  Crowley</span>, <span class="hlFld-ContribAuthor ">Anuj  Khandelwal</span>, <span class="hlFld-ContribAuthor ">Sanket  Mishra</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Stothert</span>, <span class="hlFld-ContribAuthor ">Dustin J. E.  Huard</span>, <span class="hlFld-ContribAuthor ">Jinbo  Zhao</span>, <span class="hlFld-ContribAuthor ">Aaron  Muth</span>, <span class="hlFld-ContribAuthor ">Adam S.  Duerfeldt</span>, <span class="hlFld-ContribAuthor ">James L.  Kizziah</span>, <span class="hlFld-ContribAuthor ">Raquel L.  Lieberman</span>, <span class="hlFld-ContribAuthor ">Chad A.  Dickey</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3471-3488. <a href="https://doi.org/10.1021/acs.jmedchem.6b00085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00085%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BGlucose%252BRegulated%252BProtein%252B94-Selective%252BInhibitors%252BBased%252Bon%252Bthe%252BBnIm%252Band%252BRadamide%252BScaffold%26aulast%3DCrowley%26aufirst%3DVincent%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28012016%26date%3D04042016%26date%3D14042016%26date%3D22032016%26volume%3D59%26issue%3D7%26spage%3D3471%26epage%3D3488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuradha  Ratna</span>, <span class="hlFld-ContribAuthor ">Arlene  Lim</span>, <span class="hlFld-ContribAuthor ">Zihai  Li</span>, <span class="hlFld-ContribAuthor ">Josepmaria  Argemi</span>, <span class="hlFld-ContribAuthor ">Ramon  Bataller</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Pranoti  Mandrekar</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloid Endoplasmic Reticulum Resident Chaperone
              GP96
              Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease. </span><span class="cited-content_cbyCitation_journal-name">Hepatology Communications</span><span> <strong>2021,</strong> <em>5 </em>
                                    (7)
                                     , 1165-1182. <a href="https://doi.org/10.1002/hep4.1713" title="DOI URL">https://doi.org/10.1002/hep4.1713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep4.1713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep4.1713%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%2520Communications%26atitle%3DMyeloid%252BEndoplasmic%252BReticulum%252BResident%252BChaperone%252BGP96%252BFacilitates%252BInflammation%252Band%252BSteatosis%252Bin%252BAlcohol%2525E2%252580%252590Associated%252BLiver%252BDisease%26aulast%3DRatna%26aufirst%3DAnuradha%26date%3D2021%26date%3D2021%26volume%3D5%26issue%3D7%26spage%3D1165%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofeng  Duan</span>, <span class="hlFld-ContribAuthor ">Stephen  Iwanowycz</span>, <span class="hlFld-ContribAuthor ">Soo  Ngoi</span>, <span class="hlFld-ContribAuthor ">Megan  Hill</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Bei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.629846" title="DOI URL">https://doi.org/10.3389/fonc.2021.629846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.629846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.629846%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DMolecular%252BChaperone%252BGRP94%25252FGP96%252Bin%252BCancers%25253A%252BOncogenesis%252Band%252BTherapeutic%252BTarget%26aulast%3DDuan%26aufirst%3DXiaofeng%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Woong  Kim</span>, <span class="hlFld-ContribAuthor ">Yea Bin  Cho</span>, <span class="hlFld-ContribAuthor ">Sukmook  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (3)
                                     , 670. <a href="https://doi.org/10.3390/cells10030670" title="DOI URL">https://doi.org/10.3390/cells10030670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10030670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10030670%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DCell%252BSurface%252BGRP94%252Bas%252Ba%252BNovel%252BEmerging%252BTherapeutic%252BTarget%252Bfor%252BMonoclonal%252BAntibody%252BCancer%252BTherapy%26aulast%3DKim%26aufirst%3DJi%2BWoong%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D3%26spage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (10)
                                     , 1904-1925. <a href="https://doi.org/10.1016/j.apsb.2020.01.018" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.01.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.01.018%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DModulation%252Bof%252Bprotein%252Bfate%252Bdecision%252Bby%252Bsmall%252Bmolecules%25253A%252Btargeting%252Bmolecular%252Bchaperone%252Bmachinery%26aulast%3DWang%26aufirst%3DLei%26date%3D2020%26volume%3D10%26issue%3D10%26spage%3D1904%26epage%3D1925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengrong  Yan</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Sahil  Sharma</span>, <span class="hlFld-ContribAuthor ">Adriana  Corben</span>, <span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Palak  Panchal</span>, <span class="hlFld-ContribAuthor ">Chenghua  Yang</span>, <span class="hlFld-ContribAuthor ">Weilin  Sun</span>, <span class="hlFld-ContribAuthor ">Thais L.  Araujo</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Suhasini  Joshi</span>, <span class="hlFld-ContribAuthor ">Kenneth  Robzyk</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Gandu</span>, <span class="hlFld-ContribAuthor ">Julie R.  White</span>, <span class="hlFld-ContribAuthor ">Elisa  de Stanchina</span>, <span class="hlFld-ContribAuthor ">Shanu  Modi</span>, <span class="hlFld-ContribAuthor ">Yelena Y.  Janjigian</span>, <span class="hlFld-ContribAuthor ">Elizabeth G.  Hill</span>, <span class="hlFld-ContribAuthor ">Bei  Liu</span>, <span class="hlFld-ContribAuthor ">Hediye  Erdjument-Bromage</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Neubert</span>, <span class="hlFld-ContribAuthor ">Nanette L.S.  Que</span>, <span class="hlFld-ContribAuthor ">Zihai  Li</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gewirth</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2020,</strong> <em>31 </em>
                                    (13)
                                     , 107840. <a href="https://doi.org/10.1016/j.celrep.2020.107840" title="DOI URL">https://doi.org/10.1016/j.celrep.2020.107840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2020.107840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2020.107840%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DMolecular%252BStressors%252BEngender%252BProtein%252BConnectivity%252BDysfunction%252Bthrough%252BAberrant%252BN-Glycosylation%252Bof%252Ba%252BChaperone%26aulast%3DYan%26aufirst%3DPengrong%26date%3D2020%26volume%3D31%26issue%3D13%26spage%3D107840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sejin  Jung</span>, <span class="hlFld-ContribAuthor ">Nam Gu  Yoon</span>, <span class="hlFld-ContribAuthor ">Sujae  Yang</span>, <span class="hlFld-ContribAuthor ">Darong  Kim</span>, <span class="hlFld-ContribAuthor ">Won Seok  Lee</span>, <span class="hlFld-ContribAuthor ">Ki Bum  Hong</span>, <span class="hlFld-ContribAuthor ">Changwook  Lee</span>, <span class="hlFld-ContribAuthor ">Byoung Heon  Kang</span>, <span class="hlFld-ContribAuthor ">Ji Hoon  Lee</span>, <span class="hlFld-ContribAuthor ">Soosung  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126809. <a href="https://doi.org/10.1016/j.bmcl.2019.126809" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126809%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-%252528%2525284-resorcinolyl%252529-5-aryl-1%25252C2%25252C3-triazol-1-yl%252529acetates%252Bas%252Bpotent%252BHsp90%252Binhibitors%252Bwith%252Bselectivity%252Bover%252BTRAP1%26aulast%3DJung%26aufirst%3DSejin%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John D.  Huck</span>, <span class="hlFld-ContribAuthor ">Nanette L.S.  Que</span>, <span class="hlFld-ContribAuthor ">Robert M.  Immormino</span>, <span class="hlFld-ContribAuthor ">Liza  Shrestha</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gewirth</span>. </span><span class="cited-content_cbyCitation_article-title">NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (44)
                                     , 16010-16019. <a href="https://doi.org/10.1074/jbc.RA119.009960" title="DOI URL">https://doi.org/10.1074/jbc.RA119.009960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA119.009960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA119.009960%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DNECA%252Bderivatives%252Bexploit%252Bthe%252Bparalog-specific%252Bproperties%252Bof%252Bthe%252Bsite%252B3%252Bside%252Bpocket%252Bof%252BGrp94%25252C%252Bthe%252Bendoplasmic%252Breticulum%252BHsp90%26aulast%3DHuck%26aufirst%3DJohn%2BD.%26date%3D2019%26volume%3D294%26issue%3D44%26spage%3D16010%26epage%3D16019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John D.  Huck</span>, <span class="hlFld-ContribAuthor ">Nanette L. S.  Que</span>, <span class="hlFld-ContribAuthor ">Sahil  Sharma</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gewirth</span>. </span><span class="cited-content_cbyCitation_article-title">Structures of Hsp90α and Hsp90β bound to a purine‐scaffold inhibitor reveal an exploitable residue for drug selectivity. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2019,</strong> <em>87 </em>
                                    (10)
                                     , 869-877. <a href="https://doi.org/10.1002/prot.25750" title="DOI URL">https://doi.org/10.1002/prot.25750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.25750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.25750%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DStructures%252Bof%252BHsp90%2525CE%2525B1%252Band%252BHsp90%2525CE%2525B2%252Bbound%252Bto%252Ba%252Bpurine%2525E2%252580%252590scaffold%252Binhibitor%252Breveal%252Ban%252Bexploitable%252Bresidue%252Bfor%252Bdrug%252Bselectivity%26aulast%3DHuck%26aufirst%3DJohn%2BD.%26date%3D2019%26date%3D2019%26volume%3D87%26issue%3D10%26spage%3D869%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Tramentozzi</span>, <span class="hlFld-ContribAuthor ">Paola  Finotti</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of purine-scaffold inhibitors on HUVECs: Involvement of the purinergic pathway and interference with ATP. Implications for preventing the adverse effects of extracellular Grp94. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry and Biophysics Reports</span><span> <strong>2019,</strong> <em>19 </em>, 100661. <a href="https://doi.org/10.1016/j.bbrep.2019.100661" title="DOI URL">https://doi.org/10.1016/j.bbrep.2019.100661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrep.2019.100661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrep.2019.100661%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%2520and%2520Biophysics%2520Reports%26atitle%3DEffects%252Bof%252Bpurine-scaffold%252Binhibitors%252Bon%252BHUVECs%25253A%252BInvolvement%252Bof%252Bthe%252Bpurinergic%252Bpathway%252Band%252Binterference%252Bwith%252BATP.%252BImplications%252Bfor%252Bpreventing%252Bthe%252Badverse%252Beffects%252Bof%252Bextracellular%252BGrp94%26aulast%3DTramentozzi%26aufirst%3DElisa%26date%3D2019%26volume%3D19%26spage%3D100661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teresa R.  O’Meara</span>, <span class="hlFld-ContribAuthor ">Matthew J.  O’Meara</span>, <span class="hlFld-ContribAuthor ">Elizabeth J.  Polvi</span>, <span class="hlFld-ContribAuthor ">M. Reza  Pourhaghighi</span>, <span class="hlFld-ContribAuthor ">Sean D.  Liston</span>, <span class="hlFld-ContribAuthor ">Zhen-Yuan  Lin</span>, <span class="hlFld-ContribAuthor ">Amanda O.  Veri</span>, <span class="hlFld-ContribAuthor ">Andrew  Emili</span>, <span class="hlFld-ContribAuthor ">Anne-Claude  Gingras</span>, <span class="hlFld-ContribAuthor ">Leah E.  Cowen</span>, . </span><span class="cited-content_cbyCitation_article-title">Global proteomic analyses define an environmentally contingent Hsp90 interactome and reveal chaperone-dependent regulation of stress granule proteins and the R2TP complex in a fungal pathogen. </span><span class="cited-content_cbyCitation_journal-name">PLOS Biology</span><span> <strong>2019,</strong> <em>17 </em>
                                    (7)
                                     , e3000358. <a href="https://doi.org/10.1371/journal.pbio.3000358" title="DOI URL">https://doi.org/10.1371/journal.pbio.3000358</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pbio.3000358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pbio.3000358%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Biology%26atitle%3DGlobal%252Bproteomic%252Banalyses%252Bdefine%252Ban%252Benvironmentally%252Bcontingent%252BHsp90%252Binteractome%252Band%252Breveal%252Bchaperone-dependent%252Bregulation%252Bof%252Bstress%252Bgranule%252Bproteins%252Band%252Bthe%252BR2TP%252Bcomplex%252Bin%252Ba%252Bfungal%252Bpathogen%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DTeresa%2BR.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D7%26spage%3De3000358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Du</span>, <span class="hlFld-ContribAuthor ">Ying-Li  Han</span>, <span class="hlFld-ContribAuthor ">Cong-Cong  Hou</span>, <span class="hlFld-ContribAuthor ">Jun-Quan  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Expression pattern of heat shock protein 90AB (HSP90AB) and stress-inducible protein 1 (Stip1) during spermatogenesis of mudskipper Boleophthalmus pectinirostris. </span><span class="cited-content_cbyCitation_journal-name">Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology</span><span> <strong>2019,</strong> <em>231 </em>, 42-51. <a href="https://doi.org/10.1016/j.cbpb.2019.01.016" title="DOI URL">https://doi.org/10.1016/j.cbpb.2019.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpb.2019.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpb.2019.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DComparative%2520Biochemistry%2520and%2520Physiology%2520Part%2520B%253A%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DExpression%252Bpattern%252Bof%252Bheat%252Bshock%252Bprotein%252B90AB%252B%252528HSP90AB%252529%252Band%252Bstress-inducible%252Bprotein%252B1%252B%252528Stip1%252529%252Bduring%252Bspermatogenesis%252Bof%252Bmudskipper%252BBoleophthalmus%252Bpectinirostris%26aulast%3DDu%26aufirst%3DChen%26date%3D2019%26volume%3D231%26spage%3D42%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Li</span>, <span class="hlFld-ContribAuthor ">Ran  Zhao</span>, <span class="hlFld-ContribAuthor ">Kevin  Fan</span>, <span class="hlFld-ContribAuthor ">Stephen  Iwanowycz</span>, <span class="hlFld-ContribAuthor ">Hongkuan  Fan</span>, <span class="hlFld-ContribAuthor ">Zihai  Li</span>, <span class="hlFld-ContribAuthor ">Bei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of dendritic cell function improves survival in experimental sepsis through immune chaperone. </span><span class="cited-content_cbyCitation_journal-name">Innate Immunity</span><span> <strong>2019,</strong> <em>25 </em>
                                    (4)
                                     , 235-243. <a href="https://doi.org/10.1177/1753425919840423" title="DOI URL">https://doi.org/10.1177/1753425919840423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1753425919840423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1753425919840423%26sid%3Dliteratum%253Aachs%26jtitle%3DInnate%2520Immunity%26atitle%3DRegulation%252Bof%252Bdendritic%252Bcell%252Bfunction%252Bimproves%252Bsurvival%252Bin%252Bexperimental%252Bsepsis%252Bthrough%252Bimmune%252Bchaperone%26aulast%3DLi%26aufirst%3DPengfei%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D4%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qun  Wei</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Le  Su</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhao</span>, <span class="hlFld-ContribAuthor ">BaoXiang  Zhao</span>, <span class="hlFld-ContribAuthor ">JunYing  Miao</span>, <span class="hlFld-ContribAuthor ">ZhaoMin  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Low-concentration HCP1 inhibits apoptosis in vascular endothelial cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2019,</strong> <em>511 </em>
                                    (1)
                                     , 92-98. <a href="https://doi.org/10.1016/j.bbrc.2019.02.003" title="DOI URL">https://doi.org/10.1016/j.bbrc.2019.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2019.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2019.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DLow-concentration%252BHCP1%252Binhibits%252Bapoptosis%252Bin%252Bvascular%252Bendothelial%252Bcells%26aulast%3DWei%26aufirst%3DQun%26date%3D2019%26volume%3D511%26issue%3D1%26spage%3D92%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Mark P.  Dunphy</span>, <span class="hlFld-ContribAuthor ">Adriana  Corben</span>, <span class="hlFld-ContribAuthor ">Shanu  Modi</span>, <span class="hlFld-ContribAuthor ">Monica L.  Guzman</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gewirth</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Chaperome heterogeneity and its implications for cancer study and treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (6)
                                     , 2162-2179. <a href="https://doi.org/10.1074/jbc.REV118.002811" title="DOI URL">https://doi.org/10.1074/jbc.REV118.002811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.REV118.002811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.REV118.002811%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DChaperome%252Bheterogeneity%252Band%252Bits%252Bimplications%252Bfor%252Bcancer%252Bstudy%252Band%252Btreatment%26aulast%3DWang%26aufirst%3DTai%26date%3D2019%26volume%3D294%26issue%3D6%26spage%3D2162%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 Inhibitors Blocking Multiple Oncogenic Signaling Pathways for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 397-429. <a href="https://doi.org/10.1007/978-3-030-03952-3_20" title="DOI URL">https://doi.org/10.1007/978-3-030-03952-3_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-03952-3_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-03952-3_20%26sid%3Dliteratum%253Aachs%26atitle%3DHSP90%252BInhibitors%252BBlocking%252BMultiple%252BOncogenic%252BSignaling%252BPathways%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DJiang%26aufirst%3DFen%26date%3D2019%26date%3D2019%26spage%3D397%26epage%3D429%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProteins%252Bin%252BSignaling%252BPathways%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.%2BA.%26date%3D2019%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert D.  Barrows</span>, <span class="hlFld-ContribAuthor ">Kristin M.  Blacklock</span>, <span class="hlFld-ContribAuthor ">Paul R.  Rablen</span>, <span class="hlFld-ContribAuthor ">Sagar D.  Khare</span>, <span class="hlFld-ContribAuthor ">Spencer  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Computational assessment of thioether isosteres. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2018,</strong> <em>80 </em>, 282-292. <a href="https://doi.org/10.1016/j.jmgm.2018.01.018" title="DOI URL">https://doi.org/10.1016/j.jmgm.2018.01.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2018.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2018.01.018%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DComputational%252Bassessment%252Bof%252Bthioether%252Bisosteres%26aulast%3DBarrows%26aufirst%3DRobert%2BD.%26date%3D2018%26volume%3D80%26spage%3D282%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorenz  Weidenauer</span>, <span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Suhasini  Joshi</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Manfredo R.  Quadroni</span>. </span><span class="cited-content_cbyCitation_article-title">Proteomic interrogation of HSP90 and insights for medical research. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Proteomics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (12)
                                     , 1105-1117. <a href="https://doi.org/10.1080/14789450.2017.1389649" title="DOI URL">https://doi.org/10.1080/14789450.2017.1389649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14789450.2017.1389649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14789450.2017.1389649%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Proteomics%26atitle%3DProteomic%252Binterrogation%252Bof%252BHSP90%252Band%252Binsights%252Bfor%252Bmedical%252Bresearch%26aulast%3DWeidenauer%26aufirst%3DLorenz%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D12%26spage%3D1105%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong-Zhen  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiu-Dong  Shi</span>, <span class="hlFld-ContribAuthor ">Hong-Fang  Feng</span>, <span class="hlFld-ContribAuthor ">Yu-Fang  Cheng</span>, <span class="hlFld-ContribAuthor ">Hai-Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Jiang-Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 9 H -purins as potential tubulin polymerization inhibitors: Synthesis, biological evaluation and structure−activity relationships. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 1126-1134. <a href="https://doi.org/10.1016/j.ejmech.2017.07.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B9%252BH%252B-purins%252Bas%252Bpotential%252Btubulin%252Bpolymerization%252Binhibitors%25253A%252BSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bstructure%2525E2%252588%252592activity%252Brelationships%26aulast%3DZhou%26aufirst%3DZhong-Zhen%26date%3D2017%26volume%3D138%26spage%3D1126%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A Elisa  Pasqua</span>, <span class="hlFld-ContribAuthor ">B.  Wilding</span>, <span class="hlFld-ContribAuthor ">M.D.  Cheeseman</span>, <span class="hlFld-ContribAuthor ">K.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 202-280. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12395-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12395-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12395-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12395-9%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BProtein%252BSynthesis%25252C%252BFolding%25252C%252Band%252BDegradation%252BPathways%252Bin%252BCancer%26aulast%3DPasqua%26aufirst%3DA%2BElisa%26date%3D2017%26spage%3D202%26epage%3D280%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanshan  Liu</span>, <span class="hlFld-ContribAuthor ">Timothy O.  Street</span>. </span><span class="cited-content_cbyCitation_article-title">5′-
              N
              -ethylcarboxamidoadenosine is not a paralog-specific Hsp90 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Protein Science</span><span> <strong>2016,</strong> <em>25 </em>
                                    (12)
                                     , 2209-2215. <a href="https://doi.org/10.1002/pro.3049" title="DOI URL">https://doi.org/10.1002/pro.3049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pro.3049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpro.3049%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Science%26atitle%3D5%2525E2%252580%2525B2-%252BN%252B-ethylcarboxamidoadenosine%252Bis%252Bnot%252Ba%252Bparalog-specific%252BHsp90%252Binhibitor%26aulast%3DLiu%26aufirst%3DShanshan%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D12%26spage%3D2209%26epage%3D2215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kendrick H.  Yim</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Prince</span>, <span class="hlFld-ContribAuthor ">Shiwei  Qu</span>, <span class="hlFld-ContribAuthor ">Fang  Bai</span>, <span class="hlFld-ContribAuthor ">Patricia A.  Jennings</span>, <span class="hlFld-ContribAuthor ">José N.  Onuchic</span>, <span class="hlFld-ContribAuthor ">Emmanuel A.  Theodorakis</span>, <span class="hlFld-ContribAuthor ">Leonard  Neckers</span>. </span><span class="cited-content_cbyCitation_article-title">Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2016,</strong> <em>113 </em>
                                    (33)
                                     , E4801-E4809. <a href="https://doi.org/10.1073/pnas.1606655113" title="DOI URL">https://doi.org/10.1073/pnas.1606655113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1606655113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1606655113%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DGambogic%252Bacid%252Bidentifies%252Ban%252Bisoform-specific%252Bdruggable%252Bpocket%252Bin%252Bthe%252Bmiddle%252Bdomain%252Bof%252BHsp90%2525CE%2525B2%26aulast%3DYim%26aufirst%3DKendrick%2BH.%26date%3D2016%26date%3D2016%26volume%3D113%26issue%3D33%26spage%3DE4801%26epage%3DE4809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharad  Verma</span>, <span class="hlFld-ContribAuthor ">Sukriti  Goyal</span>, <span class="hlFld-ContribAuthor ">Salma  Jamal</span>, <span class="hlFld-ContribAuthor ">Aditi  Singh</span>, <span class="hlFld-ContribAuthor ">Abhinav  Grover</span>. </span><span class="cited-content_cbyCitation_article-title">Hsp90: Friends, clients and natural foes. </span><span class="cited-content_cbyCitation_journal-name">Biochimie</span><span> <strong>2016,</strong> <em>127 </em>, 227-240. <a href="https://doi.org/10.1016/j.biochi.2016.05.018" title="DOI URL">https://doi.org/10.1016/j.biochi.2016.05.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biochi.2016.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biochi.2016.05.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimie%26atitle%3DHsp90%25253A%252BFriends%25252C%252Bclients%252Band%252Bnatural%252Bfoes%26aulast%3DVerma%26aufirst%3DSharad%26date%3D2016%26volume%3D127%26spage%3D227%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal  Marzec</span>, <span class="hlFld-ContribAuthor ">Colin P.  Hawkes</span>, <span class="hlFld-ContribAuthor ">Davide  Eletto</span>, <span class="hlFld-ContribAuthor ">Sarah  Boyle</span>, <span class="hlFld-ContribAuthor ">Ron  Rosenfeld</span>, <span class="hlFld-ContribAuthor ">Vivian  Hwa</span>, <span class="hlFld-ContribAuthor ">Jan M.  Wit</span>, <span class="hlFld-ContribAuthor ">Hermine A.  van Duyvenvoorde</span>, <span class="hlFld-ContribAuthor ">Wilma  Oostdijk</span>, <span class="hlFld-ContribAuthor ">Monique  Losekoot</span>, <span class="hlFld-ContribAuthor ">Oluf  Pedersen</span>, <span class="hlFld-ContribAuthor ">Bu Beng  Yeap</span>, <span class="hlFld-ContribAuthor ">Leon  Flicker</span>, <span class="hlFld-ContribAuthor ">Nir  Barzilai</span>, <span class="hlFld-ContribAuthor ">Gil  Atzmon</span>, <span class="hlFld-ContribAuthor ">Adda  Grimberg</span>, <span class="hlFld-ContribAuthor ">Yair  Argon</span>. </span><span class="cited-content_cbyCitation_article-title">A Human Variant of Glucose-Regulated Protein 94 That Inefficiently Supports IGF Production. </span><span class="cited-content_cbyCitation_journal-name">Endocrinology</span><span> <strong>2016,</strong> <em>157 </em>
                                    (5)
                                     , 1914-1928. <a href="https://doi.org/10.1210/en.2015-2058" title="DOI URL">https://doi.org/10.1210/en.2015-2058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/en.2015-2058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fen.2015-2058%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrinology%26atitle%3DA%252BHuman%252BVariant%252Bof%252BGlucose-Regulated%252BProtein%252B94%252BThat%252BInefficiently%252BSupports%252BIGF%252BProduction%26aulast%3DMarzec%26aufirst%3DMichal%26date%3D2016%26date%3D2016%26volume%3D157%26issue%3D5%26spage%3D1914%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liza  Shrestha</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2016,</strong> <em>23 </em>
                                    (1)
                                     , 158-172. <a href="https://doi.org/10.1016/j.chembiol.2015.12.006" title="DOI URL">https://doi.org/10.1016/j.chembiol.2015.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2015.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2015.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DChemical%252BTools%252Bto%252BInvestigate%252BMechanisms%252BAssociated%252Bwith%252BHSP90%252Band%252BHSP70%252Bin%252BDisease%26aulast%3DShrestha%26aufirst%3DLiza%26date%3D2016%26volume%3D23%26issue%3D1%26spage%3D158%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saurabh  Chhabra</span>, <span class="hlFld-ContribAuthor ">Sandeep  Jain</span>, <span class="hlFld-ContribAuthor ">Caroline  Wallace</span>, <span class="hlFld-ContribAuthor ">Feng  Hong</span>, <span class="hlFld-ContribAuthor ">Bei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2015,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-015-0177-6" title="DOI URL">https://doi.org/10.1186/s13045-015-0177-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-015-0177-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-015-0177-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DHigh%252Bexpression%252Bof%252Bendoplasmic%252Breticulum%252Bchaperone%252Bgrp94%252Bis%252Ba%252Bnovel%252Bmolecular%252Bhallmark%252Bof%252Bmalignant%252Bplasma%252Bcells%252Bin%252Bmultiple%252Bmyeloma%26aulast%3DChhabra%26aufirst%3DSaurabh%26date%3D2015%26date%3D2015%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lijing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianyong  Si</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Li</span>, <span class="hlFld-ContribAuthor ">Leilei  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Gao</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Huo</span>, <span class="hlFld-ContribAuthor ">Dongyu  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Sun</span>, <span class="hlFld-ContribAuthor ">Li  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Umbelliprenin and lariciresinol isolated from a long-term-used herb medicine Ferula sinkiangensis induce apoptosis and G0/G1 arresting in gastric cancer cells. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (110)
                                     , 91006-91017. <a href="https://doi.org/10.1039/C5RA11335K" title="DOI URL">https://doi.org/10.1039/C5RA11335K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA11335K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA11335K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DUmbelliprenin%252Band%252Blariciresinol%252Bisolated%252Bfrom%252Ba%252Blong-term-used%252Bherb%252Bmedicine%252BFerula%252Bsinkiangensis%252Binduce%252Bapoptosis%252Band%252BG0%25252FG1%252Barresting%252Bin%252Bgastric%252Bcancer%252Bcells%26aulast%3DZhang%26aufirst%3DLijing%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D110%26spage%3D91006%26epage%3D91017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. A schematic depiction of (a) <b>1</b>, (b) <b>2</b> and <b>3</b>, and the amino acids present in site 3 of Grp94 (adapted from refs <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>, <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>, and<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>); (c) <b>4</b> and the amino acids present in the allosteric site 2 of Grp94 (adapted from ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a>); and (d) <b>5</b> (pan-Hsp90 inhibitor) and the amino acids found in site 1 of Grp94. The conserved adenine binding pocket is shown in orange. The adenine moiety is shown in blue, the quinone in green, and the resorcinol core in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Schematic depiction of the pose adapted by ligands when accessing the two binding sites, site 2 being specific to Grp94 and site 1 being common to Grp94 and Hsp90. (b) Pose adapted by <b>4</b> when bound to Grp94 showing the hydrophobic stabilization of the 8-aryl group with the hydrophobic residues of site 2 and the pose adapted by <b>5</b> when bound to Hsp90. (c) Surface area of the Grp94-selective ligands reported in ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> (left) and of the pan-Hsp90 ligand <b>5</b> (right) (surface area was generated with Macromodel/Molecular Surface). (d) Proposed modification sites on the purine scaffold performed to understand the structure–activity relationship in this series (as shown in blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0015.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) neocuproine, CuI, NaO<i>t</i>-Bu or Na<sub>3</sub>PO<sub>4</sub> or K<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (b) pent-4-yn-1-yl 4-methylbenzenesulfonate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (c) Cl(CH<sub>2</sub>)<sub><i>n</i></sub>CCH or Cl(CH<sub>2</sub>)<sub><i>n</i></sub>CN or Br(CH<sub>2</sub>)<sub><i>n</i></sub>CF<sub>3</sub> or Br(CH<sub>2</sub>)<sub><i>n</i></sub>C<sub>6</sub>H<sub>5</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt or 80 °C; (d) pent-4-yn-2-yl 4-methylbenzenesulfonate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (e) ROH, PPh<sub>3</sub>, DBAD, CH<sub>2</sub>Cl<sub>2</sub>, toluene, rt.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0016.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>m</i>-CPBA, 30 min, rt; (b) P(OPh)<sub>3</sub>, pyridine, microwave 220 °C, 30 min; (c) 5-chloropent-1-yne, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (d) 2 equiv of Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0017.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-(<i>tert</i>-butoxycarbonyl-isopropyl-amino)propyl tosylate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (b) TFA, 0 °C; (c) ArI (<b>7</b>), neocuproine, CuI, NaO<i>t</i>-Bu or Na<sub>3</sub>PO<sub>4</sub> or K<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (d) TFA, 80 °C, 3 h; (e) 1,3-dibromopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 1.5–3h; (f) isopropylamine, DMF, rt.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Predicted binding poses for <b>9g</b>, <b>9g′</b>, and <b>9i</b> when bound to the N-terminal domain of Grp94 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design of <b>18c</b> and its proposed interaction with the Hsp90 paralogs. (a) Interactions of <b>9n</b> and <b>18c</b> with the amino acids lining the Grp94 allosteric site 2. (b) Docking of compound <b>18c</b> in the allosteric site 2 of Grp94. (c) Overlay of <b>18c</b> on to sites 1 and 2 of the four Hsp90 paralogs. Residues that constrain either the availability of the site 2 pocket or the interaction of <b>18c</b> with the protein are shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Grp94-specific inhibitor <b>18c</b> dose-dependently inhibits several Grp94-mediated cellular effects, such as (a) TLR9 expression, (b) TNFα production in cells stimulated with CpG, (c) IGF-II production by differentiated myoblasts, and (d) HER2 degradation in HER2-overexpressing breast cancer cells. Selectivity of <b>18c</b> for Grp94 over the cytosolic Hsp90 is demonstrated by the lack of activity in cells stimulated by LPS (b) and no Hsp70 induction in SKBr3 cells (e), both effects mediated by Hsp90. PU-H71 (<b>5</b>) and GM are pan-Hsp90 inhibitors (i.e., bind equally well to both Grp94 and the cytosolic Hsp90s). Data points are mean ± error, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Relative binding affinity of Grp94 inhibitors for Hsp90α and Grp94 was measured using a fluorescence polarization assay as previously reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (b) The HER2-overexpressing breast cancer cells SKBr3 were treated for 24 h with the indicated concentrations of Grp94 inhibitors, and proteins were analyzed by Western blot. Representative blots of triplicate experiments are shown. (c) Viability of cancer cells treated for 72 h with the indicated Grp94 inhibitor concentrations was measured using the CellTiter-Glo cell viability assay. Data points are mean ± error, <i>n</i> = 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/medium/jm-2015-00197n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo profile of <b>18c</b>. (a) <b>18c</b> (75 mg/kg, ip) was administered to mice (<i>n</i> = 4 per experimental point) bearing breast tumors, and mice were sacrificed at 2 and 24 h postadministration. Inhibitor levels in the indicated tissues and plasma were determined by LC–MS/MS following administration of <b>18c</b>. Each data point represents the mean ± error. (b) The concentrations of <b>18c</b> in tumor to brain, heart, and plasma of mice as in panel a were determined by LC–MS/MS and the ratios plotted. (c) <b>18c</b> was injected as a single dose iv or oral at 10 mg/kg to B6D2F1 mice (<i>n</i> = 2 male mice per experimental point, 20 mice total). The agent was formulated in 30% captisol, 5 mM citrate buffer at pH 4.2. Agent levels (μg/g or μg/mL) were determined by LC–MS/MS and converted to molar concentrations with the approximation that 1g = 1 mL. Concentrations were graphed against the time of sacrifice, which represents the time after agent administration. Each point represents mean ± error.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-9/acs.jmedchem.5b00197/20150508/images/large/jm-2015-00197n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00197&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i111">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sorger, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelham, H. R.</span><span> </span><span class="NLM_article-title">The glucose-regulated protein Grp94 is related to heat shock protein Hsp90</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=1987&pages=341-344&author=P.+K.+Sorgerauthor=H.+R.+Pelham&title=The+glucose-regulated+protein+Grp94+is+related+to+heat+shock+protein+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DPelham%26aufirst%3DH.%2BR.%26atitle%3DThe%2520glucose-regulated%2520protein%2520Grp94%2520is%2520related%2520to%2520heat%2520shock%2520protein%2520Hsp90%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1987%26volume%3D194%26spage%3D341%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Marzec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span> </span><span class="NLM_article-title">GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=774-787&author=M.+Marzecauthor=D.+Elettoauthor=Y.+Argon&title=GRP94%3A+An+HSP90-like+protein+specialized+for+protein+folding+and+quality+control+in+the+endoplasmic+reticulum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarzec%26aufirst%3DM.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DGRP94%253A%2520An%2520HSP90-like%2520protein%2520specialized%2520for%2520protein%2520folding%2520and%2520quality%2520control%2520in%2520the%2520endoplasmic%2520reticulum%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1823%26spage%3D774%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S. L.</span><span> </span><span class="NLM_article-title">Hsp90 and the chaperoning of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=Hsp90+and+the+chaperoning+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0lilHFIJ347X0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHsp90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Altieri, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lian, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Languino, L. R.</span><span> </span><span class="NLM_article-title">TRAP-1, the mitochondrial Hsp90</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=767-773&author=D.+C.+Altieriauthor=G.+S.+Steinauthor=J.+B.+Lianauthor=L.+R.+Languino&title=TRAP-1%2C+the+mitochondrial+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26aulast%3DStein%26aufirst%3DG.%2BS.%26aulast%3DLian%26aufirst%3DJ.%2BB.%26aulast%3DLanguino%26aufirst%3DL.%2BR.%26atitle%3DTRAP-1%252C%2520the%2520mitochondrial%2520Hsp90%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1823%26spage%3D767%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doxsey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, D. C.</span><span> </span><span class="NLM_article-title">Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=257-270&author=B.+H.+Kangauthor=J.+Plesciaauthor=T.+Dohiauthor=J.+Rosaauthor=S.+J.+Doxseyauthor=D.+C.+Altieri&title=Regulation+of+tumor+cell+mitochondrial+homeostasis+by+an+organelle-specific+Hsp90+chaperone+network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DB.%2BH.%26aulast%3DPlescia%26aufirst%3DJ.%26aulast%3DDohi%26aufirst%3DT.%26aulast%3DRosa%26aufirst%3DJ.%26aulast%3DDoxsey%26aufirst%3DS.%2BJ.%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26atitle%3DRegulation%2520of%2520tumor%2520cell%2520mitochondrial%2520homeostasis%2520by%2520an%2520organelle-specific%2520Hsp90%2520chaperone%2520network%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D257%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Costantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddalena, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calise, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscazzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirino, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fersini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landriscina, M.</span><span> </span><span class="NLM_article-title">TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1016%2Fj.canlet.2009.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=19217207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlejtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2009&pages=39-46&author=E.+Costantinoauthor=F.+Maddalenaauthor=S.+Caliseauthor=A.+Piscazziauthor=V.+Tirinoauthor=A.+Fersiniauthor=A.+Ambrosiauthor=V.+Neriauthor=F.+Espositoauthor=M.+Landriscina&title=TRAP1%2C+a+novel+mitochondrial+chaperone+responsible+for+multi-drug+resistance+and+protection+from+apoptotis+in+human+colorectal+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptosis in human colorectal carcinoma cells</span></div><div class="casAuthors">Costantino, Eleonora; Maddalena, Francesca; Calise, Serena; Piscazzi, Annamaria; Tirino, Virginia; Fersini, Alberto; Ambrosi, Antonio; Neri, Vincenzo; Esposito, Franca; Landriscina, Matteo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-46</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">TRAP1 is a component of a pro-survival mitochondrial pathway up-regulated in tumor cells.  The evaluation of TRAP1 expression in 26 human colorectal carcinomas showed up-regulation in 17/26 tumors.  Accordingly, TRAP1 levels were increased in HT-29 colorectal carcinoma cells resistant to 5-fluorouracil, oxaliplatin, and irinotecan.  Thus, we investigated the role of TRAP1 in multi-drug resistance in human colorectal cancer.  Interestingly, TRAP1 overexpression leads to 5-fluorouracil-, oxaliplatin- and irinotecan-resistant phenotypes in different neoplastic cells.  Conversely, the inhibition of TRAP1 activity by TRAP1 ATPase antagonist, shepherdin, increased the sensitivity to oxaliplatin and irinotecan in colorectal carcinoma cells resistant to the single agents.  These results suggest that the increased expression of TRAP1 could be part of a pro-survival pathway responsible for multi-drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl_RCfgt-FFbVg90H21EOLACvtfcHk0lhxsInIYNxtaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlejtrY%253D&md5=a5ea811014b3a3761dd45c3921437d9d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2009.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2009.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DE.%26aulast%3DMaddalena%26aufirst%3DF.%26aulast%3DCalise%26aufirst%3DS.%26aulast%3DPiscazzi%26aufirst%3DA.%26aulast%3DTirino%26aufirst%3DV.%26aulast%3DFersini%26aufirst%3DA.%26aulast%3DAmbrosi%26aufirst%3DA.%26aulast%3DNeri%26aufirst%3DV.%26aulast%3DEsposito%26aufirst%3DF.%26aulast%3DLandriscina%26aufirst%3DM.%26atitle%3DTRAP1%252C%2520a%2520novel%2520mitochondrial%2520chaperone%2520responsible%2520for%2520multi-drug%2520resistance%2520and%2520protection%2520from%2520apoptotis%2520in%2520human%2520colorectal%2520carcinoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D279%26spage%3D39%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lee, A. S.</span><span> </span><span class="NLM_article-title">Glucose-regulated proteins in cancer: Molecular mechanisms and therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnrc3701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=24658275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslCqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=263-276&author=A.+S.+Lee&title=Glucose-regulated+proteins+in+cancer%3A+Molecular+mechanisms+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential</span></div><div class="casAuthors">Lee, Amy S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">263-276</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The glucose-regulated proteins (GRPs) are stress-inducible chaperones that mostly reside in the endoplasmic reticulum or the mitochondria.  Recent advances show that the GRPs have functions that are distinct from those of the related heat shock proteins, and they can be actively translocated to other cellular locations and assume novel functions that control signalling, proliferation, invasion, apoptosis, inflammation and immunity.  Mouse models further identified their specific roles in development, tumorigenesis, metastasis and angiogenesis.  This Review describes their discovery and regulation, as well as their biol. functions in cancer.  Promising agents that use or target the GRPs are being developed, and their efficacy as anticancer therapeutics is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozBF42yfN9I7Vg90H21EOLACvtfcHk0ljiheInJGQuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslCqs7c%253D&md5=8a8539550b16c4ac0630114261b1302e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc3701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3701%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DGlucose-regulated%2520proteins%2520in%2520cancer%253A%2520Molecular%2520mechanisms%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D263%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zammit, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefrançois, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=215-226&author=Y.+Yangauthor=B.+Liuauthor=J.+Daiauthor=P.+K.+Srivastavaauthor=D.+J.+Zammitauthor=L.+Lefran%C3%A7oisauthor=Z.+Li&title=Heat+shock+protein+gp96+is+a+master+chaperone+for+toll-like+receptors+and+is+important+in+the+innate+function+of+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DSrivastava%26aufirst%3DP.%2BK.%26aulast%3DZammit%26aufirst%3DD.%2BJ.%26aulast%3DLefran%25C3%25A7ois%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DHeat%2520shock%2520protein%2520gp96%2520is%2520a%2520master%2520chaperone%2520for%2520toll-like%2520receptors%2520and%2520is%2520important%2520in%2520the%2520innate%2520function%2520of%2520macrophages%26jtitle%3DImmunity%26date%3D2007%26volume%3D26%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White-Gilbertson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachidi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depinho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6242</span><span class="NLM_x">–</span> <span class="NLM_lpage">6251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1158%2F1078-0432.CCR-13-2083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=24077352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6242-6251&author=Y.+Huaauthor=S.+White-Gilbertsonauthor=J.+Kellnerauthor=S.+Rachidiauthor=S.+Z.+Usmaniauthor=G.+Chiosisauthor=R.+Depinhoauthor=Z.+Liauthor=B.+Liu&title=Molecular+chaperone+gp96+is+a+novel+therapeutic+target+of+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma</span></div><div class="casAuthors">Hua, Yunpeng; White-Gilbertson, Shai; Kellner, Joshua; Rachidi, Saleh; Usmani, Saad Z.; Chiosis, Gabriela; DePinho, Ronald; Li, Zihai; Liu, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6242-6251</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: gp96 (grp94) is a key downstream chaperone in the endoplasmic reticulum (ER) to mediate unfolded protein response (UPR) and the pathogenesis of multiple myeloma is closely linked to dysregulated UPR.  In this study, we aimed to det. the roles of gp96 in the initiation and progression of multiple myeloma in vivo and in vitro.  Exptl. Design: We generated a mouse model with overexpression of XBP1s and conditional deletion of gp96 in B-cell compartment simultaneously to identify the roles of gp96 in the development of multiple myeloma in vivo.  Using a short hairpin RNA (shRNA) system, we silenced gp96 in multiple human multiple myeloma cells and examd. the effect of gp96 knockdown on multiple myeloma cells by cell proliferation, cell-cycle anal., apoptosis assay, immunohistochem., and human myeloma xenograft model.  The anticancer activity of gp96 selective inhibitor, WS13, was evaluated by apoptosis assay and MTT assay.  Results: Genetic deletion of gp96 in XBP1s-Tg mice attenuates multiple myeloma.  Silencing of gp96 causes severe compromise in human multiple myeloma cell growth through inhibiting Wnt-LRP-survivin pathway.  We also confirmed that knockdown of gp96 decreased human multiple myeloma growth in a murine xenograft model.  The targeted gp96 inhibitor induced apoptosis and blocked multiple myeloma cell growth, but did not induce apoptosis in pre-B leukemic cells.  We have demonstrated that myeloma growth is dependent on gp96 both genetically and pharmacol.  Conclusions: gp96 is essential for multiple myeloma cell proliferation and survival, suggesting that gp96 is a novel therapeutic target for multiple myeloma.  Clin Cancer Res; 19(22); 6242-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-ajwmlaUPrVg90H21EOLACvtfcHk0ljiheInJGQuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP&md5=adb618074ee3e9d6ee4795b95c1d906c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2083%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DWhite-Gilbertson%26aufirst%3DS.%26aulast%3DKellner%26aufirst%3DJ.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDepinho%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520chaperone%2520gp96%2520is%2520a%2520novel%2520therapeutic%2520target%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6242%26epage%3D6251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidler, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Que, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D.+Patelauthor=P.+Yanauthor=P.+M.+Seidlerauthor=H.+J.+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S.+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A.+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+Hsp90+inhibitors+define+tumor-specific+regulation+of+HER2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0lh_4dmyOsxPOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520Hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520HER2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Soldano, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jivan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structure of the N-terminal domain of GRP94</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">48330</span><span class="NLM_x">–</span> <span class="NLM_lpage">48338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2003&pages=48330-48338&author=K.+L.+Soldanoauthor=A.+Jivanauthor=C.+V.+Nicchittaauthor=D.+T.+Gewirth&title=Structure+of+the+N-terminal+domain+of+GRP94"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DJivan%26aufirst%3DA.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520of%2520the%2520N-terminal%2520domain%2520of%2520GRP94%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D279%26spage%3D48330%26epage%3D48338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Rosser, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span> </span><span class="NLM_article-title">Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">22798</span><span class="NLM_x">–</span> <span class="NLM_lpage">22805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22798-22805&author=M.+F.+Rosserauthor=C.+V.+Nicchitta&title=Ligand+interactions+in+the+adenosine+nucleotide-binding+domain+of+the+Hsp90+chaperone%2C+GRP94.+I.+Evidence+for+allosteric+regulation+of+ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosser%26aufirst%3DM.%2BF.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26atitle%3DLigand%2520interactions%2520in%2520the%2520adenosine%2520nucleotide-binding%2520domain%2520of%2520the%2520Hsp90%2520chaperone%252C%2520GRP94.%2520I.%2520Evidence%2520for%2520allosteric%2520regulation%2520of%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22798%26epage%3D22805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldano, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">46162</span><span class="NLM_x">–</span> <span class="NLM_lpage">46171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46162-46171&author=R.+M.+Immorminoauthor=D.+E.+Dollinsauthor=P.+L.+Shafferauthor=K.+L.+Soldanoauthor=M.+A.+Walkerauthor=D.+T.+Gewirth&title=Ligand-induced+conformational+shift+in+the+N-terminal+domain+of+GRP94%2C+an+Hsp90+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DP.%2BL.%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DWalker%26aufirst%3DM.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DLigand-induced%2520conformational%2520shift%2520in%2520the%2520N-terminal%2520domain%2520of%2520GRP94%252C%2520an%2520Hsp90%2520chaperone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46162%26epage%3D46171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: Implications for paralog-specific drug design</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=1033-1042&author=R.+M.+Immorminoauthor=L.+E.+Metzgerauthor=P.+N.+Reardonauthor=D.+E.+Dollinsauthor=B.+S.+Blaggauthor=D.+T.+Gewirth&title=Different+poses+for+ligand+and+chaperone+in+inhibitor-bound+Hsp90+and+GRP94%3A+Implications+for+paralog-specific+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DMetzger%26aufirst%3DL.%2BE.%26aulast%3DReardon%26aufirst%3DP.%2BN.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DDifferent%2520poses%2520for%2520ligand%2520and%2520chaperone%2520in%2520inhibitor-bound%2520Hsp90%2520and%2520GRP94%253A%2520Implications%2520for%2520paralog-specific%2520drug%2520design%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D1033%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taffi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of adenosine A2A receptor agonists</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.2174%2F1568026033392282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=12570757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=387-401&author=G.+Cristalliauthor=C.+Lambertucciauthor=S.+Taffiauthor=S.+Vittoriauthor=R.+Volpini&title=Medicinal+chemistry+of+adenosine+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine A2A receptor agonists</span></div><div class="casAuthors">Cristalli, Gloria; Lambertucci, Catia; Taffi, Sara; Vittori, Sauro; Volpini, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The search for potent and selective A2A adenosine receptor agonists has been particularly fruitful in the early nineties.  A series of 2-amino, 2-alkoxy, 2-alkythio-, 2-alkynyl-, and 2-alkenyl-derivs. of adenosine (Ado, 1) and N-ethylcarboxamidoadenosine (NECA, 30) have been synthesized and tested mainly on different model of rat A1 and A2A receptor subtypes.  From these studies some ligands, such as CGS 21680 (33), HENECA (42), and (S)-PHPNECA (46b), showed to possess high A2A affinity combined with good A2A vs A1 selectivity.  More detailed characterization of these ligands at the four cloned human adenosine receptor subtypes revealed that none of the prototypical adenosine receptor agonists exhibits at the same time high affinity and selectivity for the human A2AAR subtype.  Both NECA and CGS 21680, which are available as radioligands for this subtype, have lower affinity at human than at rat receptor.  The 2-alkynylNECA derivs. HENECA an PHPNECA showed high affinity also at human A3 receptors.  In particular, (S)-PHPNECA displayed Kis in the low nanomolar range at A1, A2A, and A3 subtypes and an EC50 of 220 nM at human A2B receptor.  It is now well known that the coronary vasodilation induced by Ado in different species is mediated by activation of A2AAR and a compd. capable of producing coronary vasodilation through activation of A2AAR, but that is devoid of A1-and A3-agonist activity would have advantage over Ado for use in myocardial perfusion imaging studies.  Other potential therapeutic applications of selective A2AAR agonists are as anti-aggregatory, anti-inflammatory, anti-psychotic, and anti-Huntington's disease agents.  This review is aimed at presenting a complete overview of the medicinal chem. development of A2A adenosine receptor agonists and at stressing the strong need for more selective ligands at A2A human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZ9WytCwyQLVg90H21EOLACvtfcHk0lj8w2P5f8GgCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D&md5=4d2aef4b8cb3f1f30efe8d4f839e01d1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1568026033392282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392282%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DTaffi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26atitle%3DMedicinal%2520chemistry%2520of%2520adenosine%2520A2A%2520receptor%2520agonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Clevenger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4459</span><span class="NLM_x">–</span> <span class="NLM_lpage">4462</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol048266o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4459-4462&author=R.+C.+Clevengerauthor=B.+S.+Blagg&title=Design%2C+synthesis%2C+and+evaluation+of+a+radicicol+and+geldanamycin+chimera%2C+radamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fol048266o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol048266o%26sid%3Dliteratum%253Aachs%26aulast%3DClevenger%26aufirst%3DR.%2BC.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520radicicol%2520and%2520geldanamycin%2520chimera%252C%2520radamide%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4459%26epage%3D4462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Duerfeldt, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinogle, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9804</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lhFvlR8SVCGyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Stothert, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suntharalingam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span> </span><span class="NLM_article-title">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6470</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1093%2Fhmg%2Fddu367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=25027323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=6470-6480&author=A.+R.+Stothertauthor=A.+Suntharalingamauthor=D.+J.+Huardauthor=S.+N.+Fontaineauthor=V.+M.+Crowleyauthor=S.+Mishraauthor=B.+S.+Blaggauthor=R.+L.+Liebermanauthor=C.+A.+Dickey&title=Exploiting+the+interaction+between+Grp94+and+aggregated+myocilin+to+treat+glaucoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span></div><div class="casAuthors">Stothert, Andrew R.; Suntharalingam, Amirthaa; Huard, Dustin J. E.; Fontaine, Sarah N.; Crowley, Vincent M.; Mishra, Sanket; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6470-6480</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Gain-of-function mutations in the olfactomedin domain of the MYOC gene facilitate the toxic accumulation of amyloid-contg. myocilin aggregates, hastening the onset of the prevalent ocular disorder primary open-angle glaucoma.  Aggregation of wild-type myocilin has been reported in other glaucoma subtypes, suggesting broader relevance of misfolded myocilin across the disease spectrum, but the absence of myocilin does not cause disease.  Thus, strategies aimed at eliminating myocilin could be therapeutically relevant for glaucoma.  Here, a novel and selective Grp94 inhibitor reduced the levels of several mutant myocilin proteins as well as wild-type myocilin when forced to misfold in cells.  This inhibitor rescued mutant myocilin toxicity in primary human trabecular meshwork cells.  Mechanistically, in vitro kinetics studies demonstrate that Grp94 recognizes on-pathway aggregates of the myocilin olfactomedin domain (myoc-OLF), accelerates rates of aggregation and co-ppts. with myoc-OLF.  These results indicate that aberrant myocilin quaternary structure drives Grp94 recognition, rather than peptide motifs exposed by unfolded protein.  Inhibition of Grp94 ameliorates the effects of Grp94-accelerated myoc-OLF aggregation, and Grp94 remains in soln.  In cells, when wild-type myocilin is driven to misfold and aggregate, it becomes a client of Grp94 and sensitive to Grp94 inhibition.  Taken together, the interaction of Grp94 with myocilin aggregates can be manipulated by cellular environment and genetics; this process can be exploited with Grp94 inhibitors to promote the clearance of toxic forms of myocilin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQYeK777kKLVg90H21EOLACvtfcHk0lhFvlR8SVCGyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D&md5=cbabbce383403838a4cbc3ffe24bdce8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu367%26sid%3Dliteratum%253Aachs%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DSuntharalingam%26aufirst%3DA.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%26aulast%3DFontaine%26aufirst%3DS.%2BN.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DExploiting%2520the%2520interaction%2520between%2520Grp94%2520and%2520aggregated%2520myocilin%2520to%2520treat%2520glaucoma%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D6470%26epage%3D6480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zifcak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atoyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DellaRocca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span> </span><span class="NLM_article-title">CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4046</span><span class="NLM_x">–</span> <span class="NLM_lpage">4057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1158%2F1078-0432.CCR-09-0152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=19509149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntlOisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=4046-4057&author=R.+Baoauthor=C.+J.+Laiauthor=H.+Quauthor=D.+Wangauthor=L.+Yinauthor=B.+Zifcakauthor=R.+Atoyanauthor=J.+Wangauthor=M.+Samsonauthor=J.+Forresterauthor=S.+DellaRoccaauthor=G.+X.+Xuauthor=X.+Taoauthor=H.+X.+Zhaiauthor=X.+Caiauthor=C.+Qian&title=CUDC-305%2C+a+novel+synthetic+HSP90+inhibitor+with+unique+pharmacologic+properties+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy</span></div><div class="casAuthors">Bao, Rudi; Lai, Cheng-Jung; Qu, Hui; Wang, Dagong; Yin, Ling; Zifcak, Brian; Atoyan, Ruzanna; Wang, Jing; Samson, Maria; Forrester, Jeffrey; Della Rocca, Steven; Xu, Guang-Xin; Tao, Xu; Zhai, Hai-Xiao; Cai, Xiong; Qian, Changgeng</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4046-4057</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We designed and synthesized CUDC-305, an HSP90 inhibitor of the novel imidazopyridine class.  Here, we report its unique pharmacol. properties and antitumor activities in a variety of tumor types.  The potency of the compd. was analyzed by fluorescence polarization competition binding assay.  Its antiproliferative activities were assessed in 40 human cancer cell lines.  Its pharmacol. properties and antitumor activities were evaluated in a variety of tumor xenograft models.  CUDC-305 shows high affinity for HSP90α/β (IC50, ∼100 nmol/L) and HSP90 complex derived from cancer cells (IC50, 48.8 nmol/L).  It displays potent antiproliferative activity against a broad range of cancer cell lines (mean IC50, 220 nmol/L).  CUDC-305 exhibits high oral bioavailability (96.0%) and selective retention in tumor (half-life, 20.4 h) compared with normal tissues.  Furthermore, CUDC-305 can cross blood-brain barrier and reach therapeutic levels in brain tissue.  CUDC-305 exhibits dose-dependent antitumor activity in an s.c. xenograft model of U87MG glioblastoma and significantly prolongs animal survival in U87MG orthotopic model.  CUDC-305 also displays potent antitumor activity in animal models of erlotinib-resistant non-small cell lung cancer and induces tumor regression in animal models of MDA-MB-468 breast cancer and MV4-11 acute myelogenous leukemia.  Correlating with its efficacy in these various tumor models, CUDC-305 robustly inhibits multiple signaling pathways, including PI3K/AKT and RAF/MEK/ERK, and induces apoptosis.  In combination studies, CUDC-305 enhances the antitumor activity of std.-of-care agents in breast and colorectal tumor models.  CUDC-305 is a promising drug candidate for the treatment of a variety of cancers, including brain malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxsZpWkM4MrVg90H21EOLACvtfcHk0liX-m1ogmJQJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntlOisL4%253D&md5=b872c7658a2fc98f263f7e6a23cb58f6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-0152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-0152%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DC.%2BJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DZifcak%26aufirst%3DB.%26aulast%3DAtoyan%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSamson%26aufirst%3DM.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DDellaRocca%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DG.%2BX.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.%2BX.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DCUDC-305%252C%2520a%2520novel%2520synthetic%2520HSP90%2520inhibitor%2520with%2520unique%2520pharmacologic%2520properties%2520for%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D4046%26epage%3D4057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cai, X.; Qian, C.; Zhai, H.</span><span> </span><span class="NLM_article-title">Preparation of imidazo[4,5-c]pyridine derivatives as HSP90 inhibitors</span>. Patent WO2008115719A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=X.+Cai&author=C.+Qian&author=H.+Zhai&title=Preparation+of+imidazo%5B4%2C5-c%5Dpyridine+derivatives+as+HSP90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26atitle%3DPreparation%2520of%2520imidazo%255B4%252C5-c%255Dpyridine%2520derivatives%2520as%2520HSP90%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Synthesis of a red-shifted fluorescence polarization probe for Hsp90</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4515-4518&author=K.+Moulickauthor=C.+C.+Clementauthor=J.+Aguirreauthor=J.+Kimauthor=Y.+Kangauthor=S.+Feltsauthor=G.+Chiosis&title=Synthesis+of+a+red-shifted+fluorescence+polarization+probe+for+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520a%2520red-shifted%2520fluorescence%2520polarization%2520probe%2520for%2520Hsp90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4515%26epage%3D4518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6803</span><span class="NLM_x">–</span> <span class="NLM_lpage">6818</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400619b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6803-6818&author=T.+Taldoneauthor=P.+D.+Patelauthor=M.+Patelauthor=H.+J.+Patelauthor=C.+E.+Evansauthor=A.+Rodinaauthor=S.+Ochianaauthor=S.+K.+Shahauthor=M.+Uddinauthor=D.+Gewirthauthor=G.+Chiosis&title=Experimental+and+structural+testing+module+to+analyze+paralogue-specificity+and+affinity+in+the+Hsp90+inhibitors+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series</span></div><div class="casAuthors">Taldone, Tony; Patel, Pallav D.; Patel, Maulik; Patel, Hardik J.; Evans, Christopher E.; Rodina, Anna; Ochiana, Stefan; Shah, Smit K.; Uddin, Mohammad; Gewirth, Daniel; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6803-6818</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We here describe the first reported comprehensive anal. of Hsp90 paralogue affinity and selectivity in the clin. Hsp90 inhibitor chemotypes.  This has been possible through the development of a versatile exptl. assay based on a new FP-probe that we both describe here.  The assay can test rapidly and accurately the binding affinity of all major Hsp90 chemotypes and has a testing range that spans low nanomolar to millimolar binding affinities.  We couple this assay with a computational anal. that allows for rationalization of paralogue selectivity and defines not only the major binding modes that relay pan-paralogue binding or, conversely, paralogue selectivity, but also identifies mol. characteristics that impart such features.  The methods developed here provide a blueprint for parsing out the contribution of the four Hsp90 paralogues to the perceived biol. activity with the current Hsp90 chemotypes and set the ground for the development of paralogue selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgOst3-n58BrVg90H21EOLACvtfcHk0liCoOfShllDrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWltbvM&md5=bda49f7f2f61553e344b100d5d6949dd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm400619b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400619b%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DEvans%26aufirst%3DC.%2BE.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DOchiana%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DUddin%26aufirst%3DM.%26aulast%3DGewirth%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DExperimental%2520and%2520structural%2520testing%2520module%2520to%2520analyze%2520paralogue-specificity%2520and%2520affinity%2520in%2520the%2520Hsp90%2520inhibitors%2520series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6803%26epage%3D6818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">General method for the synthesis of 8-arylsulfanyl adenine derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3230</span><span class="NLM_x">–</span> <span class="NLM_lpage">3232</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049875c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3230-3232&author=H.+Heauthor=L.+Llaugerauthor=N.+Rosenauthor=G.+Chiosis&title=General+method+for+the+synthesis+of+8-arylsulfanyl+adenine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo049875c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049875c%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DGeneral%2520method%2520for%2520the%2520synthesis%2520of%25208-arylsulfanyl%2520adenine%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D3230%26epage%3D3232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2892</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049012b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2892-2905&author=L.+Llaugerauthor=H.+Heauthor=J.+Kimauthor=J.+Aguirreauthor=N.+Rosenauthor=U.+Petersauthor=P.+Daviesauthor=G.+Chiosis&title=Evaluation+of+8-arylsulfanyl%2C+8-arylsulfoxyl%2C+and+8-arylsulfonyl+adenine+derivatives+as+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm049012b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049012b%26sid%3Dliteratum%253Aachs%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DEvaluation%2520of%25208-arylsulfanyl%252C%25208-arylsulfoxyl%252C%2520and%25208-arylsulfonyl%2520adenine%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2892%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Orally active purine-based inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=817-828&author=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Hongauthor=D.+C.+Hurstauthor=L.+Zhangauthor=J.+Fanauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=A.+A.+Maldonadoauthor=J.+L.+Sensintaffarauthor=Y.+C.+Yangauthor=A.+Kamalauthor=R.+E.+Loughauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=G.+A.+Timonyauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Orally+active+purine-based+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0503087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503087%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DHurst%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DMaldonado%26aufirst%3DA.%2BA.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.%2BC.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DOrally%2520active%2520purine-based%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D817%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">About the reaction of aryl fluorides with sodium sulfide: Investigation into the selectivity of substitution of fluorobenzonitriles to yield mercaptobenzonitriles via SNAr displacement of fluorine</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2548</span><span class="NLM_x">–</span> <span class="NLM_lpage">2551</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=2548-2551&author=T.+Taldoneauthor=P.+D.+Patelauthor=H.+J.+Patelauthor=G.+Chiosis&title=About+the+reaction+of+aryl+fluorides+with+sodium+sulfide%3A+Investigation+into+the+selectivity+of+substitution+of+fluorobenzonitriles+to+yield+mercaptobenzonitriles+via+SNAr+displacement+of+fluorine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAbout%2520the%2520reaction%2520of%2520aryl%2520fluorides%2520with%2520sodium%2520sulfide%253A%2520Investigation%2520into%2520the%2520selectivity%2520of%2520substitution%2520of%2520fluorobenzonitriles%2520to%2520yield%2520mercaptobenzonitriles%2520via%2520SNAr%2520displacement%2520of%2520fluorine%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D2548%26epage%3D2551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Microwave-assisted one step synthesis of 8-arylmethyl-9<i>H</i>-purin-6-amines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=415-417&author=H.+Taoauthor=Y.+Kangauthor=T.+Taldoneauthor=G.+Chiosis&title=Microwave-assisted+one+step+synthesis+of+8-arylmethyl-9H-purin-6-amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DMicrowave-assisted%2520one%2520step%2520synthesis%2520of%25208-arylmethyl-9H-purin-6-amines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D415%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0liHgJK5PKAh2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shtil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3555</span><span class="NLM_x">–</span> <span class="NLM_lpage">3564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=3555-3564&author=G.+Chiosisauthor=B.+Lucasauthor=A.+Shtilauthor=H.+Huezoauthor=N.+Rosen&title=Development+of+a+purine-scaffold+novel+class+of+Hsp90+binders+that+inhibit+the+proliferation+of+cancer+cells+and+induce+the+degradation+of+Her2+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DShtil%26aufirst%3DA.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DDevelopment%2520of%2520a%2520purine-scaffold%2520novel%2520class%2520of%2520Hsp90%2520binders%2520that%2520inhibit%2520the%2520proliferation%2520of%2520cancer%2520cells%2520and%2520induce%2520the%2520degradation%2520of%2520Her2%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D3555%26epage%3D3564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4953</span><span class="NLM_x">–</span> <span class="NLM_lpage">4960</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060297x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4953-4960&author=R.+M.+Immorminoauthor=Y.+Kangauthor=G.+Chiosisauthor=D.+T.+Gewirth&title=Structural+and+quantum+chemical+studies+of+8-aryl-sulfanyl+adenine+class+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060297x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060297x%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructural%2520and%2520quantum%2520chemical%2520studies%2520of%25208-aryl-sulfanyl%2520adenine%2520class%2520Hsp90%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4953%26epage%3D4960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0ljoVmXjnJdsCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Selective targeting of the stress chaperome as a therapeutic strategy</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">592</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=592-603&author=T.+Taldoneauthor=S.+Ochianaauthor=P.+D.+Patelauthor=G.+Chiosis&title=Selective+targeting+of+the+stress+chaperome+as+a+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DOchiana%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSelective%2520targeting%2520of%2520the%2520stress%2520chaperome%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D592%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Medzhitov, R.</span><span> </span><span class="NLM_article-title">Toll-like receptors and innate immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2F35100529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=11905821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=135-145&author=R.+Medzhitov&title=Toll-like+receptors+and+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors and innate immunity</span></div><div class="casAuthors">Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-145</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors have a crucial role in the detection of microbial infection in mammals and insects.  In mammals, these receptors have evolved to recognize conserved products unique to microbial metab.  This specificity allows the Toll proteins to detect the presence of infection and to induce activation of inflammatory and antimicrobial innate immune responses.  Recognition of microbial products by Toll-like receptors expressed on dendritic cells triggers functional maturation of dendritic cells and leads to initiation of antigen-specific adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouf0HceqTgkrVg90H21EOLACvtfcHk0ljoVmXjnJdsCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qu74%253D&md5=d88de3ef802486ba2611b056bcfd0c41</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2F35100529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35100529%26sid%3Dliteratum%253Aachs%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DToll-like%2520receptors%2520and%2520innate%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2001%26volume%3D1%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Brooks, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leifer, C. A.</span><span> </span><span class="NLM_article-title">Heat shock protein gp96 regulates toll-like receptor 9 proteolytic processing and conformational stability</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=780-784&author=J.+C.+Brooksauthor=W.+Sunauthor=G.+Chiosisauthor=C.+A.+Leifer&title=Heat+shock+protein+gp96+regulates+toll-like+receptor+9+proteolytic+processing+and+conformational+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DJ.%2BC.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLeifer%26aufirst%3DC.%2BA.%26atitle%3DHeat%2520shock%2520protein%2520gp96%2520regulates%2520toll-like%2520receptor%25209%2520proteolytic%2520processing%2520and%2520conformational%2520stability%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D421%26spage%3D780%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ostrovsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span> </span><span class="NLM_article-title">The chaperone activity of GRP94 towards of insulin-like growth factor II is necessary for the stress response to serum deprivation</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1091%2Fmbc.E08-04-0346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=19158397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1855-1864&author=O.+Ostrovskyauthor=N.+T.+Ahmedauthor=Y.+Argon&title=The+chaperone+activity+of+GRP94+towards+of+insulin-like+growth+factor+II+is+necessary+for+the+stress+response+to+serum+deprivation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The chaperone activity of GRP94 toward insulin-like growth factor II is necessary for the stress response to serum deprivation</span></div><div class="casAuthors">Ostrovsky, Olga; Ahmed, Noreen T.; Argon, Yair</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1855-1864</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Insulin-like growth factor (IGF)-II is a hormone with mitogenic activity for many cell types and tissues.  We demonstrate that its intracellular processing and secretion strictly depend on the endoplasmic reticulum chaperone glucose-regulated protein (GRP) 94.  GRP94 interacts phys. and transiently with pro-IGF-II intermediates, and its activity is essential for secretion of active IGF-II, thus establishing IGF-II as a client of GRP94.  Embryonic stem (ES) cells that lack GRP94 are hypersensitive to stress conditions such as serum deprivation and die by apoptosis because they cannot respond to the stress by producing active IGF-II.  This chaperone-client interaction may explain the previously documented antiapoptotic activity of GRP94 in a no. of stress responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknJ115ssE_rVg90H21EOLACvtfcHk0li0Oz2NPMCCJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFygs74%253D&md5=a38b8f235e33dd0e6c01fe3a04d3587e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E08-04-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E08-04-0346%26sid%3Dliteratum%253Aachs%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DAhmed%26aufirst%3DN.%2BT.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DThe%2520chaperone%2520activity%2520of%2520GRP94%2520towards%2520of%2520insulin-like%2520growth%2520factor%2520II%2520is%2520necessary%2520for%2520the%2520stress%2520response%2520to%2520serum%2520deprivation%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2009%26volume%3D20%26spage%3D1855%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90: The cancer chaperone</span> <span class="citation_source-journal">J. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1007%2Fs12038-007-0051-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=17536171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFamu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=517-530&author=L.+Neckers&title=Heat+shock+protein+90%3A+The+cancer+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90: the cancer chaperone</span></div><div class="casAuthors">Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biosciences (Bangalore, India)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-530</span>CODEN:
                <span class="NLM_cas:coden">JOBSDN</span>;
        ISSN:<span class="NLM_cas:issn">0250-5991</span>.
    
            (<span class="NLM_cas:orgname">Indian Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is a mol. chaperone required for the stability and function of a no. of conditionally activated and/or expressed signaling proteins, as well as multiple mutated, chimeric, and/or overexpressed signaling proteins, that promote cancer cell growth and/or survival.  Hsp90 inhibitors are unique in that, although they are directed towards a specific mol. target, they simultaneously inhibit multiple cellular signaling pathways.  By inhibiting nodal points in multiple overlapping survival pathways utilized by cancer cells, combination of an Hsp90 inhibitor with std. chemotherapeutic agents may dramatically increase the in vivo efficacy of the std. agent.  Hsp90 inhibitors may circumvent the characteristic genetic plasticity that has allowed cancer cells to eventually evade the toxic effects of most molecularly targeted agents.  The mechanism-based use of Hsp90 inhibitors, both alone and in combination with other drugs, should be effective toward multiple forms of cancer.  Further, because Hsp90 inhibitors also induce Hsf-1-dependent expression of Hsp70, and because certain mutated Hsp90 client proteins are neurotoxic, these drugs display ameliorative properties in several neurodegenerative disease models, suggesting a novel role for Hsp90 inhibitors in treating multiple pathologies involving neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorZSMvQPzup7Vg90H21EOLACvtfcHk0li0Oz2NPMCCJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFamu7k%253D&md5=ffc9fd7cba8e3b9e03b2da9c29bc275f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs12038-007-0051-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12038-007-0051-y%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520The%2520cancer%2520chaperone%26jtitle%3DJ.%2520Biosci.%26date%3D2007%26volume%3D32%26spage%3D517%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Supko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span> </span><span class="NLM_article-title">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1007%2FBF00689048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=7628050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=305-315&author=J.+G.+Supkoauthor=R.+L.+Hickmanauthor=M.+R.+Greverauthor=L.+Malspeis&title=Preclinical+pharmacologic+evaluation+of+geldanamycin+as+an+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent</span></div><div class="casAuthors">Supko, Jeffrey G.; Hickman, Robert L.; Grever, Michael R.; Malspeis, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-15</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The plasma pharmacokinetics of the antitumor antibiotic geldanamycin (GM; NSC 122750), a naturally occurring benzoquinoid ansamycin, were characterized in mice and a beagle dog.  Concns. of GM well above 0.1 μg/mL, which were typically effective against neoplastic cell lines responsive to the drug in vitro, were achieved in the plasma of the mice and the dog treated by i.v. injection.  However, the systemic duration of the drug was relatively short.  Plasma levels decayed to <0.1 μg/mL within 3-4 h after administration of the apparent max. tolerated doses, which were approx. 20 mg/kg for the mice and 4 mg/kg for the dog.  The drug exhibited linear pharmacokinetic behavior within the dose ranges studied.  However, there were significant interspecies differences in its disposition.  Whereas the mean biol. half-life of GM was slightly longer in the mice (77.7 min) than in the dog (57.9 min), its mean residence time in the dog (46.6 min) was >2-fold greater than that in the mice (20.7 min).  Nevertheless, the drug was cleared from plasma much faster by the dog (49.4 mL/min/kg) than by the mice (30.5 mL/min/kg).  These apparent anomalies were principally assocd. with differences in the relative significance of the terminal phase upon overall drug disposition.  The liver appeared to be the principal target organ of acute drug toxicity in the dog.  Doses of 2.0 and 4.2 mg/kg both produced elevations in serum levels of the transaminases and other indicators of liver function characteristic of acute hepatic necrosis.  Addnl. effects included symptoms of minor gastrointestinal toxicity and alterations in serum chem. parameters consistent with less severe nephrotoxicity.  The drug-related toxicity appeared to be reversible.  In consideration of the potential for acute hepatotoxic reactions to GM, as well as to the other benzoquinoid ansamycins based upon structural analogy, addnl. pharmacol. and therapeutic information is required to ascertain whether these compds. are viable candidates for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-P4wBmA1f7Vg90H21EOLACvtfcHk0li0Oz2NPMCCJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFShtLs%253D&md5=cde4aa9e616ff38b67dafed67b05d174</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2FBF00689048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00689048%26sid%3Dliteratum%253Aachs%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DHickman%26aufirst%3DR.%2BL.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26aulast%3DMalspeis%26aufirst%3DL.%26atitle%3DPreclinical%2520pharmacologic%2520evaluation%2520of%2520geldanamycin%2520as%2520an%2520antitumor%2520agent%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1995%26volume%3D36%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Chaperoning oncogenes: Hsp90 as a target of geldanamycin</span> <span class="citation_source-journal">Handb. Exp. Pharmacol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1007%2F3-540-29717-0_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=16610363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWqsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=259-277&author=L.+Neckers&title=Chaperoning+oncogenes%3A+Hsp90+as+a+target+of+geldanamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Chaperoning oncogenes: Hsp90 as a target of geldanamycin</span></div><div class="casAuthors">Neckers, L.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">Molecular Chaperones in Health and Disease</span>),
    <span class="NLM_cas:pages">259-277</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is a mol. chaperone required for the stability and function of a no. of conditionally activated and/or expressed signaling proteins, as well as multiple mutated, chimeric, and/or over-expressed signaling proteins, that promote cancer cell growth and/or survival.  Hsp90 inhibitors, by interacting specifically with a single mol. target, cause the inactivation, destabilization, and eventual degrdn. of Hsp90 client proteins, and they have shown promising anti-tumor activity in preclin. model systems.  One Hsp90 inhibitor, 17-AAG, has completed Phase I clin. trial and several Phase II trials of this agent are in progress.  Hsp90 inhibitors are unique in that, although they are directed toward a specific mol. target, they simultaneously inhibit multiple signaling pathways that frequently interact to promote cancer cell survival.  Further, by inhibiting nodal points in multiple overlapping survival pathways utilized by cancer cells, a combination of an Hsp90 inhibitor with std. chemotherapeutic agents may dramatically increase the in vivo efficacy of the std. agent.  Hsp90 inhibitors may circumvent the characteristic genetic plasticity that has allowed cancer cells to eventually evade the toxic effects of most molecularly targeted agents.  The mechanism-based use of Hsp90 inhibitors, both alone and in combination with other drugs, should be effective toward multiple forms of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9Ocei7to9NrVg90H21EOLACvtfcHk0li0Oz2NPMCCJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWqsbvO&md5=e30ac77974f27ca96cadbe45bf516f7a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2F3-540-29717-0_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F3-540-29717-0_11%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DChaperoning%2520oncogenes%253A%2520Hsp90%2520as%2520a%2520target%2520of%2520geldanamycin%26jtitle%3DHandb.%2520Exp.%2520Pharmacol%26date%3D2006%26spage%3D259%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Jhaveri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerecitano, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corben, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janjigian, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes-DaGama, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koren, J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=611-628&author=K.+Jhaveriauthor=S.+O.+Ochianaauthor=M.+P.+Dunphyauthor=J.+F.+Gerecitanoauthor=A.+D.+Corbenauthor=R.+I.+Peterauthor=Y.+Y.+Janjigianauthor=E.+M.+Gomes-DaGamaauthor=J.+Korenauthor=S.+Modiauthor=G.+Chiosis&title=Heat+shock+protein+90+inhibitors+in+the+treatment+of+cancer%3A+Current+status+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DDunphy%26aufirst%3DM.%2BP.%26aulast%3DGerecitano%26aufirst%3DJ.%2BF.%26aulast%3DCorben%26aufirst%3DA.%2BD.%26aulast%3DPeter%26aufirst%3DR.%2BI.%26aulast%3DJanjigian%26aufirst%3DY.%2BY.%26aulast%3DGomes-DaGama%26aufirst%3DE.%2BM.%26aulast%3DKoren%26aufirst%3DJ.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHeat%2520shock%2520protein%252090%2520inhibitors%2520in%2520the%2520treatment%2520of%2520cancer%253A%2520Current%2520status%2520and%2520future%2520directions%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D611%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span> </span><span class="NLM_article-title">Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=559-587&author=H.+J.+Patelauthor=S.+Modiauthor=G.+Chiosisauthor=T.+Taldone&title=Advances+in+the+discovery+and+development+of+heat-shock+protein+90+inhibitors+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DTaldone%26aufirst%3DT.%26atitle%3DAdvances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520heat-shock%2520protein%252090%2520inhibitors%2520for%2520cancer%2520treatment%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D559%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Matts, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">A systematic protocol for the characterization of Hsp90 modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1016%2Fj.bmc.2010.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=21129982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1eisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=684-692&author=R.+L.+Mattsauthor=G.+E.+Brandtauthor=Y.+Luauthor=A.+Dixitauthor=M.+Mollapourauthor=S.+Wangauthor=A.+C.+Donnellyauthor=L.+Neckersauthor=G.+Verkhivkerauthor=B.+S.+Blagg&title=A+systematic+protocol+for+the+characterization+of+Hsp90+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic protocol for the characterization of Hsp90 modulators</span></div><div class="casAuthors">Matts, Robert L.; Brandt, Gary E. L.; Lu, Yuanming; Dixit, Anshuman; Mollapour, Mehdi; Wang, Suiquan; Donnelly, Alison C.; Neckers, Leonard; Verkhivker, Gennady; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">684-692</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several Hsp90 modulators have been identified including the N-terminal ligand geldanamycin (GDA), the C-terminal ligand novobiocin (NB), and the co-chaperone disruptor celastrol.  Other Hsp90 modulators elicit a mechanism of action that remains unknown.  For example, the natural product gedunin and the synthetic anti-spermatogenic agent H2-gamendazole, recently identified Hsp90 modulators, manifest biol. activity through undefined mechanisms.  Herein, we report a series of biochem. techniques used to classify such modulators into identifiable categories.  Such studies provided evidence that gedunin and H2-gamendazole both modulate Hsp90 via a mechanism similar to celastrol, and unlike NB or GDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosBErc5glK77Vg90H21EOLACvtfcHk0lhGJjQuhAxhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1eisw%253D%253D&md5=d271e44296a05bab9c70cb0d0ea48748</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DMatts%26aufirst%3DR.%2BL.%26aulast%3DBrandt%26aufirst%3DG.%2BE.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DDixit%26aufirst%3DA.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DDonnelly%26aufirst%3DA.%2BC.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DVerkhivker%26aufirst%3DG.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DA%2520systematic%2520protocol%2520for%2520the%2520characterization%2520of%2520Hsp90%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D684%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes DaGama, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas-Lopes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpaugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillarsetty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnchembio.670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=21946277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1anurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=818-826&author=K.+Moulickauthor=J.+H.+Ahnauthor=H.+Zongauthor=A.+Rodinaauthor=L.+Cerchiettiauthor=E.+M.+Gomes+DaGamaauthor=E.+Caldas-Lopesauthor=K.+Beebeauthor=F.+Pernaauthor=K.+Hatziauthor=L.+P.+Vuauthor=X.+Zhaoauthor=D.+Zatorskaauthor=T.+Taldoneauthor=P.+Smith-Jonesauthor=M.+Alpaughauthor=S.+S.+Grossauthor=N.+Pillarsettyauthor=T.+Kuauthor=J.+S.+Lewisauthor=S.+M.+Larsonauthor=R.+Levineauthor=H.+Erdjument-Bromageauthor=M.+L.+Guzmanauthor=S.+D.+Nimerauthor=A.+Melnickauthor=L.+Neckersauthor=G.+Chiosis&title=Affinity-based+proteomics+reveal+cancer-specific+networks+coordinated+by+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90</span></div><div class="casAuthors">Moulick, Kamalika; Ahn, James H.; Zong, Hongliang; Rodina, Anna; Cerchietti, Leandro; Gomes DaGama, Erica M.; Caldas-Lopes, Eloisi; Beebe, Kristin; Perna, Fabiana; Hatzi, Katerina; Vu, Ly P.; Zhao, Xinyang; Zatorska, Danuta; Taldone, Tony; Smith-Jones, Peter; Alpaugh, Mary; Gross, Steven S.; Pillarsetty, Nagavarakishore; Ku, Thomas; Lewis, Jason S.; Larson, Steven M.; Levine, Ross; Erdjument-Bromage, Hediye; Guzman, Monica L.; Nimer, Stephen D.; Melnick, Ari; Neckers, Len; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-826</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Most cancers were characterized by multiple mol. alterations, but identification of the key proteins involved in these signaling pathways is currently beyond reach.  The inhibitor PU-H71 preferentially targets tumor-enriched Hsp90 complexes and affinity captures Hsp90-dependent oncogenic client proteins.  The authors used PU-H71 affinity capture to design a proteomic approach that, when combined with bioinformatic pathway anal., identifies dysregulated signaling networks and key oncoproteins in chronic myeloid leukemia.  The identified interactome overlaps with the well-characterized altered proteome in this cancer, indicating that this method can provide global insights into the biol. of individual tumors, including primary patient specimens.  In addn., this approach can be used to identify previously uncharacterized oncoproteins and mechanisms, potentially leading to new targeted therapies.  Further the abundance of the PU-H71-enriched Hsp90 species, which is not dictated by Hsp90 expression alone, is predictive of the cell's sensitivity to Hsp90 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXTlQWF_MFU7Vg90H21EOLACvtfcHk0lhGJjQuhAxhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1anurbN&md5=d62e663a2e054f3715a3a6e2d5e2c10e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.670%26sid%3Dliteratum%253Aachs%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DZong%26aufirst%3DH.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DGomes%2BDaGama%26aufirst%3DE.%2BM.%26aulast%3DCaldas-Lopes%26aufirst%3DE.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DPerna%26aufirst%3DF.%26aulast%3DHatzi%26aufirst%3DK.%26aulast%3DVu%26aufirst%3DL.%2BP.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DSmith-Jones%26aufirst%3DP.%26aulast%3DAlpaugh%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DS.%2BS.%26aulast%3DPillarsetty%26aufirst%3DN.%26aulast%3DKu%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DLevine%26aufirst%3DR.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAffinity-based%2520proteomics%2520reveal%2520cancer-specific%2520networks%2520coordinated%2520by%2520Hsp90%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D818%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scroggins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zierer, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.18632%2Foncotarget.1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=23867252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1065-1074&author=K.+Beebeauthor=M.+Mollapourauthor=B.+Scrogginsauthor=C.+Prodromouauthor=W.+Xuauthor=M.+Tokitaauthor=T.+Taldoneauthor=L.+Pullenauthor=B.+K.+Ziererauthor=M.+J.+Leeauthor=J.+Trepelauthor=J.+Buchnerauthor=D.+Bolonauthor=G.+Chiosisauthor=L.+Neckers&title=Posttranslational+modification+and+conformational+state+of+heat+shock+protein+90+differentially+affect+binding+of+chemically+diverse+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors</span></div><div class="casAuthors">Beebe Kristin; Mollapour Mehdi; Scroggins Bradley; Prodromou Chrisostomos; Xu Wanping; Tokita Mari; Taldone Tony; Pullen Lester; Zierer Bettina K; Lee Min-Jung; Trepel Jane; Buchner Johannes; Bolon Daniel; Chiosis Gabriela; Neckers Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1065-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an essential molecular chaperone in eukaryotes that facilitates the conformational maturation and function of a diverse protein clientele, including aberrant and/or over-expressed proteins that are involved in cancer growth and survival.  A role for Hsp90 in supporting the protein homeostasis of cancer cells has buoyed interest in the utility of Hsp90 inhibitors as anti-cancer drugs.  Despite the fact that all clinically evaluated Hsp90 inhibitors target an identical nucleotide-binding pocket in the N domain of the chaperone, the precise determinants that affect drug binding in the cellular environment remain unclear, and it is possible that chemically distinct inhibitors may not share similar binding preferences.  Here we demonstrate that two chemically unrelated Hsp90 inhibitors, the benzoquinone ansamycin geldanamycin and the purine analog PU-H71, select for overlapping but not identical subpopulations of total cellular Hsp90, even though both inhibitors bind to an amino terminal nucleotide pocket and prevent N domain dimerization.  Our data also suggest that PU-H71 is able to access a broader range of N domain undimerized Hsp90 conformations than is geldanamycin and is less affected by Hsp90 phosphorylation, consistent with its broader and more potent anti-tumor activity.  A more complete understanding of the impact of the cellular milieu on small molecule inhibitor binding to Hsp90 should facilitate their more effective use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLZ-jT50Ygfa91pGlMMoT5fW6udTcc2ebzNdTk8-h6c7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitVahsw%253D%253D&md5=1db8c9dca9517cd39a1b911107869582</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1099%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DScroggins%26aufirst%3DB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DTokita%26aufirst%3DM.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPullen%26aufirst%3DL.%26aulast%3DZierer%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26aulast%3DBolon%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DPosttranslational%2520modification%2520and%2520conformational%2520state%2520of%2520heat%2520shock%2520protein%252090%2520differentially%2520affect%2520binding%2520of%2520chemically%2520diverse%2520small%2520molecule%2520inhibitors%26jtitle%3DOncotarget%26date%3D2013%26volume%3D4%26spage%3D1065%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourboulia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodford, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chelluri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotooh-Abadi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetler-Stevenson, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bratslavsky, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1016%2Fj.molcel.2013.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=24462205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=317-329&author=M.+Mollapourauthor=D.+Bourbouliaauthor=K.+Beebeauthor=M.+R.+Woodfordauthor=S.+Polierauthor=A.+Hoangauthor=R.+Chelluriauthor=Y.+Liauthor=A.+Guoauthor=M.+J.+Leeauthor=E.+Fotooh-Abadiauthor=S.+Khanauthor=T.+Princeauthor=N.+Miyajimaauthor=S.+Yoshidaauthor=S.+Tsutsumiauthor=W.+Xuauthor=B.+Panaretouauthor=W.+G.+Stetler-Stevensonauthor=G.+Bratslavskyauthor=J.+B.+Trepelauthor=C.+Prodromouauthor=L.+Neckers&title=Asymmetric+Hsp90+N+domain+SUMOylation+recruits+Aha1+and+ATP-competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors</span></div><div class="casAuthors">Mollapour, Mehdi; Bourboulia, Dimitra; Beebe, Kristin; Woodford, Mark R.; Polier, Sigrun; Hoang, Anthony; Chelluri, Raju; Li, Yu; Guo, Ailan; Lee, Min-Jung; Fotooh-Abadi, Elham; Khan, Sahar; Prince, Thomas; Miyajima, Naoto; Yoshida, Soichiro; Tsutsumi, Shinji; Xu, Wanping; Panaretou, Barry; Stetler-Stevenson, William G.; Bratslavsky, Gennady; Trepel, Jane B.; Prodromou, Chrisostomos; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-329</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The stability and activity of numerous signaling proteins in both normal and cancer cells depends on the dimeric mol. chaperone heat shock protein 90 (Hsp90).  Hsp90's function is coupled to ATP binding and hydrolysis and requires a series of conformational changes that are regulated by cochaperones and numerous post-translational modifications (PTMs).  SUMOylation is one of the least-understood Hsp90 PTMs.  Here, we show that asym. SUMOylation of a conserved lysine residue in the N domain of both yeast (K178) and human (K191) Hsp90 facilitates both recruitment of the ATPase-activating cochaperone Aha1, and unexpectedly, the binding of Hsp90 inhibitors, suggesting that these drugs assoc. preferentially with Hsp90 proteins that are actively engaged in the chaperone cycle.  Importantly, cellular transformation is accompanied by elevated steady-state N domain SUMOylation, and increased Hsp90 SUMOylation sensitizes yeast and mammalian cells to Hsp90 inhibitors, providing a mechanism to explain the sensitivity of cancer cells to these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptnIeF9glnb7Vg90H21EOLACvtfcHk0lhtQJL0WItA-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kjtr8%253D&md5=a55d7b394c04a4d8a9a0fe0afd67a86d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DBourboulia%26aufirst%3DD.%26aulast%3DBeebe%26aufirst%3DK.%26aulast%3DWoodford%26aufirst%3DM.%2BR.%26aulast%3DPolier%26aufirst%3DS.%26aulast%3DHoang%26aufirst%3DA.%26aulast%3DChelluri%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DFotooh-Abadi%26aufirst%3DE.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DPrince%26aufirst%3DT.%26aulast%3DMiyajima%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DStetler-Stevenson%26aufirst%3DW.%2BG.%26aulast%3DBratslavsky%26aufirst%3DG.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DAsymmetric%2520Hsp90%2520N%2520domain%2520SUMOylation%2520recruits%2520Aha1%2520and%2520ATP-competitive%2520inhibitors%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D53%26spage%3D317%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0lhtQJL0WItA-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Cerchietti, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsikitas, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varticovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaknovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span> </span><span class="NLM_article-title">A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1369</span><span class="NLM_x">–</span> <span class="NLM_lpage">1376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnm.2059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=19966776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWksb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1369-1376&author=L.+C.+Cerchiettiauthor=E.+C.+Lopesauthor=S.+N.+Yangauthor=K.+Hatziauthor=K.+L.+Buntingauthor=L.+A.+Tsikitasauthor=A.+Mallikauthor=A.+I.+Roblesauthor=J.+Wallingauthor=L.+Varticovskiauthor=R.+Shaknovichauthor=K.+N.+Bhallaauthor=G.+Chiosisauthor=A.+Melnick&title=A+purine+scaffold+Hsp90+inhibitor+destabilizes+BCL-6+and+has+specific+antitumor+activity+in+BCL-6-dependent+B+cell+lymphomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas</span></div><div class="casAuthors">Cerchietti, Leandro C.; Lopes, Eloisi C.; Yang, Shao Ning; Hatzi, Katerina; Bunting, Karen L.; Tsikitas, Lucas A.; Mallik, Alka; Robles, Ana I.; Walling, Jennifer; Varticovski, Lyuba; Shaknovich, Rita; Bhalla, Kapil N.; Chiosis, Gabriela; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1369-1376</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors report that heat shock protein 90 (Hsp90) inhibitors selectively kill diffuse large B cell lymphomas (DLBCLs) that depend on the BCL-6 transcriptional repressor.  The authors found that endogenous Hsp90 interacts with BCL-6 in DLBCL cells and can stabilize BCL-6 mRNA and protein.  Hsp90 formed a complex with BCL-6 at its target promoters, and Hsp90 inhibitors derepressed BCL-6 target genes.  A stable mutant of BCL-6 rescued DLBCL cells from Hsp90 inhibitor-induced apoptosis.  BCL-6 and Hsp90 were almost invariantly coexpressed in the nuclei of primary DLBCL cells, suggesting that their interaction is relevant in this disease.  The authors examd. the pharmacokinetics, toxicity and efficacy of PU-H71, a recently developed purine-derived Hsp90 inhibitor.  PU-H71 preferentially accumulated in lymphomas compared to normal tissues and selectively suppressed BCL-6-dependent DLBCLs in vivo, inducing reactivation of key BCL-6 target genes and apoptosis.  PU-H71 also induced cell death in primary human DLBCL specimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQhx-_9IeVp7Vg90H21EOLACvtfcHk0lioDJFB9QjXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWksb3N&md5=5d6da58190e2418631034e71c8a5730e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnm.2059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2059%26sid%3Dliteratum%253Aachs%26aulast%3DCerchietti%26aufirst%3DL.%2BC.%26aulast%3DLopes%26aufirst%3DE.%2BC.%26aulast%3DYang%26aufirst%3DS.%2BN.%26aulast%3DHatzi%26aufirst%3DK.%26aulast%3DBunting%26aufirst%3DK.%2BL.%26aulast%3DTsikitas%26aufirst%3DL.%2BA.%26aulast%3DMallik%26aufirst%3DA.%26aulast%3DRobles%26aufirst%3DA.%2BI.%26aulast%3DWalling%26aufirst%3DJ.%26aulast%3DVarticovski%26aufirst%3DL.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DA%2520purine%2520scaffold%2520Hsp90%2520inhibitor%2520destabilizes%2520BCL-6%2520and%2520has%2520specific%2520antitumor%2520activity%2520in%2520BCL-6-dependent%2520B%2520cell%2520lymphomas%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D1369%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Breinig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas-Lopes, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goeppert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirmacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, M. A.</span><span> </span><span class="NLM_article-title">Targeting the heat shock protein Hsp90 with non-quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=102-112&author=M.+Breinigauthor=E.+M.+Caldas-Lopesauthor=B.+Goeppertauthor=M.+Malzauthor=F.+Bergmannauthor=R.+Riekerauthor=P.+Schirmacherauthor=G.+Chiosisauthor=M.+A.+Kern&title=Targeting+the+heat+shock+protein+Hsp90+with+non-quinone+inhibitors%3A+A+novel+chemotherapeutic+approach+in+human+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreinig%26aufirst%3DM.%26aulast%3DCaldas-Lopes%26aufirst%3DE.%2BM.%26aulast%3DGoeppert%26aufirst%3DB.%26aulast%3DMalz%26aufirst%3DM.%26aulast%3DBergmann%26aufirst%3DF.%26aulast%3DRieker%26aufirst%3DR.%26aulast%3DSchirmacher%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DKern%26aufirst%3DM.%2BA.%26atitle%3DTargeting%2520the%2520heat%2520shock%2520protein%2520Hsp90%2520with%2520non-quinone%2520inhibitors%253A%2520A%2520novel%2520chemotherapeutic%2520approach%2520in%2520human%2520hepatocellular%2520carcinoma%26jtitle%3DHepatology%26date%3D2009%26volume%3D50%26spage%3D102%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Caldas-Lopes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Stanchina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varticovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">8368</span><span class="NLM_x">–</span> <span class="NLM_lpage">8373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=8368-8373&author=E.+Caldas-Lopesauthor=L.+Cerchiettiauthor=J.+H.+Ahnauthor=C.+C.+Clementauthor=A.+I.+Roblesauthor=A.+Rodinaauthor=K.+Moulickauthor=T.+Taldoneauthor=A.+Gozmanauthor=Y.+Guoauthor=N.+Wuauthor=E.+de+Stanchinaauthor=J.+Whiteauthor=S.+S.+Grossauthor=Y.+Maauthor=L.+Varticovskiauthor=A.+Melnickauthor=G.+Chiosis&title=Hsp90+inhibitor+PU-H71%2C+a+multimodal+inhibitor+of+malignancy%2C+induces+complete+responses+in+triple-negative+breast+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaldas-Lopes%26aufirst%3DE.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DRobles%26aufirst%3DA.%2BI.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DGozman%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3Dde%2BStanchina%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DS.%2BS.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DVarticovski%26aufirst%3DL.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHsp90%2520inhibitor%2520PU-H71%252C%2520a%2520multimodal%2520inhibitor%2520of%2520malignancy%252C%2520induces%2520complete%2520responses%2520in%2520triple-negative%2520breast%2520cancer%2520models%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D8368%26epage%3D8373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodsky, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Selective compounds define Hsp90 as a major inhibitor of apoptosis in small cell lung cancer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=10.1038%2Fnchembio.2007.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=17603540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFaru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=498-507&author=A.+Rodinaauthor=M.+Vilenchikauthor=K.+Moulickauthor=J.+Aguirreauthor=J.+Kimauthor=A.+Chiangauthor=J.+Litzauthor=C.+C.+Clementauthor=Y.+Kangauthor=Y.+Sheauthor=N.+Wuauthor=S.+Feltsauthor=P.+Wipfauthor=J.+Massagueauthor=X.+Jiangauthor=J.+L.+Brodskyauthor=G.+W.+Krystalauthor=G.+Chiosis&title=Selective+compounds+define+Hsp90+as+a+major+inhibitor+of+apoptosis+in+small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer</span></div><div class="casAuthors">Rodina, Anna; Vilenchik, Maria; Moulick, Kamalika; Aguirre, Julia; Kim, Joungnam; Chiang, Anne; Litz, Julie; Clement, Cristina C.; Kang, Yanlong; She, Yuhong; Wu, Nian; Felts, Sara; Wipf, Peter; Massague, Joan; Jiang, Xuejun; Brodsky, Jeffrey L.; Krystal, Geoffrey W.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">498-507</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The heat shock protein 90 (Hsp90) has a crit. role in malignant transformation.  Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood.  By using selective compds., the authors the authors have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90.  Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled.  These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZlX5SIced7Vg90H21EOLACvtfcHk0lioDJFB9QjXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFaru78%253D&md5=79f2a09bca626726b09895f80c40f001</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2007.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2007.10%26sid%3Dliteratum%253Aachs%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DA.%26aulast%3DLitz%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DMassague%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DBrodsky%26aufirst%3DJ.%2BL.%26aulast%3DKrystal%26aufirst%3DG.%2BW.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DSelective%2520compounds%2520define%2520Hsp90%2520as%2520a%2520major%2520inhibitor%2520of%2520apoptosis%2520in%2520small%2520cell%2520lung%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D498%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structure of unliganded GRP94, the endoplasmic reticulum Hsp90. Basis for nucleotide-induced conformational change</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">30438</span><span class="NLM_x">–</span> <span class="NLM_lpage">30447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30438-30447&author=D.+E.+Dollinsauthor=R.+M.+Immorminoauthor=D.+T.+Gewirth&title=Structure+of+unliganded+GRP94%2C+the+endoplasmic+reticulum+Hsp90.+Basis+for+nucleotide-induced+conformational+change"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520of%2520unliganded%2520GRP94%252C%2520the%2520endoplasmic%2520reticulum%2520Hsp90.%2520Basis%2520for%2520nucleotide-induced%2520conformational%2520change%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30438%26epage%3D30447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span> </span><span class="NLM_article-title">Development and testing of the OPLS-All Atom force field on conformational energetics and properties of organic liquids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">11225</span><span class="NLM_x">–</span> <span class="NLM_lpage">11236</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9621760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=11225-11236&author=W.+L.+Jorgensenauthor=D.+Maxwellauthor=J.+Tirado-Rives&title=Development+and+testing+of+the+OPLS-All+Atom+force+field+on+conformational+energetics+and+properties+of+organic+liquids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fja9621760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9621760%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMaxwell%26aufirst%3DD.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520the%2520OPLS-All%2520Atom%2520force%2520field%2520on%2520conformational%2520energetics%2520and%2520properties%2520of%2520organic%2520liquids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D11225%26epage%3D11236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lhPLqoDyrKW_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span> </span><span class="NLM_article-title">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1750</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+A+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lhPLqoDyrKW_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520A%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaushik-Basu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talele, T. T.</span><span> </span><span class="NLM_article-title">3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700266z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWgu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=42-55&author=P.+D.+Patelauthor=M.+R.+Patelauthor=N.+Kaushik-Basuauthor=T.+T.+Talele&title=3D+QSAR+and+molecular+docking+studies+of+benzimidazole+derivatives+as+hepatitis+C+virus+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">3D QSAR and Molecular Docking Studies of Benzimidazole Derivatives as Hepatitis C Virus NS5B Polymerase Inhibitors</span></div><div class="casAuthors">Patel, Pallav D.; Patel, Maulik R.; Kaushik-Basu, Neerja; Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-55</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The urgent need for novel HCV antiviral agents has provided an impetus for understanding the structural requisites of NS5B polymerase inhibitors at the mol. level.  Toward this objective, comparative mol. field anal. (CoMFA) and comparative mol. similarity indexes anal. (CoMSIA) of 67 HCV NS5B polymerase inhibitors were performed using two methods.  First, ligand-based 3D QSAR studies were performed based on the lowest energy conformations employing the atom fit alignment method.  Second, receptor-based 3D QSAR models were derived from the predicted binding conformations obtained by docking all NS5B inhibitors at the allosteric binding site of NS5B (PDB ID: 2dxs).  Results generated from the ligand-based model were found superior (r2cv values of 0.630 for CoMFA and 0.668 for CoMSIA) to those obtained by the receptor-based model (r2cv values of 0.536 and 0.561 for CoMFA and CoMSIA, resp.).  The predictive ability of the models was validated using a structurally diversified test set of 22 compds. that had not been included in a preliminary training set of 45 compds.  The predictive r2 values for the ligand-based CoMFA and CoMSIA models were 0.734 and 0.800, resp., while the corresponding predictive r2 values for the receptor-based CoMFA and CoMSIA models were 0.538 and 0.639, resp.  The greater potency of the tryptophan derivs. over that of the tyrosine derivs. was interpreted based on CoMFA steric and electrostatic contour maps.  The CoMSIA results revealed that for a NS5B inhibitor to have appreciable inhibitory activity it requires hydrogen bond donor and acceptor groups at the 5-position of the indole ring and an R substituent at the chiral carbon, resp.  Interpretation of the CoMFA and CoMSIA contour maps in context of the topol. of the allosteric binding site of NS5B provided insight into NS5B-inhibitor interactions.  Taken together, the present 3D QSAR models were found to accurately predict the HCV NS5B polymerase inhibitory activity of structurally diverse test set compds. and to yield reliable clues for further optimization of the benzimidazole derivs. in the data set.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHU3VUoaMP-LVg90H21EOLACvtfcHk0lhbw_iLY0Te4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWgu7zL&md5=3cfac0244f3b6447997dd97626fdc7c2</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fci700266z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700266z%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DKaushik-Basu%26aufirst%3DN.%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3D3D%2520QSAR%2520and%2520molecular%2520docking%2520studies%2520of%2520benzimidazole%2520derivatives%2520as%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D42%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD','PDB','2GFD'); return false;">PDB: 2GFD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS','PDB','2FXS'); return false;">PDB: 2FXS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F','PDB','3O2F'); return false;">PDB: 3O2F</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i106"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00197">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87817"></div></div></div></div></div><hr /></hr><p class="last">Experimental details for the synthesis of <b>18g</b> and Figures S1–S4. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00197/suppl_file/jm5b00197_si_001.pdf">jm5b00197_si_001.pdf (1.04 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-9%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00197%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00197" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990126dceb3da0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
